"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_MEYER",2000,24,5.625,3.41666666666667,0.75,0.5,0.75,1.35,1.05882352941176,1.33333333333333,1.05882352941176,0.208333333333333,1,11,6,0,7,0.46,0.25,0,0.29,38.33,0.845632177934833,NA,0.208333333333333,0.541666666666667,0.417,0.221,0.268,0.221,"A VIERUCCI;GIANPAOLO DONZELLI;ELIO NOVEMBRE;NERI PUCCI;ENRICO LOMBARDI;SIMONE PRATESI;PAOLO LIONETTI;MARCO CALAMANDREI;MARIA MORIONDO;R. BERNARDINI;CHIARA AZZARI;ELISABETTA PASQUINI;LAWRENCE FAULKNER;MARIA ALICE DONATI;ROBERTO FERRARI;MASSIMO RESTI;ANDREA MESSERI;ENRICO ZAMMARCHI;GIOVANNI MARIA POGGI;F. CIANI","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GIANPAOLO DONZELLI;SIMONE PRATESI;ERIK BONTEN;MARCO CALAMANDREI;ANDREA MESSERI;A VIERUCCI;CHRISTIAN NÉRI;I GHINI;ELIO NOVEMBRE;NERI PUCCI;ENRICO LOMBARDI;ELISABETTA PASQUINI;MARIA ALICE DONATI;ENRICO ZAMMARCHI;GIOVANNI MARIA POGGI;F. CIANI;PAOLO LIONETTI;MURGANIC;MARIA MORIONDO;CHIARA AZZARI","1.25;1;1;0.75;0.75;0.62;0.5;0.5;0.43;0.43;0.43;0.34;0.34;0.34;0.34;0.34;0.33;0.33;0.33;0.33","A VIERUCCI;GIANPAOLO DONZELLI;ELIO NOVEMBRE;NERI PUCCI;ENRICO LOMBARDI;SIMONE PRATESI;PAOLO LIONETTI;MARCO CALAMANDREI;MARIA MORIONDO;R. BERNARDINI;CHIARA AZZARI;ELISABETTA PASQUINI;LAWRENCE FAULKNER;MARIA ALICE DONATI;ROBERTO FERRARI;MASSIMO RESTI;ANDREA MESSERI;ENRICO ZAMMARCHI;GIOVANNI MARIA POGGI;F. CIANI","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GIANPAOLO DONZELLI;SIMONE PRATESI;ERIK BONTEN;MARCO CALAMANDREI;ANDREA MESSERI;A VIERUCCI;I GHINI;ELIO NOVEMBRE;NERI PUCCI;ENRICO LOMBARDI;ELISABETTA PASQUINI;MARIA ALICE DONATI;ENRICO ZAMMARCHI;GIOVANNI MARIA POGGI;F. CIANI;PAOLO LIONETTI;MARIA MORIONDO;CHIARA AZZARI;B ABBATE;MASSIMO RESTI","1.25;1;1;0.75;0.75;0.62;0.5;0.43;0.43;0.43;0.34;0.34;0.34;0.34;0.34;0.33;0.33;0.33;0.33;0.33","A VIERUCCI;CHRISTIANE GOERKE;CHRISTIANE WOLZ;GERD DÖRING;K BOTZENHART;MANFRED G. BAYER;SILVIA CAMPANA;ERIK BONTEN;LAWRENCE FAULKNER;A. E. G. KR. VON DEM BORNE;CLAUDIA C. FOLMAN;MARJOLEIN PETERS;MARRIE C.A. BRUIN;MASJA DE HAAS;SONJA VAN DEN OUDENRIJN;ROBERTO FERRARI;FERNANDA FALCINI;FRANCESCA GRISOLIA;GABRIELE SIMONINI;GIOVAN BATTISTA CALABRI","204;204;204;204;204;204;204;140;139;125;125;125;125;125;125;124;112;112;112;112","A VIERUCCI;SILVIA CAMPANA;ERIK BONTEN;LAWRENCE FAULKNER;ROBERTO FERRARI;FERNANDA FALCINI;FRANCESCA GRISOLIA;GABRIELE SIMONINI;GIOVAN BATTISTA CALABRI;CHIARA AZZARI;MARIA MORIONDO;MASSIMO RESTI;PAOLO LIONETTI;ELIO NOVEMBRE;ENRICO LOMBARDI;NERI PUCCI;ELISABETTA ROSSI;ROBERTO BERNARDINI;SILVIA FARIÑA;TANIA FAVILLI","204;204;140;139;124;112;112;112;112;109;109;109;109;95;95;95;76;76;76;76","A VIERUCCI;ELIO NOVEMBRE;ENRICO LOMBARDI;NERI PUCCI;ROBERTO FERRARI;CHIARA AZZARI;ELISABETTA PASQUINI;ENRICO ZAMMARCHI;GIOVANNI MARIA POGGI;LAWRENCE FAULKNER;MARIA ALICE DONATI;MARIA MORIONDO;MASSIMO RESTI;PAOLO LIONETTI;R. BERNARDINI;SIMONE PRATESI;ALBERTO GARAVENTA;ANDREA MESSERI;ANGELA TAMBURINI;ANNA INGARGIOLA","5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","MEDICINE;BIOLOGY;ENGINEERING;CHEMISTRY;MATHEMATICS;PHILOSOPHY;PHYSICS","21;10;4;2;1;1;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;SURGERY;PEDIATRICS;ANESTHESIA;BIOCHEMISTRY;ELECTRICAL ENGINEERING;PATHOLOGY;VIROLOGY;GASTROENTEROLOGY;MICROBIOLOGY;PSYCHIATRY;AEROSPACE ENGINEERING;ANATOMY;CANCER RESEARCH;DERMATOLOGY;EMERGENCY MEDICINE;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;FISHERY;GENERAL SURGERY;INTENSIVE CARE MEDICINE;LINGUISTICS;OPTICS;ORGANIC CHEMISTRY;PHYSIOLOGY;STATISTICS","11;9;9;6;5;4;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GENE;ALLERGY;PREGNANCY;VIRUS;ANTIBODY;BACTERIA;BONE MARROW;BRACHIAL PLEXUS;CATHETER;CYSTIC FIBROSIS;DISEASE;HEPATITIS C;IN VITRO;MALABSORPTION;NEUROLOGY;PERCUTANEOUS;PERIPHERAL;STEM CELL;THROMBOSIS;TRANSMISSION (TELECOMMUNICATIONS);VEIN;VITAMIN B12","5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AXILLARY VEIN;BRACHIAL PLEXUS BLOCK;CD34;CLINICAL IMMUNOLOGY;HAEMATOPOIESIS;HEPATITIS C VIRUS;METHYLMALONIC ACID;MUTATION;OFFSPRING;PERIPHERAL BLOOD MONONUCLEAR CELL;STAPHYLOCOCCUS AUREUS;VIRAL LOAD;VIREMIA;ANISAKIS;ANISAKIS SIMPLEX;ANTIBIOTIC RESISTANCE;BURKHOLDERIA;CATHEPSIN;COLONISATION RESISTANCE;DERMATOLOGY LIFE QUALITY INDEX;DWARFISM;EOSINOPHIL;EXOCRINE PANCREATIC INSUFFICIENCY;GENE EXPRESSION;GESTATIONAL AGE;HEPATITIS A;HEPATITIS A VIRUS;HEPATITIS VIRUS;IMMUNOGLOBULIN E;INSERTION TIME;JUVENILE RHEUMATOID ARTHRITIS;KETONURIA;LYSOSOMAL STORAGE DISEASE;LYSOSOME;MACROCYTIC ANEMIA;MEGALOBLASTIC ANEMIA;METHIONINE;MINIMAL RESIDUAL DISEASE;MUTANT;MUTASE;NEURAMINIDASE;NEUROBLASTOMA;NEURORADIOLOGY;OSTEOARTHRITIS;OXYGEN SATURATION;PHENOTYPE;POSTOPERATIVE NAUSEA AND VOMITING;PSEUDOMONAS AERUGINOSA;PULSE (MUSIC);RESPIRATORY TRACT;RESPIRATORY TRACT INFECTIONS;SUBCLAVIAN VEIN;VIRULENCE","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HEPACIVIRUS;METHYLMALONIC ACIDURIA;BONE MARROW FAILURE;CARTILAGE OLIGOMERIC MATRIX PROTEIN;CATHEPSIN A;EOSINOPHIL CATIONIC PROTEIN;FACIAL DYSMORPHISM;HOMOCYSTINURIA;LEUKAPHERESIS;MEGAKARYOCYTE;REGULON;SCORAD;SIALIDASE;THROMBOPOIETIN","2;2;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;CHILD;CHILD, PRESCHOOL;FEMALE;INFANT;ADOLESCENT;INFANT, NEWBORN;NEUROBLASTOMA;CYSTIC FIBROSIS;DERMATITIS, ATOPIC;DWARFISM;INFANT, PREMATURE, DISEASES;MUCOLIPIDOSES;RNA, MESSENGER;BONE MARROW NEOPLASMS;IMMUNOGLOBULIN E;METHYLMALONIC ACID;NEURAMINIDASE;AMINO ACID SUBSTITUTION","22;12;11;10;10;10;8;8;7;6;5;5;5;5;5;4;4;4;4;3","HEPATITIS C INFECTION AND TREATMENT;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;PERIOPERATIVE CARDIAC RISK ASSESSMENT AND MANAGEMENT;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ATOPIC DERMATITIS AND SKIN MICROBIOME;BIOMEDICAL OPTICAL IMAGING AND SPECTROSCOPY;ECOLOGICAL INTERACTIONS OF PARASITES IN ECOSYSTEMS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;HEPATITIS E INFECTION AND TREATMENT;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND PATHOPHYSIOLOGY OF TRAUMATIC BRAIN INJURY;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS;MOYAMOYA DISEASE AND SYNDROME;NEUROBLASTOMA RESEARCH AND TREATMENT;PEDIATRIC URINARY TRACT INFECTIONS;PLATELET DISORDERS AND THROMBOSIS MECHANISMS","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AXILLARY VEIN;BRACHIAL PLEXUS BLOCK;CENTRAL VENOUS CATHETERIZATION;CLINICAL IMMUNOLOGY;CYSTIC FIBROSIS;HBV INFECTION;HEPATITIS C;INBORN ERRORS OF METABOLISM;METHYLMALONIC ACIDURIA;PERIPHERALLY INSERTED CENTRAL CATHETERS;VIREMIA;ABUSIVE HEAD TRAUMA;ANISAKIS;ANISAKIS SIMPLEX;BILIRUBIN MEASUREMENT;BONE MARROW FAILURE;BRAIN OXYGENATION MONITORING;CATHEPSIN A;CELL DEATH;CEREBRAL BLOOD FLOW MEASUREMENT","2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","BLOOD MONONUCLEAR;CELL INFECTION;CYSTIC FIBROSIS;MATERNAL PERIPHERAL;METHYLMALONIC ACIDURIA;MONONUCLEAR CELL;PERIPHERAL BLOOD;VERTICAL TRANSMISSION;ACIDURIA DUE;ACUTE ONSET;AMEGAKARYOCYTIC THROMBOCYTOPENIA;ANISAKIS SIMPLEX;ANTI-HAV ANTIBODIES;ANTIBODIES HEPATITIS;ATOPIC DERMATITIS;AXILLARY BLOCK;BACTERIAL INFECTIONS;BRACHIAL PLEXUS;CATIONIC PROTEIN;CBLB METHYLMALONIC;CELL SORTINGENHANCED;CENTRAL VENOUS;CEPHALOSKELETAL DYSPLASIA;CEREBRAL OXYGENATION;CHILDREN CONSIDERATIONS;CHILDREN IMPORTANCE;CLINICAL SEVERITY;COATED MICROSPHERE;COMMON PAEDIATRIC;CONGENITAL AMEGAKARYOCYTIC","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CLINICAL IMMUNOLOGY;FAX NA;GIORDANO FLORENCEITALYTEL;HOSPITALVIA LUCA;IMMUNOLOGY UNITDEPARTMENT;LUCA GIORDANO;MEYER HOSPITALVIA;PEDIATRICSANNA MEYER;SEARCH NA;BONE MARROW;ALLERGY CLIN;AMINO ACID;AUTHORA VIERUCCI;AUTHORE LOMBARDI;AUTHORE NOVEMBRE;AUTHORN PUCCI;BERNARDINI ALLERGY;CATALYTICALLY INACTIVE;CLIN IMMUNOL;CLINICAL SEVERITY;FULL-TEXT VERSION;LOMBARDI ALLERGY;MEGAKARYOCYTE FORMATION;NOVEMBRE ALLERGY;PUCCI ALLERGY;ROSSI ALLERGY;SKIN TESTS;STEM CELLS;TYPE II;U-EPX LEVELS","12;12;12;12;12;12;12;12;12;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",7,0.29,3.25,2.5,2,0,0,0,7.75,0,1,2.5,0,0,0,0,1.75,0,0,0,0,0,0,57,57.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2001,12,8.41666666666667,2.91666666666667,0.333333333333333,0.333333333333333,0.333333333333333,1.66666666666667,1,2,1,0.5,1,7,4,0,1,0.58,0.33,0,0.08,48.17,1.05414983833293,NA,0.333333333333333,0.833333333333333,0.442,0.061,0,0.061,"ELIO NOVEMBRE;ENRICO LOMBARDI;A VIERUCCI;R. BERNARDINI;ENRICO ZAMMARCHI;ANTONELLA CIANFERONI;KIRSTEN STAFFORD;ROSELLA FULCERI;ANGELO BENEDETTI;MASSIMO RESTI;NERI PUCCI;ROSANNA LEUZZI;PAOLA MARCOLONGO;GÁBOR BÁNHEGYI;ANN N. BURCHELL;LUCIANA CAENAZZO;AMELIA MORRONE;G. CONCUTELLI;FABRIZIO BARBETTI;FLAVIA BORTOLOTTI","4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","ENRICO LOMBARDI;ELIO NOVEMBRE;A VIERUCCI;R. BERNARDINI;ENRICO ZAMMARCHI;ANTONELLA CIANFERONI;NERI PUCCI;KIRSTEN STAFFORD;ROSELLA FULCERI;ANGELO BENEDETTI;ROSANNA LEUZZI;PAOLA MARCOLONGO;GÁBOR BÁNHEGYI;ANN N. BURCHELL;MASSIMO RESTI;AMELIA MORRONE;MARIA MORIONDO;CHIARA AZZARI;ELISABETTA PASQUINI;MARIA ALICE DONATI","1.43;0.58;0.58;0.42;0.39;0.31;0.31;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.22;0.14;0.14;0.14;0.14;0.14","ELIO NOVEMBRE;ENRICO LOMBARDI;A VIERUCCI;R. BERNARDINI;ENRICO ZAMMARCHI;ANTONELLA CIANFERONI;MASSIMO RESTI;NERI PUCCI;G. CONCUTELLI;MARIA MORIONDO;PETER D. SLY;SONIA TONI;U. RICCI;G VENERUSO;ELEONORA GAMBINERI;MARIA DOMENICA CAPPELLINI;CLAUDIO FONDA;LUCA MUGNAINI;GIOVANNI FRONGIA;MARIA ELISABETTA ROSSI","4;4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","ENRICO LOMBARDI;ELIO NOVEMBRE;A VIERUCCI;R. BERNARDINI;ENRICO ZAMMARCHI;ANTONELLA CIANFERONI;NERI PUCCI;MASSIMO RESTI;MARIA MORIONDO;ELEONORA GAMBINERI;MARIA DOMENICA CAPPELLINI;CLAUDIO FONDA;LUCA MUGNAINI;MARIA ELISABETTA ROSSI;ROBERTO BERNARDINI;G. CONCUTELLI;PETER D. SLY;G VENERUSO;GIOVANNI FRONGIA;SONIA TONI","1.43;0.58;0.58;0.42;0.39;0.31;0.31;0.22;0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.12;0.12;0.12;0.12;0.08","ENRICO LOMBARDI;A VIERUCCI;ELIO NOVEMBRE;ANTONELLA CIANFERONI;NERI PUCCI;R. BERNARDINI;ANDREA CAUMO;ANTONIO L. CUESTA‐MUÑOZ;DARIO IAFUSCO;F CERUTTI;FABRIZIO BARBETTI;FRANCO MESCHI;FRANZ M. MATSCHINSKY;LAURA GUAZZAROTTI;N. SULLI;ORNELLA MASSA;RENATA LORINI;SONIA TONI;VALENTINO CHERUBINI;LUCA MUGNAINI","344;264;263;240;240;137;135;135;135;135;135;135;135;135;135;135;135;135;135;118","ENRICO LOMBARDI;A VIERUCCI;ELIO NOVEMBRE;NERI PUCCI;R. BERNARDINI;SONIA TONI;ANTONELLA CIANFERONI;LUCA MUGNAINI;ROBERTO BERNARDINI;ENRICO ZAMMARCHI;U. RICCI;CLAUDIO FONDA;MARIA DOMENICA CAPPELLINI;G VENERUSO;G. CONCUTELLI;GIOVANNI FRONGIA;PETER D. SLY;MASSIMO RESTI;ELEONORA GAMBINERI;MARIA ELISABETTA ROSSI","344;263;263;240;137;135;122;118;118;38;24;23;23;14;14;14;14;13;9;9","A VIERUCCI;ELIO NOVEMBRE;ENRICO LOMBARDI;R. BERNARDINI;ENRICO ZAMMARCHI;MASSIMO RESTI;NERI PUCCI;ANTONELLA CIANFERONI;CLAUDIO FONDA;ELEONORA GAMBINERI;G VENERUSO;G. CONCUTELLI;GIOVANNI FRONGIA;LUCA MUGNAINI;MARIA DOMENICA CAPPELLINI;MARIA ELISABETTA ROSSI;MARIA MORIONDO;PETER D. SLY;ROBERTO BERNARDINI;SONIA TONI","4;4;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;ENGINEERING;PHILOSOPHY","9;4;3;1;1","INTERNAL MEDICINE;IMMUNOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PEDIATRICS;ENVIRONMENTAL HEALTH;DERMATOLOGY;CHROMATOGRAPHY;ELECTRICAL ENGINEERING;EPISTEMOLOGY;GENETICS;PSYCHIATRY;RADIOLOGY;VIROLOGY","9;5;4;4;4;3;2;1;1;1;1;1;1;1","ASTHMA;ALLERGY;GENE;INSULIN;POPULATION;ANTIBODY;ENDOPLASMIC RETICULUM;ENZYME;EPINEPHRINE;GLYCOGEN;RETROSPECTIVE COHORT STUDY;VIRUS;ANGIOEDEMA;ANTIHISTAMINE;ATOPIC DERMATITIS;DIABETES MELLITUS;DNA;EMERGENCY DEPARTMENT;EPIDEMIOLOGY;FORENSIC SCIENCE;GENERAL HOSPITAL;HEPATITIS C;HUMAN IMMUNODEFICIENCY VIRUS (HIV);INBORN ERROR OF METABOLISM;MAGNETIC RESONANCE IMAGING;MECHANISM (BIOLOGY);NATURAL HISTORY;OBESITY;SAMPLE (MATERIAL);TRANSMISSION (TELECOMMUNICATIONS)","4;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AIRWAY RESISTANCE;ANAPHYLAXIS;GLUCOSE 6-PHOSPHATASE;GLUCOSE 6-PHOSPHATE;GLUCOSE TRANSPORTER;GLYCOGEN STORAGE DISEASE;HEXOSE;MICROSOME;PHOSPHATASE;WHEEZE;ALLELE;ATOPY;CLINICAL IMMUNOLOGY;COINFECTION;DNA PROFILING;GENOTYPE;GLUCOKINASE;HEPATITIS C VIRUS;IMMUNOGLOBULIN E;IMMUNOGLOBULIN G;INSULIN RESISTANCE;MUTATION;OVERWEIGHT;TYPE 2 DIABETES;WHITE MATTER;Y CHROMOSOME","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GLYCOGEN STORAGE DISEASE TYPE I;GLUCOSE TOLERANCE TEST;HAPLOTYPE;IMPAIRED GLUCOSE TOLERANCE;MATURITY ONSET DIABETES OF THE YOUNG;MICROSATELLITE;MISSENSE MUTATION;PREDIABETES;TORQUE TENO VIRUS","2;1;1;1;1;1;1;1;1","HUMANS;HYPERSENSITIVITY;MALE;ANAPHYLAXIS;CHILD;CHILD, PRESCHOOL;DERMATITIS, ATOPIC;DIABETES MELLITUS, TYPE 2;FEMALE;FIBROBLASTS;;ANTIPORTERS;ASTHMA;DIABETES MELLITUS;GLUCOSE-6-PHOSPHATASE;GLYCOGEN STORAGE DISEASE TYPE I;IMMUNOGLOBULINS, INTRAVENOUS;IMMUNOLOGIC DEFICIENCY SYNDROMES;INSULIN;ITALY","9;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","ASTHMA;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;ATOPIC DERMATITIS AND SKIN MICROBIOME;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF URTICARIA;GENOMIC ANALYSIS OF ANCIENT DNA;HEPATITIS C INFECTION AND TREATMENT;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;PANCREATIC ISLET DYSFUNCTION AND REGENERATION;VIRAL DISEASES IN LIVESTOCK AND POULTRY","2;2;1;1;1;1;1;1;1;1","GLUCOSE 6-PHOSPHATASE;GLUCOSE 6-PHOSPHATE;GLUCOSE-6-PHOSPHATASE SYSTEM;GLYCOGEN STORAGE DISEASES;HEXOSE;METABOLISM;RESPIRATORY;WHEEZE;ALLERGEN-SPECIFIC IMMUNOTHERAPY;ANAPHYLAXIS;ATOPY;CLINICAL IMMUNOLOGY;DIAGNOSIS;DNA PROFILING;GENERAL HOSPITAL;GLUCOKINASE;GLUCOSE TOLERANCE TEST;HEPATITIS C;HEPATITIS C VIRUS;INBORN ERRORS OF METABOLISM","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","GLUCOSE -PHOSPHATE;PHOSPHATE TRANSPORT;DISEASE TYPE;FIBROBLAST MICROSOMES;GLYCOGEN STORAGE;HEALTHY PRESCHOOL;INTERRUPTER RESPIRATORY;ITALIAN CHILDREN;MULTIPLE GLUCOSE;PATIENTS EVIDENCE;PRESCHOOL WHITE;REFERENCE VALUES;RESPIRATORY RESISTANCE;STORAGE DISEASE;TRANSPORT SYSTEMS;WHITE CHILDREN;ACUTE ANAPHYLAXIS;ATOPIC DERMATITIS;CLINICAL FEATURES;COLLABORATIVE DATABASE;EPIDEMIOLOGICAL SURVEY;FIRST-PHASE INSULIN;GEFI COLLABORATIVE;GLUCOKINASE MUTATIONS;GLUCOSE TOLERANCE;HMGCL GENE;HYDROXY--METHYLGLUTARIC ACIDURIA;INSULIN RESPONSE;INSULIN SENSITIVITY;INTRINSIC ATOPIC","4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANNA MEYER;CLINICAL IMMUNOLOGY;FAX NA;FLORENCE ITALYTEL;GIORDANO FLORENCE;IMMUNOLOGY UNIT;LUCA GIORDANO;MEYER HOSPITAL;PEDIATRICS ANNA;SEARCH NA;UNIT DEPARTMENT;ATOPIC DERMATITIS;LUNG FUNCTION;GLUCOSE TOLERANCE;PRESCHOOL CHILDREN;AGE HEIGHT;INDEPENDENTLY CORRELATED;REFERENCE RINT;RINT MEASUREMENTS;RINT VALUES;SHORT TERM;TERM REPEATABILITY;TTV INFECTION;WHITE CHILDREN;GLUCOSE -PHOSPHATE;AGE RANGE;AIRWAY COMPLIANCE;ALLERGY DOI;ASSESSING LUNG;AUTHORA CIANFERONI","12;12;12;12;12;12;12;12;12;12;12;6;6;5;5;4;4;4;4;4;4;4;4;4;3;2;2;2;2;2",1,0.08,3,1,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,49,49,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2002,38,7.73684210526316,2.55263157894737,0.578947368421053,0.210526315789474,0.578947368421053,1.24675324675325,1,1.14285714285714,1,0.394736842105263,2,13,7,6,9,0.34,0.18,0.16,0.24,55.92,1.01363711618412,NA,0.210526315789474,0.710526315789474,0.452,0.176,0.382,0.187,"ENRICO ZAMMARCHI;MARIA ALICE DONATI;AMELIA MORRONE;ELIO NOVEMBRE;BRUNO NOCCIOLI;ROSSELLA PARINI;MARCO MARTINUCCI;SALVATORE SEMINARA;CHIARA AZZARI;ROBERTO CAPUTO;SILVIA PANCANI;ELISABETTA PASQUINI;STEFANO STAGI;ANDREA BIONDI;ANNA CACIOTTI;F PAMPALONI;A PAMPALONI;NERI PUCCI;P BUSONI;N CENTONZE","7;6;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ENRICO ZAMMARCHI;PAOLO LIONETTI;JOHN OLDHAM;MARIA ALICE DONATI;P BUSONI;AMELIA MORRONE;N CENTONZE;LEONARDO BUSSOLIN;DANIELA CODRICH;ANTONIO MESSINEO;A BAGGIANI;F FABBRINI;BRUNO NOCCIOLI;ANNA CACIOTTI;ELIO NOVEMBRE;B ABBATE;DANTI DA;SILVIA PANCANI;ROSSELLA PARINI;PATRIZIO FIORINI","1.13;1;1;0.74;0.67;0.64;0.53;0.5;0.5;0.5;0.5;0.5;0.42;0.4;0.38;0.33;0.33;0.32;0.31;0.29","ENRICO ZAMMARCHI;MARIA ALICE DONATI;AMELIA MORRONE;ELIO NOVEMBRE;BRUNO NOCCIOLI;MARCO MARTINUCCI;CHIARA AZZARI;ROBERTO CAPUTO;ELISABETTA PASQUINI;ANNA CACIOTTI;F PAMPALONI;P BUSONI;A. LIPPI;A VIERUCCI;PATRIZIO FIORINI;IACOPO SARDI;RAFFAELE PIUMELLI;PAOLO LIONETTI;DANTE ALFREDO DANTI;RAFFAELLA BLOISE","7;6;4;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","ENRICO ZAMMARCHI;PAOLO LIONETTI;JOHN OLDHAM;MARIA ALICE DONATI;P BUSONI;AMELIA MORRONE;LEONARDO BUSSOLIN;ANTONIO MESSINEO;A BAGGIANI;BRUNO NOCCIOLI;ANNA CACIOTTI;ELIO NOVEMBRE;B ABBATE;PATRIZIO FIORINI;A VIERUCCI;F PAMPALONI;MARIA DOMENICA CAPPELLINI;ELISABETTA PASQUINI;ROBERTO CAPUTO;MARCO MARTINUCCI","1.13;1;1;0.74;0.67;0.64;0.5;0.5;0.5;0.42;0.4;0.38;0.33;0.29;0.27;0.25;0.25;0.24;0.24;0.22","ABRAHAM BENATAR;ANGELICA BIBIANA DELOGU;BARBARA COLOMBI;CARLO NAPOLITANO;FABRIZIO DRAGO;FERNANDO COLTORTI;FERNANDO E. S. CRUZ FILHO;GABRIELE VIGNATI;LUCIANO DESIMONE;MAURIZIO GASPARINI;MIRELLA MEMMI;RAFFAELLA BLOISE;ROBERTO KEEGAN;SILVIA G. PRIORI;ENRICO ZAMMARCHI;MARIA ALICE DONATI;ALI NAINI;ANTONELLA SPINAZZOLA;ANTONI L. ANDREU;ICHIZO NISHINO","1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;371;351;227;227;227;227","ABRAHAM BENATAR;ANGELICA BIBIANA DELOGU;BARBARA COLOMBI;CARLO NAPOLITANO;FABRIZIO DRAGO;FERNANDO COLTORTI;FERNANDO E. S. CRUZ FILHO;GABRIELE VIGNATI;LUCIANO DESIMONE;MAURIZIO GASPARINI;MIRELLA MEMMI;RAFFAELLA BLOISE;ROBERTO KEEGAN;SILVIA G. PRIORI;ENRICO ZAMMARCHI;MARIA ALICE DONATI;ALI NAINI;ANTONELLA SPINAZZOLA;ANTONI L. ANDREU;ICHIZO NISHINO","1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;1131;371;351;227;227;227;227","ENRICO ZAMMARCHI;MARIA ALICE DONATI;AMELIA MORRONE;ANNA CACIOTTI;BRUNO NOCCIOLI;ELISABETTA PASQUINI;P BUSONI;ROBERTO CAPUTO;A VIERUCCI;A. LIPPI;ABRAHAM BENATAR;ALFREDO DANTI;ALI NAINI;ANGELICA BIBIANA DELOGU;ANTONELLA SPINAZZOLA;ANTONI L. ANDREU;B ABBATE;BARBARA COLOMBI;CALABRI GB;CARLO NAPOLITANO","7;6;4;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;COMPUTER SCIENCE;CHEMISTRY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;SOCIOLOGY","33;21;5;3;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;IMMUNOLOGY;MOLECULAR BIOLOGY;PATHOLOGY;ANATOMY;ANESTHESIA;INTENSIVE CARE MEDICINE;LIBRARY SCIENCE;OPTICS;ASTRONOMY;CARDIOLOGY;DERMATOLOGY;FAMILY MEDICINE;GENERAL SURGERY;RADIOLOGY","20;15;12;11;7;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2","GENE;DISEASE;POPULATION;DIABETES MELLITUS;HORMONE;INCIDENCE (GEOMETRY);CENTRAL NERVOUS SYSTEM;CITATION;ENZYME;HALOTHANE;INTENSIVE CARE;NEONATAL INTENSIVE CARE UNIT;PREGNANCY;SEVOFLURANE;THYROID;URINARY SYSTEM;VERNAL KERATOCONJUNCTIVITIS;VIRUS;ADVERSE EFFECT;AIRWAY;ALLERGY;ALTERNATIVE MEDICINE;AMINO ACID;ANEURYSM;ANTHROPOMETRY;ANTIGEN;ARTERY;ASCITES;ASPHYXIA;ASYMPTOMATIC;ATRESIA;BACTERIA;BIOPSY;BLOOD LOSS;CALCIUM;CATECHOLAMINE;CELL CULTURE;CHEMOTHERAPY;CHOLINE;CLINICAL TRIAL;COHORT;COLONIZATION;CONTROL (MANAGEMENT);CREATINE;CYST;CYSTIC FIBROSIS;DNA;DYSGENESIS;ECTASIA;ENCEPHALOPATHY;ENDOSCOPY;EPIDEMIOLOGY;EPIDERMOID CYST;ETIOLOGY;EYE DISEASE;FAMILY HISTORY;FISTULA;FRUCTOSE;GENERAL ANAESTHESIA;GENITOURINARY SYSTEM;GLYCOGEN;GONADAL DYSGENESIS;GORILLA;HEMATOLOGY;HEPATITIS C;HETEROTOPIA (MEDICINE);HYPOKALEMIA;ILEOSTOMY;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;IN VITRO;INHALATION;INSULIN;INTENSIVE CARE UNIT;ISOFLURANE;KERATOCONJUNCTIVITIS;LAPAROSCOPY;LESION;LEUKEMIA;LYMPHOCYTE;MAGNETIC RESONANCE IMAGING;MALIGNANT HYPERTHERMIA;MEATUS;MEDICAL TREATMENT;MEMPHIS;METABOLISM;METABOLITE;MOTION SICKNESS;MYOCARDIAL INFARCTION;NAUSEA;NEWBORN SCREENING;PAIN CONTROL;PAIN RELIEF;PALLIATIVE CARE;PARALYSIS;PEDIATRIC SURGERY;PERCUTANEOUS;PERIOPERATIVE;PHOSPHORYLATION;PRIMARY (ASTRONOMY);PRIMARY CARE;PUNCHING;RENAL FUNCTION;REPRINT;RESPIRATORY SYSTEM;SAMPLE (MATERIAL);SESSION (WEB ANALYTICS);SHORT STATURE;SKELETAL MUSCLE;SORE THROAT;SPLEEN;SUDDEN CARDIAC DEATH;TACHYCARDIA;TALL STATURE;TRANSCRIPTION (LINGUISTICS);URETHRA;URINE;VENTILATION (ARCHITECTURE);VENTRICULAR FIBRILLATION;VENTRICULAR TACHYCARDIA;VOMITING","15;5;5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MUTATION;GENOTYPE;PHENOTYPE;CHROMOSOME;COMPLEMENTARY DNA;ENZYME REPLACEMENT THERAPY;GENE EXPRESSION;GROWTH HORMONE;NEONATOLOGY;ACUTE CORONARY SYNDROME;AGE OF ONSET;AIRWAY MANAGEMENT;ALLELE;ARGININE;AUTOIMMUNITY;BASAL GANGLIA;BIOTINIDASE DEFICIENCY;BLOT;CATECHOLAMINERGIC;CELL CYCLE;CERCOPITHECUS AETHIOPS;CHOROID PLEXUS;CHROMOSOMAL TRANSLOCATION;CLINICAL IMMUNOLOGY;COELIAC DISEASE;COLONISATION;CORONARY ARTERIES;CYTARABINE;ENTEROPATHY;EPENDYMA;EXON;FRUCTOSE 1,6-BISPHOSPHATASE;GENE DUPLICATION;GENOMIC DNA;GLIAL FIBRILLARY ACIDIC PROTEIN;GLYCOGEN STORAGE DISEASE;GLYCOGEN SYNTHASE;HEPATITIS C VIRUS;HOMOLOGOUS CHROMOSOME;HUMAN GENETICS;HUMAN LEUKOCYTE ANTIGEN;HYPOKALEMIC PERIODIC PARALYSIS;HYPOVENTILATION;INSULIN RESISTANCE;INTRON;KAWASAKI DISEASE;LAPAROSCOPIC SURGERY;LARYNGEAL MASK AIRWAY;LIVER BIOPSY;LYMPHOBLASTIC LEUKEMIA;NEONATAL ENCEPHALOPATHY;NEPHROSTOMY;NEUROBLASTOMA;NUCLEOTIDE;PEDIATRIC SURGEON;PERFORATION;PERINATAL ASPHYXIA;PERIODIC PARALYSIS;PERIPHERAL BLOOD MONONUCLEAR CELL;PLACEBO;PSEUDOMONAS AERUGINOSA;REGULATION OF GENE EXPRESSION;RYANODINE RECEPTOR;SPLENECTOMY;STOP CODON;THYMIDINE;THYMIDINE PHOSPHORYLASE;THYROGLOBULIN;TRACHEOESOPHAGEAL FISTULA;TRANSCRIPTION FACTOR;TROPISM;TYPE 1 DIABETES;UPPER URINARY TRACT;URINARY TRACT OBSTRUCTION;VASCULITIS;VIRAL DISEASE;VIRAL LOAD","5;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COMPOUND HETEROZYGOSITY;KARYOTYPE;ACUTE LYMPHOCYTIC LEUKEMIA;AMINO ACID SUBSTITUTION;CHROMOSOME 22;CHROMOSOME ENGINEERING;CHROMOSOME REGIONS;CONGENITAL CENTRAL HYPOVENTILATION SYNDROME;ENHANCER;FRAMESHIFT MUTATION;GENE EXPRESSION PROFILING;GENETIC HETEROGENEITY;GENOTYPE-PHENOTYPE DISTINCTION;GLYCOGEN DEBRANCHING ENZYME;GLYCOGEN STORAGE DISEASE TYPE II;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;IDARUBICIN;LENTIVIRUS;MISSENSE MUTATION;MOLECULAR MEDICINE;MUCOPOLYSACCHARIDOSIS TYPE I;MUTATION TESTING;NUCLEOTIDE SALVAGE;ONCOGENE;PENETRANCE;PROBAND;PROMOTER;RYANODINE RECEPTOR 2;THYROID TRANSCRIPTION FACTOR 1;UREA CYCLE","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;CHILD;CHILD, PRESCHOOL;DNA;ITALY;ADOLESCENT;GROWTH DISORDERS;INFANT;;CONJUNCTIVITIS, ALLERGIC;HUMAN GROWTH HORMONE;INFANT, NEWBORN;MUTATION;ADULT;DIABETES MELLITUS, TYPE 1;CHORISTOMA;DNA MUTATIONAL ANALYSIS;PHARYNGEAL DISEASES","31;18;16;13;12;11;10;8;8;8;7;7;7;7;7;6;6;5;5;5","DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;THYROID DISEASE AND HORMONE REGULATION;;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;DIAGNOSIS, TREATMENT, AND EPIDEMIOLOGY OF NONTUBERCULOUS MYCOBACTERIAL DISEASES;ENDOSCOPIC SKULL BASE SURGERY TECHNIQUES;ESOPHAGEAL INTERVENTION TECHNIQUES;ETIOLOGY AND MANAGEMENT OF PERITONEAL ADHESIONS;GENETIC BASIS OF NEUTROPENIA DISORDERS;GENOMIC ANALYSIS OF ANCIENT DNA;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HEMATOPOIETIC STEM CELL BIOLOGY;HEPATITIS C INFECTION AND TREATMENT;IMPACT OF FRUCTOSE ON METABOLIC HEALTH;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF DIFFICULT AIRWAY IN ANESTHESIA PRACTICE;MANAGEMENT OF SPLEEN TRAUMA IN POLYTRAUMA PATIENTS;MECHANOSENSITIVE ION CHANNELS IN PHYSIOLOGY AND DISEASE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COMPOUND HETEROZYGOSITY;DIABETES;DIABETES MELLITUS;NEONATOLOGY;THYROID HORMONE;TYPE 1 DIABETES;VERNAL KERATOCONJUNCTIVITIS;ACUTE LYMPHOBLASTIC LEUKEMIA;ACUTE LYMPHOCYTIC LEUKEMIA;ACUTE NECROTIZING ENCEPHALOPATHY;ADOLESCENT AND YOUNG ADULT ONCOLOGY;AMINO ACID SUBSTITUTION;ANESTHESIA COMPLICATIONS;APOPTOSIS;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;BIOTINIDASE DEFICIENCY;BONE GROWTH;CARDIAC CHANNELOPATHIES;CARDIAC REMODELING;CELIAC DISEASE","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","DIABETES MELLITUS;GROWTH HORMONE;ACUTE HYPOXIC;ACUTE LYMPHOBLASTIC;AERUGINOSA COLONISATION;ALBANIAN POPULATION;ALTERED THYMIDINE;ANNA MEYER;ASCITES SECONDARY;BIOTINIDASE DEFICIENCY;BLOOD MONONUCLEAR;BRAIN HETEROTOPIA;CARDIOVASCULAR INVOLVEMENT;CATECHOLAMINERGIC POLYMORPHIC;CDNA ARRAY;CELIAC DISEASE;CENTRAL HYPOVENTILATION;CHILDHOOD HIGHRISK;CHILDHOOD TYPE;CHILDREN AFFECTED;CHILDRENS HOSPITAL;CHROMOSOME MAPPING;CHRONIC INTESTINAL;CLINICAL CHARACTERISTICS;CLINICAL IMMUNOLOGY;COAGULATING SHEARS;CONGENITAL CENTRAL;CONTROL PAIN;CUFFED OROPHARYNGEAL;CULTURED LYMPHOCYTE","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MNGIE PATIENTS;PUBMED SCOPUS;CROSSREF PUBMED;PUBMED GOOGLE;BIOL CHEM;CHEM -ABSTRACT;THYMIDINE LEVELS;TP ACTIVITY;BUFFY COATS;CULTURE MEDIUM;THYMIDINE CONCENTRATION;MNGIE FIBROBLASTS;PLASMA THYMIDINE;THYMIDINE PHOSPHORYLASE;TP GENE;ACTA -CROSSREF;AUTOSOMAL RECESSIVE;BESTWICK RK;BIOCHIM BIOPHYS;BIOPHYS ACTA;BRAIN HETEROTOPIA;MATHEWS CK;MITOCHONDRIAL DNA;NORMAL CONTROLS;RENAL CLEARANCE;THYMIDINE METABOLISM;VENTRICULAR TACHYCARDIA;DEOXY-D-RIBOSE -PHOSPHATE;DNTP POOLS;ENZYME ACTIVITY","27;27;25;16;12;12;11;9;8;8;8;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4",6,0.16,3.19,2,1,0,0,0,1,0,1,2,0,0,1,0,2.25,0,0,1,0,0,0,15.25,15.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,24,3300,1.35,1,1,126,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROBLASTOMA;NEUROSCIENCES;PEDIATRIC;PREVENTION;RARE DISEASES","1;1;1;1;1;1;1;1","CANCER","1","6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","1;1;1","NEUROBLASTOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2003,34,12.7058823529412,4.17647058823529,0.558823529411765,0.264705882352941,0.558823529411765,1.23684210526316,1.1875,1.5,1.1875,0.205882352941176,1,10,7,5,6,0.29,0.21,0.15,0.18,34.59,0.65349719475588,NA,0.264705882352941,0.852941176470588,0.64,0.349,0.327,0.349,"U. RICCI;ILARIA SANI;MARIA LUISA GIOVANNUCCI UZIELLI;M. MORTILLA;N. CERRI;LAURA GIUNTI;GABRIELLA BERNINI;ANTONELLA CIANFERONI;R. BERNARDINI;SILVANO PRESCIUTTINI;MILENA ALÙ;M. ANTONELLO;PAOLO PICCO;STEFANO STAGI;RANIERI DOMENICI;GIANCARLO LA MARCA;MARIA ALICE DONATI;D. COUANET;A. PICCININI;MICHAEL KLINTSCHAR","7;5;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","M CHANDRI;U. RICCI;ILARIA SANI;MARIA LUISA GIOVANNUCCI UZIELLI;GIANCARLO LA MARCA;ENRICO ZAMMARCHI;MICHAEL KLINTSCHAR;LAURA GIUNTI;M. MORTILLA;N. CERRI;BRUNO CASETTA;FABIO FALCINI;MARIA ALICE DONATI;GABRIELLA BERNINI;STEFANO STAGI;ELISABETTA LAPI;ROBERTO SALTI;G. BINDI;MARIA LUISA GIOVANNUCCI-UZIELLI;F. GALLUZZI","1;0.96;0.83;0.79;0.5;0.5;0.42;0.39;0.38;0.38;0.33;0.31;0.31;0.29;0.29;0.29;0.29;0.29;0.29;0.29","U. RICCI;ILARIA SANI;MARIA LUISA GIOVANNUCCI UZIELLI;M. MORTILLA;LAURA GIUNTI;GABRIELLA BERNINI;M. ANTONELLO;STEFANO STAGI;GIANCARLO LA MARCA;MARIA ALICE DONATI;FABIO FALCINI;ELISABETTA LAPI;FÁBIO C. TUCCI;MASSIMO RESTI;MARIA DOMENICA CAPPELLINI;LAURA LACITIGNOLA;ANDREA MESSERI;A BRUSAFERRI;CLAUDIO FONDA;ENRICO ZAMMARCHI","7;5;5;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","M CHANDRI;U. RICCI;ILARIA SANI;MARIA LUISA GIOVANNUCCI UZIELLI;GIANCARLO LA MARCA;ENRICO ZAMMARCHI;LAURA GIUNTI;M. MORTILLA;FABIO FALCINI;MARIA ALICE DONATI;GABRIELLA BERNINI;STEFANO STAGI;ELISABETTA LAPI;MARIA LUISA GIOVANNUCCI-UZIELLI;A BRUSAFERRI;ALBERTO LASAGNI;SILVIA GUARDUCCI;MASSIMO RESTI;I. POLLINI;FÁBIO C. TUCCI","1;0.96;0.83;0.79;0.5;0.5;0.39;0.38;0.31;0.31;0.29;0.29;0.29;0.29;0.27;0.27;0.27;0.22;0.22;0.2","GABRIELLA BERNINI;FRANCESCO ZULIAN;PAOLO PICCO;ALESSANDRA LONGHI;CRISTIANA FORNI;DAVIDE MARÍA DONATI;FRANCO BERTONI;GAETANO BACCI;MARCO MANFRINI;PATRIZIA BACCHINI;R. BIAGINI;STEFANO FERRARI;STEFANO LARI;MASSIMO RESTI;ALEXANDROS A. DROSOS;ANNA ŠEDIVÁ;ANNACHIARA CASADEI;CARLOS D. ROSÉ;FERNANDA FALCINI;FLÁVIO SZTAJNBOK","247;230;230;227;227;227;227;227;227;227;227;227;227;214;162;162;162;162;162;162","GABRIELLA BERNINI;MASSIMO RESTI;FERNANDA FALCINI;CHIARA AZZARI;GHERARDO RAPISARDI;CRISTIANA BENUCCI;FRANCESCO MANNELLI;FABIO FALCINI;LUCIANA CAMPA;ROBERTO CAPUTO;IVANA PELA;MARIA ALICE DONATI;U. RICCI;ANDREA MESSERI;ENRICO ZAMMARCHI;GIANCARLO LA MARCA;M. MORTILLA;DANIELA BUTI;BRUNO NOCCIOLI;P BUSONI","243;214;162;146;135;102;102;68;55;55;51;37;36;33;32;32;21;20;17;17","U. RICCI;ILARIA SANI;MARIA LUISA GIOVANNUCCI UZIELLI;M. MORTILLA;ANDREA MESSERI;ENRICO ZAMMARCHI;GABRIELLA BERNINI;GIANCARLO LA MARCA;MARIA ALICE DONATI;MASSIMO RESTI;A HAGEN;A SUTLER;A ZITMNERMANN;A. LIPPI;A. MESSERI;A. MUNNICH;ALICE GOLDENBERG;AMELIA MORRONE;ANGELA TAMBURINI;ANNALISA TONDO","7;4;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;ENGINEERING;ART;PSYCHOLOGY;SOCIOLOGY","27;15;4;4;3;3;2;1;1","GENETICS;INTERNAL MEDICINE;PEDIATRICS;SURGERY;PSYCHIATRY;CARDIOLOGY;COMPUTATIONAL BIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PATHOLOGY;BIOCHEMISTRY;RADIOLOGY;ANESTHESIA;CHROMATOGRAPHY;DATABASE;ENDOCRINOLOGY;GERONTOLOGY;NUCLEAR MEDICINE;OPTICS;VIROLOGY","14;13;8;6;5;4;4;4;4;4;3;3;2;2;2;2;2;2;2;2","GENE;POPULATION;DNA;HYPOPLASIA;ANTIBODY;CANCER;CHEMOTHERAPY;COGNITION;DISEASE;LOBE;MAGNETIC RESONANCE IMAGING;MASS SPECTROMETRY;PREGNANCY;THYROID;VIRUS;ACETAMINOPHEN;ACTION (PHYSICS);ADVERSE EFFECT;ALLERGY;ANALGESIC;ANTIBIOTICS;ANTIMICROBIAL;ARTERY;ASTHMA;ASYMPTOMATIC;BACTERIA;BLOOD FLOW;CATHETER;CENTRAL NERVOUS SYSTEM;CENTRAL NERVOUS SYSTEM DISEASE;CONFIDENCE INTERVAL;CREATINE;DIABETES MELLITUS;DIARRHEA;EPIDEMIOLOGY;EPILEPSY;FORENSIC IDENTIFICATION;FORENSIC SCIENCE;GLYCOGEN;HEART DISEASE;HEPATITIS B;HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY;HUMAN PHYSIOLOGY;INCIDENCE (GEOMETRY);INFRARED;INSOMNIA;ISCHEMIA;KETOPROFEN;MEDULLOBLASTOMA;MULTIPLE SCLEROSIS;MULTIPLEX;NEPHROLOGY;NEUROLOGY;NEWBORN SCREENING;OROTIC ACID;OSTEOSARCOMA;PERCUTANEOUS;PERFORMANCE ART;PERIPHERAL;PRIMER (COSMETICS);PULMONARY ARTERY;RANDOMIZED CONTROLLED TRIAL;REINFORCED CONCRETE;RENAL FUNCTION;REPRODUCIBILITY;SIGNS AND SYMPTOMS;SLEEP (SYSTEM CALL);STEM CELL;STENOSIS;STROKE (ENGINE);SUBJECT (DOCUMENTS);THROMBOSIS;TRANSMISSION (TELECOMMUNICATIONS);TYPING;URINE;VACCINATION;VENTRICLE;VERNAL KERATOCONJUNCTIVITIS;VISUAL ANALOGUE SCALE","9;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLELE;DNA SEQUENCING;FLUID-ATTENUATED INVERSION RECOVERY;GENOTYPE;LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY;LOCUS (GENETICS);MUTATION;TANDEM MASS SPECTROMETRY;THYROID FUNCTION;WILLIAMS SYNDROME;AMELOGENIN;ANTIBIOTIC RESISTANCE;ANTIPHOSPHOLIPID SYNDROME;ATOPY;BIRTH WEIGHT;BREAST CANCER;CARCINOGENESIS;CD34;CELL CYCLE;CEREBRAL INFARCTION;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;CIPROFLOXACIN;CYCLOPHOSPHAMIDE;DEEP VEIN;EOSINOPHIL;EPILEPSY SYNDROMES;FETUS;GENTAMICIN;GLYCOGEN STORAGE DISEASE;GLYCOGEN SYNTHASE;HAZARD RATIO;HEPATITIS B VIRUS;HEPATITIS C VIRUS;HUM;IMMUNOGLOBULIN E;IN VIVO MAGNETIC RESONANCE SPECTROSCOPY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INTERVENTRICULAR SEPTUM;ISOTOPE DILUTION;LINEAGE (GENETIC);LOW BIRTH WEIGHT;LUPUS ANTICOAGULANT;MITOCHONDRIAL DNA;MYOCLONIC EPILEPSY;NEURORADIOLOGY;PHENOTYPE;PLASMAPHERESIS;POLYMERASE CHAIN REACTION;PSEUDOMONAS AERUGINOSA;PULMONARY ATRESIA;RADIAL ARTERY;SLEEP DISORDER;SYSTEMIC LUPUS ERYTHEMATOSUS;TOLERABILITY;TRANSVERSE MYELITIS;TRICUSPID ATRESIA;VIRAL DISEASE;WHITE MATTER;Y CHROMOSOME","5;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DNA SEQUENCER;MICROSATELLITE;HAPLOTYPE;ALLELE FREQUENCY;AMPLICON;CEFTAZIDIME;CORONAVIRUS DISEASE 2019 (COVID-19);EOSINOPHIL CATIONIC PROTEIN;FLAVIVIRIDAE;GENETIC HETEROGENEITY;GLYCOGEN DEBRANCHING ENZYME;HBSAG;IMIPENEM;IN UTERO;LEUKAPHERESIS;LOSS OF HETEROZYGOSITY;MEROPENEM;NEOADJUVANT THERAPY;ONCOGENE;PRENATAL DIAGNOSIS;SELECTED REACTION MONITORING;SLEEP MEDICINE;TOBRAMYCIN;TUMOR SUPPRESSOR GENE","3;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;CHILD;ADOLESCENT;CHILD, PRESCHOOL;LUPUS ERYTHEMATOSUS, SYSTEMIC;INFANT, NEWBORN;COHORT STUDIES;CONJUNCTIVITIS, ALLERGIC;INFANT;MAGNETIC RESONANCE IMAGING;CEREBRAL INFARCTION;DNA FINGERPRINTING;ESCHERICHIA COLI INFECTIONS;HEMIPLEGIA;HEPATITIS B;HEPATITIS C;ITALY","22;16;13;11;10;7;7;7;6;5;5;5;5;4;4;4;4;4;4;4","GENOMIC ANALYSIS OF ANCIENT DNA;;GENETIC AND NEURODEVELOPMENTAL ASPECTS OF WILLIAMS SYNDROME;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;DEVELOPMENTAL PHARMACOLOGY IN PEDIATRIC DRUG USE;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF SJÖGREN'S SYNDROME;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPILEPSY AND SEIZURES;FLUORIDE CONTAMINATION IN DRINKING WATER AND DEFLUORIDATION METHODS;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;GENOMIC STUDIES AND ASSOCIATION ANALYSES;GLIOMAS;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HEPATITIS B INFECTION AND TREATMENT;HEPATITIS C INFECTION AND TREATMENT;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE","6;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANCESTRY INFORMATIVE MARKERS;FORENSIC GENETICS;DNA BARCODING;FLUID-ATTENUATED INVERSION RECOVERY;LOBE;TANDEM MASS SPECTROMETRY;TREATMENT;WILLIAMS SYNDROME;ACETAMINOPHEN;ADSORPTION;ADULT CONGENITAL HEART DISEASE;AMELOGENIN;AMPLICON;ANTIMICROBIAL RESISTANCE;ANTIPHOSPHOLIPID SYNDROME;ATOPY;BRAIN DEATH;CEFEPIME;CHEMOTHERAPY;CONGENITAL HEART DISEASE","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CHROMATOGRAPHYTANDEM MASS;DNA SEQUENCER;GIRLS AFFECTED;LEFT LOBE;LIQUID CHROMATOGRAPHYTANDEM;THYROID HYPOPLASIA;WILLIAMS SYNDROME;ABSTRACTS SCIENTIFIC;ACQUIRED HEPATITIS;ACYL COA;ALLELE SHARING;AMPFLSTR PROFILER;ANALGESIC EFFICACY;ANNUAL MEETING;ANTIMICROBIAL SUSCEPTIBILITY;ANTIPHOSPHOLIPID SYNDROME;ARNOLD POUND;ARTERY CATHETER;AUTOMATED DNA;AUTOMATIC DNA;BACTERIA ISOLATED;BIOLOGICAL PATERNAL;BIRTH-WEIGHT NEWBORNS;BLOOD PROGENITOR;BRAIN STUDY;CARDIOLOGY AMSTERDAM;CATIONIC PROTEIN;CELL COLLECTION;CENTRAL ITALY;CENTRAL OSTEOSARCOMA","2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHILDRENS HOSPITAL;FLORENCE FLORENCE;HOSPITAL UNIVERSITY;MEYER CHILDRENS;NEUROMUSCOLAR UNIT;PEDIATRIC CLINIC;ST PEDIATRIC;UNIT ST;FLORENCE ITALYSEARCH;CLIN CHEM;CHACE HD;OROTIC ACID;ROE CR;ALICE DONATI;ARCH DIS;CHEM CHACE;DIS CHILD;GIANCARLO LA;LA MARCA;MILLINGTON SD;ANDRESEN BS;AUTHOR GIANCARLO;HILLMAN LS;KAHLER GS;LEONARD JV;MASS SPECTROMETRY;RASHED SM;ADAM WB;AMELIA MORRONE;AUTHORAMELIA MORRONE","14;14;14;14;14;14;14;14;12;8;7;6;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2",4,0.12,3.25,16.75,0,0,0,0,41.5,0,1,16.75,0,0,1,0,0,0,0,1,0,0,0,32.75,32.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2004,34,8.76470588235294,2.52941176470588,0.470588235294118,0.323529411764706,0.470588235294118,1.45762711864407,1.23076923076923,1.375,1.23076923076923,0.323529411764706,2,14,9,1,4,0.41,0.26,0.03,0.12,42.26,0.898224453756534,NA,0.264705882352941,0.852941176470588,0.474,0.243,0.242,0.243,"U. RICCI;GIUSEPPE INDOLFI;ANGELA PISTORIO;ALBERTO MARTINI;ANDREA MESSERI;P BUSONI;MARIA LUISA GIOVANNUCCI UZIELLI;GRAZIELLA UZIEL;RAFFAELE PIUMELLI;PAOLO LIONETTI;B. PAPADATOU;MICHELA CASANOVA;GIOVANNI TACCETTI;MARIA SERENELLA PIGNOTTI;ROBERTO BERNI CANANI;GUIA HANAU;ROBERTO LUKSCH;MARIA ALICE DONATI;A. TAMBURINI;NICO WULFFRAAT","4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","GIOVANNI TACCETTI;FILIPPO FESTINI;ANDREA MESSERI;U. RICCI;P BUSONI;MARIA LUISA GIOVANNUCCI UZIELLI;GIUSEPPE INDOLFI;SIMONA CAPRILLI;MARIA SERENELLA PIGNOTTI;RAFFAELE PIUMELLI;G DONZELLI;GIANPAOLO DONZELLI;LAURA GIUNTI;ILARIA SANI;PAOLO LIONETTI;B. PAPADATOU;ROBERTO BERNI CANANI;RICCARDO CIUTI;LEONARDO BUSSOLIN;ARMANDO SARTI","1.1;1.1;1;0.99;0.92;0.79;0.75;0.67;0.58;0.5;0.5;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.25","U. RICCI;GIUSEPPE INDOLFI;ANDREA MESSERI;P BUSONI;MARIA LUISA GIOVANNUCCI UZIELLI;RAFFAELE PIUMELLI;PAOLO LIONETTI;MICHELA CASANOVA;GIOVANNI TACCETTI;MARIA SERENELLA PIGNOTTI;GUIA HANAU;ROBERTO LUKSCH;MARIA ALICE DONATI;A. TAMBURINI;SÉRGIO FERRARI;ARCANGELO PRETE;FILIPPO FESTINI;FRANCA FAGIOLI;ELENA GRIGNANI;ENRICO ZAMMARCHI","4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GIOVANNI TACCETTI;FILIPPO FESTINI;ANDREA MESSERI;U. RICCI;P BUSONI;MARIA LUISA GIOVANNUCCI UZIELLI;GIUSEPPE INDOLFI;SIMONA CAPRILLI;MARIA SERENELLA PIGNOTTI;RAFFAELE PIUMELLI;G DONZELLI;LAURA GIUNTI;ILARIA SANI;PAOLO LIONETTI;LEONARDO BUSSOLIN;MS PIGNOTTI;GIANPAOLO DONZELLI;PIGNOTTI;MICHELA CASANOVA;GUIA HANAU","1.1;1.1;1;0.99;0.92;0.79;0.75;0.67;0.58;0.5;0.5;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.2;0.2","ALBERTO MARTINI;NICO WULFFRAAT;ANGELA PISTORIO;FERNANDA FALCINI;NICOLINO RUPERTO;FABRIZIA CORONA;EILEEN BAILDAM;FRANCESCO ZULIAN;HELEN FOSTER;HURI ÖZDOĞAN;JOYCE DAVIDSON;JULIA GARCÌA CONSUEGRA;KEVIN MURRAY;L ASPLIN;MARIA ALESSIO;PAT WOO;PAVLA DOLEŽALOVÁ;RICHARD VESELÝ;RIK JOOS;ROTRAUD K. SAURENMANN","548;540;511;472;472;439;363;363;363;363;363;363;363;363;363;363;363;363;363;363","FERNANDA FALCINI;MARIA ALICE DONATI;L. FAULKNER;ANDREA MESSERI;SIMONA CAPRILLI;P BUSONI;ENRICO ZAMMARCHI;GIUSEPPE SALVI;MARCO MARTINUCCI;GIOVANNI TACCETTI;CINZIA MARCHI;LAURA LACITIGNOLA;LAWRENCE FAULKNER;G. F. HOFFMANN;ELENA PROCOPIO;FILIPPO FESTINI;GIANFRANCO MERGNI;L MARIANELLI;MAURIZIO DE MARTINO;ML CIONI","472;323;177;119;109;107;86;76;61;40;39;39;39;30;25;25;25;25;25;25","U. RICCI;GIUSEPPE INDOLFI;MARIA LUISA GIOVANNUCCI UZIELLI;ANDREA MESSERI;ENRICO ZAMMARCHI;FERNANDA FALCINI;FILIPPO FESTINI;GIOVANNI TACCETTI;MARIA ALICE DONATI;P BUSONI;PAOLO LIONETTI;SIMONA CAPRILLI;AMELIA MORRONE;ANNA CACIOTTI;BENEDETTA TOSCHI;CINZIA MARCHI;COSTANZA BACCI;E PAMPALONI;ELENA ANDREUCCI;ELENA PROCOPIO","4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;SOCIOLOGY;PHILOSOPHY;PHYSICS;COMPUTER SCIENCE;ECONOMICS;GEOGRAPHY;PSYCHOLOGY","28;14;4;2;2;1;1;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;ANESTHESIA;ENVIRONMENTAL HEALTH;PSYCHIATRY;DEMOGRAPHY;ENDOCRINOLOGY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;RADIOLOGY;BIOCHEMISTRY;COMPUTATIONAL BIOLOGY;EPISTEMOLOGY;IMMUNOLOGY;OBSTETRICS;OPTICS;PATHOLOGY;ANTHROPOLOGY;CARDIOLOGY;CLINICAL PSYCHOLOGY;DEVELOPMENTAL PSYCHOLOGY;ECONOMETRICS;EMERGENCY MEDICINE;EVOLUTIONARY BIOLOGY;INTENSIVE CARE MEDICINE;MEDICAL EMERGENCY;NURSING;ONCOLOGY;PHARMACOLOGY;PHYSICAL THERAPY;UROLOGY","16;13;10;8;6;5;5;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DISEASE;GENE;POPULATION;CHEMOTHERAPY;PREGNANCY;ANXIETY;BONE MARROW;DIABETES MELLITUS;DILEMMA;EPIDEMIOLOGY;GENERAL ANAESTHESIA;INCIDENCE (GEOMETRY);MULTIPLEX;PREMEDICATION;RHEUMATOLOGY;SEDATION;SUDDEN INFANT DEATH SYNDROME;TYPING;ADENOMA;ADRENALECTOMY;ANEMIA;ANESTHESIOLOGY;ANGIOPLASTY;ANTIBODY;ANTICHOLINERGIC;ARTHRITIS;ASPHYXIA;BLOOD PRESSURE;BOTULINUM TOXIN;CAPILLARY ELECTROPHORESIS;CARDIAC TAMPONADE;CATHETER;CELL CULTURE;CONCORDANCE;CYSTIC FIBROSIS;DNA;DOSE;ENDOSCOPY;ENZYME;EXCRETION;FORAMEN MAGNUM;FORENSIC IDENTIFICATION;FORENSIC SCIENCE;HEPATOLOGY;HERITABILITY;HORMONE;INHALATION;INTENSIVE CARE;INTENSIVE CARE UNIT;INTERQUARTILE RANGE;INTERVENTIONAL NEURORADIOLOGY;KETAMINE;KIDNEY;KINSHIP;LACTIC ACIDOSIS;LAPAROSCOPY;MAGNETIC RESONANCE IMAGING;METHOTREXATE;MINOR SURGERY;MYELOID;NAUSEA;NEUROINTENSIVE CARE;NEUROLOGY;NEWBORN SCREENING;ORDINAL DATA;PEDIATRIC INTENSIVE CARE UNIT;PERCUTANEOUS;PERICARDIAL EFFUSION;PERIPHERAL BLOOD;PLEURAL EFFUSION;PROPOFOL;PSYCHOLOGICAL INTERVENTION;PSYCHOSOCIAL;QUALITY OF LIFE (HEALTHCARE);RANDOMIZED CONTROLLED TRIAL;RENAL FUNCTION;RHEUMATISM;SEDATIVE;SEVERITY OF ILLNESS;SEVOFLURANE;SHOCK (CIRCULATORY);SPINAL CORD;STENOSIS;SWEAT;TOXICITY;TOXIN;TRANSPLANTATION;URINARY SYSTEM;VOMITING;ZYGOSITY","7;7;6;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MUTATION;ALLELE;PHENOTYPE;BIRTH WEIGHT;EXON;GESTATION;MELPHALAN;POLYMERASE CHAIN REACTION;RNA;ANTICHOLINERGIC AGENTS;ANTIEMETIC;ASPHYXIA NEONATORUM;AUTOLOGOUS STEM-CELL TRANSPLANTATION;CENTRAL VENOUS CATHETER;CROHN'S DISEASE;CYCLOPHOSPHAMIDE;DIASTOLE;DNA SEQUENCING;DROPERIDOL;FAMILIAL MEDITERRANEAN FEVER;GENERAL ANAESTHETIC;GENOTYPE;GESTATIONAL AGE;HEALTH RELATED QUALITY OF LIFE;HEMOPERICARDIUM;INFLAMMATORY BOWEL DISEASE;INTRON;JUVENILE RHEUMATOID ARTHRITIS;LAPAROSCOPIC SURGERY;LEUKOENCEPHALOPATHY;LUPUS NEPHRITIS;MITOCHONDRIAL DNA;MONOCLONAL ANTIBODY;MOVEMENT DISORDERS;NEPHRON;NEPHROPATHY;NEUROBLASTOMA;NEURORADIOLOGY;NEUTROPENIA;PEDIATRIC GASTROENTEROLOGY;PERICARDIOCENTESIS;POISSON REGRESSION;POLYCLONAL ANTIBODIES;POPULATION GENETICS;PRECOCIOUS PUBERTY;RANDOMIZATION;REFLUX;RENAL ARTERY;RENAL BLOOD FLOW;RENOVASCULAR HYPERTENSION;SECONDARY HYPERTENSION;SPINAL CANAL;STATE-TRAIT ANXIETY INVENTORY;SULFATASE;SWEAT TEST;SYRINGOMYELIA;SYSTEMIC DISEASE;THORACENTESIS;TWIN STUDY;TYPE 1 DIABETES;ULCERATIVE COLITIS","4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DNA SEQUENCER;MICROSATELLITE;MISSENSE MUTATION;MULTIPLEX POLYMERASE CHAIN REACTION;RNA SPLICING;CHIARI I MALFORMATION;CHIARI MALFORMATION;COMPOUND HETEROZYGOSITY;DOPPLER ECHOCARDIOGRAPHY;EFFECTIVE RENAL PLASMA FLOW;FIBROMUSCULAR DYSPLASIA;FLUDARABINE;GENETIC HETEROGENEITY;LEIGH DISEASE;MITOCHONDRIAL ENCEPHALOMYOPATHY;MITOCHONDRIAL MYOPATHY;MONOCLONAL;MUTATION TESTING;NUCLEAR DNA;NUCLEAR GENE;PRETERM LABOUR;RENAL ARTERY STENOSIS;RIGHT RENAL ARTERY;TRANSVERSION;VESICOURETERAL REFLUX","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;;CHILD, PRESCHOOL;ADOLESCENT;LUPUS ERYTHEMATOSUS, SYSTEMIC;KIDNEY DISEASES;ADULT;ARTHRITIS, JUVENILE;INFANT;ITALY;INFANT, NEWBORN;STRESS, PSYCHOLOGICAL;AMINO ACID METABOLISM, INBORN ERRORS;ANXIETY;BRAIN;CONSCIOUS SEDATION;MUTATION","23;16;16;14;11;10;9;9;7;6;6;6;6;5;5;4;4;4;4;4","GENOMIC ANALYSIS OF ANCIENT DNA;GENDER IMBALANCE IN EAST AND SOUTH ASIA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;NEURAL MECHANISMS OF RESPIRATORY CONTROL AND HOMEOSTASIS;SARCOMA RESEARCH AND TREATMENT;ANESTHESIA AND SEDATION MANAGEMENT;DIAGNOSIS AND TREATMENT OF RENAL ARTERY STENOSIS;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MANAGEMENT OF POSTOPERATIVE PAIN AND COMPLICATIONS;MANAGEMENT OF VASCULAR ACCESS IN HEALTHCARE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;NEUROBLASTOMA RESEARCH AND TREATMENT;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INBORN ERRORS OF METABOLISM;LOW BIRTH WEIGHT;MELPHALAN;MULTIPLEX;PREMEDICATION;SUDDEN INFANT DEATH SYNDROME;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TUMOR MICROENVIRONMENT;ADRENAL VEIN SAMPLING;ANTICHOLINERGIC AGENTS;ASPHYXIA NEONATORUM;AUTOLOGOUS STEM-CELL TRANSPLANTATION;CELL MIGRATION;CENTRAL VENOUS CATHETER;CHIARI I MALFORMATION;CHIARI MALFORMATION;COMPOUND HETEROZYGOSITY;CONCORDANCE;CYSTIC FIBROSIS;DIABETES","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","RISK EFTS;BIRTH WEIGHT;BONEBONE MARROW;BOWEL DISEASE;COOPERATIVE STUDY;DEATH SYNDROME;EFTS COOPERATIVE;EWINGS FAMILY;FAMILY TUMORS;INFANT DEATH;INFLAMMATORY BOWEL;ITALY RESULTS;LUPUS ERYTHEMATOSUS;MARROW METASTASES;NATIONAL REGISTRER;ONSET VERY-HIGH;PAEDIATRIC INFLAMMATORY;PSYCHOLOGICAL EVALUATION;SUDDEN INFANT;SYNDROME DILEMMA;SYSTEMIC LUPUS;UP-FRONT MELPHALAN;VERY-HIGH RISK;ADDITIONAL THERAPEUTIC;ADRENAL SURGERY;ADRENOCORTICAL NEOPLASMS;AGE CENTILES;AMPLIFICATION SYSTEMS;ANAESTHESIA INDUCTION;ANAESTHETIC TECHNIQUES","4;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","ACR PEDIATRIC;INTERMEDIATE DOSE;MGM WEEK;PATIENTS AFFECTED;PEDIATRIC RESPONSE;RESPONSE RATE;SIGNIFICANT DIFFERENCE;TYPE DIABETES;ARAB EMIRATES;MALES FEMALES;PAEDIATRIC PATIENTS;PBSC SAMPLES;PERINATAL ASPHYXIA;POSITIVE RESULTS;SAUDI ARABIA;SWEAT CHLORIDE;UNITED ARAB;APNOEA BRADYCARDIA;BM PB;BOYS AGED;CARE UNIT;CATALYTIC ACTIVITY;CHLORIDE CONCENTRATIONS;CLINICAL FEATURES;COMPLETE ABSENCE;COMPLETE DISEASE;CONSTANT INCREASE;COS- CELLS;CYSTIC FIBROSIS;DIAGNOSTIC ACCURACY","10;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2",4,0.12,9.75,6,1,1,0,0,4,0,2,7.5,0,0,0,0,2,0,0,0,0,0,0,103.25,103.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,13,368,1.72,0,0,12,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States;Germany;Japan;Netherlands;Sweden","2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1",NA,NA,NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2005,44,8.93181818181818,2.79545454545455,0.409090909090909,0.340909090909091,0.431818181818182,1.39772727272727,1,1.25,1,0.409090909090909,1,28,9,2,3,0.64,0.2,0.05,0.07,54.91,1.0371217200689,NA,0.25,0.863636363636364,0.355,0.275,0.273,0.325,"AMELIA MORRONE;ENRICO ZAMMARCHI;ENRICO LOMBARDI;STEFANO STAGI;MASSIMO RESTI;FLAVIA BORTOLOTTI;CARLO DANI;MARIA ALICE DONATI;MARIA GUIDO;FRANCESCO CHIARELLI;ANNA CACIOTTI;FILIPPO FESTINI;ALESSANDRA D’AZZO;CLAUDIO FONDA;ROBERTO SALTI;FRANCA RUSCONI;FERNANDA FALCINI;PAOLO LIONETTI;SALVATORE SEMINARA;ANGELO GATTA","5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2","MARIA SERENELLA PIGNOTTI;ENRICO LOMBARDI;AMELIA MORRONE;ENRICO ZAMMARCHI;CARLO DANI;MASSIMO RESTI;STEFANO STAGI;LUCIA CALISTRI;CLAUDIO FONDA;CINZIA SCALAS;FLAVIA BORTOLOTTI;MARIA GUIDO;FRANCA RUSCONI;ANDREA MESSERI;SIMONA CAPRILLI;MARIA ALICE DONATI;ANGELO GATTA;F PIGHIN;FIRMINO F. RUBALTELLI;GIOVANNA BERTINI","1.2;0.69;0.62;0.62;0.6;0.6;0.52;0.5;0.5;0.5;0.45;0.45;0.43;0.42;0.42;0.41;0.4;0.4;0.4;0.4","AMELIA MORRONE;ENRICO ZAMMARCHI;ENRICO LOMBARDI;STEFANO STAGI;MASSIMO RESTI;MARIA ALICE DONATI;FRANCESCO CHIARELLI;ANNA CACIOTTI;FILIPPO FESTINI;CLAUDIO FONDA;ROBERTO SALTI;FRANCA RUSCONI;FERNANDA FALCINI;PAOLO LIONETTI;SALVATORE SEMINARA;GIOVANNI TACCETTI;MARIA SERENELLA PIGNOTTI;ELISABETTA PASQUINI;ELIO NOVEMBRE;SONIA TONI","5;5;5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","MARIA SERENELLA PIGNOTTI;ENRICO LOMBARDI;AMELIA MORRONE;ENRICO ZAMMARCHI;MASSIMO RESTI;STEFANO STAGI;LUCIA CALISTRI;CLAUDIO FONDA;CINZIA SCALAS;FRANCA RUSCONI;ANDREA MESSERI;SIMONA CAPRILLI;MARIA ALICE DONATI;ROBERTO SALTI;FRANCESCO CHIARELLI;GABRIELLA BERNINI;A. LIPPI;FILIPPO FESTINI;SALVATORE SEMINARA;ANNA CACIOTTI","1.2;0.69;0.62;0.62;0.6;0.52;0.5;0.5;0.5;0.43;0.42;0.42;0.41;0.39;0.38;0.37;0.37;0.35;0.32;0.32","MAURIZIO DE MARTINO;FERNANDA FALCINI;MASSIMO RESTI;ANNALISA MICHELI;ELENA CHIAPPINI;FRANCESCA GRISOLIA;SANDRA TRAPANI;ANDREA MESSERI;SIMONA CAPRILLI;ARIANNA ROBIGLIO;LAURA VAGNOLI;ROSSELLA PARINI;ALESSANDRO SIMONATI;ALICE DONATI;EGILL BRIEM;ELEONORA LAMANTEA;FRANCO CARRARA;GIOVANFRANCESCO FERRARI;MASSIMILIANO FILOSTO;MASSIMO ZEVIANI","618;609;466;427;427;427;427;392;392;352;352;352;294;294;294;294;294;294;294;294","MAURIZIO DE MARTINO;FERNANDA FALCINI;MASSIMO RESTI;ANNALISA MICHELI;ELENA CHIAPPINI;FRANCESCA GRISOLIA;SANDRA TRAPANI;ANDREA MESSERI;SIMONA CAPRILLI;ARIANNA ROBIGLIO;LAURA VAGNOLI;ALICE DONATI;PAOLO LIONETTI;ENRICO LOMBARDI;SONIA TONI;ELENA POZZI;M. CAVICCHI;ENRICO ZAMMARCHI;STEFANO STAGI;FRANCA RUSCONI","618;609;466;427;427;427;427;392;392;352;352;294;183;163;162;149;149;135;129;117","AMELIA MORRONE;ENRICO ZAMMARCHI;MASSIMO RESTI;FILIPPO FESTINI;CLAUDIO FONDA;ENRICO LOMBARDI;FERNANDA FALCINI;MAURIZIO DE MARTINO;STEFANO STAGI;FRANCA RUSCONI;A VIERUCCI;ANDREA MESSERI;ANNA CACIOTTI;F. CIANI;F. GALLUZZI;FRANCESCO CHIARELLI;GIOVANNI TACCETTI;MARIA SERENELLA PIGNOTTI;PAOLO LIONETTI;ROBERTO SALTI","4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;PHYSICS;SOCIOLOGY;ENGINEERING;MATHEMATICS","38;21;5;3;3;3;3;2;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;ENDOCRINOLOGY;IMMUNOLOGY;SURGERY;BIOCHEMISTRY;PATHOLOGY;PSYCHIATRY;MOLECULAR BIOLOGY;CLINICAL PSYCHOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;ANESTHESIA;BOTANY;FAMILY MEDICINE;MACROECONOMICS;MICROBIOLOGY;OBSTETRICS;PHYSICAL THERAPY;RADIOLOGY;SOCIAL PSYCHOLOGY","27;16;16;9;7;7;6;6;6;5;4;4;4;3;2;2;2;2;2;2;2;2;2","GENE;PREGNANCY;COHORT;DISEASE;ANTIBODY;ANXIETY;ENZYME;CYSTIC FIBROSIS;DIABETES MELLITUS;EPIDEMIOLOGY;POPULATION;RETROSPECTIVE COHORT STUDY;THYROID;VIRUS;ANTIBIOTICS;ASTHMA;BILIRUBIN;COHORT STUDY;DEPRESSION (ECONOMICS);DNA;ELASTIN;EXCHANGE TRANSFUSION;HEPATITIS B;HORMONE;JAUNDICE;MAGNETIC RESONANCE IMAGING;NEUROLOGY;RECEPTOR","12;6;5;5;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;FETUS;GANGLIOSIDOSIS;ALLELE;AUTOANTIBODY;GENOTYPE;GESTATION;GESTATIONAL AGE;KERNICTERUS;LOW BIRTH WEIGHT;MITOCHONDRIAL DNA;SERUM BILIRUBIN;THYROID FUNCTION;TYPE 1 DIABETES;ACTIVATOR (GENETICS);ALLERGEN;ANISAKIS;ANISAKIS SIMPLEX;ANTIBIOTIC THERAPY;AZATHIOPRINE;BIRTH WEIGHT;BONE MARROW SUPPRESSION;CARBAMYL PHOSPHATE;CD36;CHONDROITIN SULFATE;CHROMOSOMAL TRANSLOCATION;CHRONIC HEPATITIS;CHRONIC MIGRAINE;CONGENITAL HYPOTHYROIDISM;CONSTRUCT VALIDITY;CONTINUING MEDICAL EDUCATION;CONTINUING PROFESSIONAL DEVELOPMENT;CROHN'S DISEASE;CROSS REACTIONS;DEMENTIA;DNA DAMAGE;DOWNREGULATION AND UPREGULATION;ENTERAL ADMINISTRATION;EPIGLOTTIS;ESCHERICHIA COLI;GENE EXPRESSION;GENOMIC DNA;GLYCEMIC;GROWTH HORMONE;HELMHOLTZ COIL;HEPATITIS B VIRUS;HEPATITIS C VIRUS;HOSPITAL ANXIETY AND DEPRESSION SCALE;HYPERINTENSITY;HYPERVARIABLE REGION;HYPOGLYCEMIA;IMMUNOGLOBULIN E;INFLAMMATORY BOWEL DISEASE;INTERNAL CONSISTENCY;INTERNATIONAL CLASSIFICATION OF HEADACHE DISORDERS;LIPOPROTEIN;LIVER BIOPSY;LOW-DENSITY LIPOPROTEIN;LUMBAR PUNCTURE;MANDIBLE (ARTHROPOD MOUTHPART);METHYLMALONIC ACID;MIDAZOLAM;NEPHROPATHY;NEURORADIOLOGY;OLIGONUCLEOTIDE;PARATHYROID HORMONE;PHENOTYPE;PLATELET ACTIVATION;POLYMERASE CHAIN REACTION;POPULATION GENETICS;PRIMARY HEADACHE;PROTEINURIA;REACTIVITY (PSYCHOLOGY);RELATIVE RISK;RESPIRATORY SOUNDS;SACCHAROMYCES CEREVISIAE;SEROCONVERSION;SUMMATIVE ASSESSMENT;TENSION HEADACHE;THYROGLOBULIN;THYROID FUNCTION TESTS;THYROID PEROXIDASE;TROPOELASTIN;UNIVARIATE ANALYSIS;VASCULITIS;VIREMIA;WHEEZE;WORRY","4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMNIOTIC FLUID;ANTI-THYROID AUTOANTIBODIES;PRENATAL DIAGNOSIS;PROBAND;ALLELE FREQUENCY;BETA-GALACTOSIDASE;BREAKPOINT;BRONCHOPULMONARY DYSPLASIA;COMET ASSAY;COMPOUND HETEROZYGOSITY;CROHN DISEASE;CROSS-REACTIVITY;CYSTIC HYGROMA;DISCRIMINANT VALIDITY;GENOTYPING;HAPLOTYPE;HBSAG;HENOCH-SCHONLEIN PURPURA;HEPACIVIRUS;INSULIN PUMP;KERATAN SULFATE;LDL RECEPTOR;LEUKOARAIOSIS;METHYLMALONIC ACIDURIA;MICROSATELLITE;MISSENSE MUTATION;MITOCHONDRIAL DISEASE;OSTEOPROTEGERIN;PHARMACOGENETICS;POINT MUTATION;RANKL;SMALL FOR GESTATIONAL AGE;THIOPURINE METHYLTRANSFERASE","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;ITALY;ADOLESCENT;CHILD, PRESCHOOL;GANGLIOSIDOSIS, GM1;INFANT;;ADULT;RECEPTORS, CELL SURFACE;FIBROBLASTS;INFANT, NEWBORN;THYROID GLAND;ANXIETY;BETA-GALACTOSIDASE;IMMUNOSUPPRESSIVE AGENTS;ASTHMA;DIABETES MELLITUS, TYPE 1","35;28;25;19;14;12;12;11;11;9;8;8;7;7;7;6;6;6;5;5","LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;HEPATITIS B INFECTION AND TREATMENT;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ANESTHESIA AND SEDATION MANAGEMENT;ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;BIOLOGICAL EFFECTS OF ELECTROMAGNETIC FIELDS;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING;ECOLOGICAL INTERACTIONS OF PARASITES IN ECOSYSTEMS;EPIDEMIOLOGY AND MANAGEMENT OF BURN WOUND INFECTIONS;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENETIC AND NEURODEVELOPMENTAL ASPECTS OF WILLIAMS SYNDROME;GENETIC INFLUENCE ON HUMAN ATHLETIC PERFORMANCE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC ANALYSIS OF ANCIENT DNA;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS","3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GANGLIOSIDOSIS;LYSOSOMAL STORAGE DISORDERS;PRETERM INFANTS;ANTI-THYROID AUTOANTIBODIES;BILIRUBIN MEASUREMENT;CYSTIC FIBROSIS;DEPRESSION (ECONOMICS);EXCHANGE TRANSFUSION;HEPATITIS B;INBORN ERRORS OF METABOLISM;KERNICTERUS;PAIN MANAGEMENT;PROBAND;SERUM BILIRUBIN;ADHD;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ALLERGEN IMMUNOTHERAPY;ANESTHESIA;ANISAKIS;ANISAKIS SIMPLEX","3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","ITALIAN CHILDREN;BABY SYNDROME;BRONZE BABY;CAUCASIAN CHILDREN;CHRONIC HEPATITIS;CYSTIC FIBROSIS;HOMOGENEOUS COHORT;REMAINS FAVOURABLE;THYROID FUNCTION;TYPE DIABETES;ACTIVITY CORE;ACUTE LINFOBLASTIC;ACUTE PHASE;ADHD SYMPTOMS;ADOLESCENTS AFFECTED;AFFECT DNA;ANTENATAL STEROIDS;ANTI-PLATELET ACTIVITY;ANTIBIOTIC THERAPY;ANTIBIOTIC TREATMENT;ARGHIS MUTATION;ASTHMA EDUCATION;ATRISK PREGNANCIES;AUTHORS REPLY;BINDING PROTEIN;BIOCHEMICAL APPROACH;BIRTH WEIGHT;BONE MARROW;BONE STATUS;BOWEL DISEASE","3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CORE SET;IMPAIRED ELASTOGENESIS;NEUROGLIAL TISSUE;PLATELET COUNT;HETEROTOPIC NEUROGLIAL;GENE EXPRESSION;GM GANGLIOSIDOSIS;MAGNETIC RESONANCE;MANDIBULAR BONE;PATIENTS SERUM;PLATELET INDICES;PRENATAL DIAGNOSIS;RESONANCE IMAGING;BLOOD PRESSURE;CGA PARGHIS;DISEASE ACTIVITY;DISORDER CAUSED;DNA DAMAGE;DP EXTRACT;EXPRESSION PROFILES;EXTREMELY LOW-FREQUENCY;GLB GENE;LYSOSOMAL STORAGE;MW RANGING;PROTEIN EBP;RANGING APPROXIMATELY;RISK FACTORS;STORAGE DISORDER;THYROID AGENESIS;THYROID ECTOPY","6;6;6;6;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",9,0.2,3,1,1,1,0,1,0,0,1.5,2,0,1,3.5,0,1,0,1,3,0,0,0,59,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,1683,1.28,0,0,139,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY","1;1;1","BLOOD","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2006,65,7.93846153846154,2.83076923076923,0.430769230769231,0.446153846153846,0.446153846153846,1.53333333333333,1.07692307692308,1.26086956521739,1.11538461538462,0.184615384615385,1,19,25,9,3,0.29,0.38,0.14,0.05,25.45,0.498180246543688,NA,0.184615384615385,0.784615384615385,0.369,0.336,0.393,0.329,"MASSIMO RESTI;LORENZO GENITORI;GIUSEPPE INDOLFI;CHIARA AZZARI;U. RICCI;MAURIZIO DE MARTINO;PAOLO LIONETTI;G. SALVIA;MARIA MORIONDO;GIANLUCA TERRIN;LAURA LEGA;FLAVIO GIORDANO;F. BRONZINI;CRISTINA MASSAI;C. CASCIOLI;ROBERTO BERNI CANANI;GIANCARLO LA MARCA;ELENA POZZI;SABRINA MALVAGIA;PAOLO FATTORINI","7;6;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3","U. RICCI;MASSIMO RESTI;NULL AUTHOR_ID;F. BRONZINI;GIUSEPPE INDOLFI;PAOLO LIONETTI;CHIARA AZZARI;LORENZO GENITORI;MAURIZIO DE MARTINO;MARIA MORIONDO;ELENA POZZI;PAOLO FATTORINI;DANIELE MUGNAINI;G A FABIANO;ANDREA MESSERI;SIMONA CAPRILLI;FLAVIO GIORDANO;CRISTINA MASSAI;MAURIZIO DE MARTINO;G. SALVIA","1.12;1.06;1;0.85;0.8;0.78;0.77;0.73;0.73;0.66;0.65;0.54;0.5;0.5;0.5;0.5;0.48;0.48;0.45;0.44","MASSIMO RESTI;LORENZO GENITORI;GIUSEPPE INDOLFI;CHIARA AZZARI;U. RICCI;MAURIZIO DE MARTINO;PAOLO LIONETTI;MARIA MORIONDO;GIANLUCA TERRIN;LAURA LEGA;FLAVIO GIORDANO;F. BRONZINI;CRISTINA MASSAI;C. CASCIOLI;ROBERTO BERNI CANANI;GIANCARLO LA MARCA;ELENA POZZI;SABRINA MALVAGIA;FRANCA RUSCONI;R. BERNARDINI","7;6;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;2","U. RICCI;MASSIMO RESTI;NULL AUTHOR_ID;F. BRONZINI;GIUSEPPE INDOLFI;PAOLO LIONETTI;CHIARA AZZARI;LORENZO GENITORI;MAURIZIO DE MARTINO;MARIA MORIONDO;ELENA POZZI;DANIELE MUGNAINI;ANDREA MESSERI;SIMONA CAPRILLI;FLAVIO GIORDANO;CRISTINA MASSAI;MAURIZIO DE MARTINO;LAURA LEGA;GIANLUCA TERRIN;GIANCARLO LA MARCA","1.12;1.06;1;0.85;0.8;0.78;0.77;0.73;0.73;0.66;0.65;0.5;0.5;0.5;0.48;0.48;0.45;0.44;0.43;0.42","A. EBERHARD;ANA P. N. LOTITO;ANGELO RAVELLI;ANTONELLA BUONCOMPAGNI;BALU H. ATHREYA;CLODOVEO FERRI;DANA NĚMCOVÁ;FERNANDA FALCINI;FLÁVIO SZTAJNBOK;FRANCESCO ZULIAN;GALINA LYSKINA;GIORGIA MARTINI;GORDANA SUŠIĆ;HERMAN GIRSCHICK;ILONKA ORBÁN;IVAN FOELDVARI;PATRICIA WOO;RICARDO RUSSO;ROBERT P. SUNDEL;RUBÉN CUTTICA","209;209;209;209;209;209;209;209;209;209;209;209;209;209;209;209;209;209;209;209","FERNANDA FALCINI;FÁBIO C. TUCCI;FRANCA RUSCONI;LORENZO GENITORI;NICOLA SANTORO;FLAVIO GIORDANO;DANIELA BUTI;ANDREA MESSERI;SIMONA CAPRILLI;MAURIZIO DE MARTINO;GIANCARLO LA MARCA;SABRINA MALVAGIA;CHIARA AZZARI;SONIA TONI;MARIA LUISA GIOVANNUCCI UZIELLI;CONCETTA MICALIZZI;ENRICA PACQUOLA;FABRIZIO FABRIS;LUIGI ZANESCO;MARGHERITA SCAPIN","209;208;203;160;146;122;111;108;108;93;83;83;82;80;72;62;62;62;62;62","MASSIMO RESTI;LORENZO GENITORI;MAURIZIO DE MARTINO;GIUSEPPE INDOLFI;CHIARA AZZARI;U. RICCI;FLAVIO GIORDANO;LAURA LEGA;MARIA MORIONDO;PAOLO LIONETTI;A VIERUCCI;CRISTINA MASSAI;GIANCARLO LA MARCA;SABRINA MALVAGIA;FRANCA RUSCONI;ELEONORA GAMBINERI;ELIO NOVEMBRE;ENRICO ZAMMARCHI;FÁBIO C. TUCCI;GIOVANNI MARIA POGGI","7;6;6;5;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PHILOSOPHY;ENGINEERING;POLITICAL SCIENCE;PSYCHOLOGY;HISTORY;MATHEMATICS;SOCIOLOGY;ART;ECONOMICS;GEOLOGY;MATERIALS SCIENCE","59;21;9;7;4;4;3;3;3;2;2;2;1;1;1;1","INTERNAL MEDICINE;PEDIATRICS;IMMUNOLOGY;GENETICS;SURGERY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;PATHOLOGY;BIOCHEMISTRY;PSYCHIATRY;ANESTHESIA;ENDOCRINOLOGY;VIROLOGY;CHROMATOGRAPHY;NURSING;RADIOLOGY;LAW;LINGUISTICS;OPTICS;ARCHAEOLOGY;ASTROBIOLOGY;COMPUTATIONAL BIOLOGY;DEMOGRAPHY;DERMATOLOGY;ECOLOGY;ELECTRICAL ENGINEERING;EMERGENCY MEDICINE;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;MICROBIOLOGY;ONCOLOGY;OPERATING SYSTEM;PALEONTOLOGY;PHARMACOLOGY","36;16;15;13;11;9;9;8;7;7;5;5;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GENE;DISEASE;VIRUS;ALLERGY;ANTIBODY;ASTHMA;DNA;IMMUNE SYSTEM;RESPIRATORY SYSTEM;ENZYME;EPILEPSY;HYDROCEPHALUS;INCIDENCE (GEOMETRY);TRANSMISSION (TELECOMMUNICATIONS);ANEMIA;ASYMPTOMATIC;ATTENTION DEFICIT HYPERACTIVITY DISORDER;BACTERIA;CANCER;CHEMOTHERAPY;CONFIDENCE INTERVAL;DIABETES MELLITUS;ETIOLOGY;HEPATITIS;HEPATITIS C;INSULIN;INTERVENTION (COUNSELING);LESION;NEUROSURGERY;PARENTERAL NUTRITION;POPULATION;PREGNANCY;RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL;REFRACTORY (PLANETARY SCIENCE);RETROSPECTIVE COHORT STUDY;URINE","10;9;5;4;4;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","AZATHIOPRINE;HEPATITIS C VIRUS;ANAPHYLAXIS;AUTOIMMUNE HEMOLYTIC ANEMIA;AUTOIMMUNITY;COLLOID CYST;FOOD ALLERGY;FOXP3;GENOTYPE;INTESTINAL FAILURE;MITOCHONDRIAL DNA;MUTATION;POLYMERASE CHAIN REACTION;RNA;TYPE 1 DIABETES;ULCERATIVE COLITIS;ACUTE CARE;ALANINE;ALKALINE PHOSPHATASE;ALLELE;ASTROCYTOMA;ATTENTION DEFICIT;AUTOANTIBODY;BRONCHIECTASIS;BURKHOLDERIA;CARDIOMYOPATHY;CHROMOSOME;CHRONIC COUGH;CHRONIC HEPATITIS;CHRONIC INFECTION;COGNITIVE IMPAIRMENT;CRANIOFACIAL ABNORMALITY;CRANIOFACIAL SURGERY;CREATURES;DIABETIC KETOACIDOSIS;DNA PROFILING;ELECTROSPRAY;ELECTROSPRAY IONIZATION;ESSENTIAL THROMBOCYTHEMIA;FABRY DISEASE;GANGLIOGLIOMA;GENOMIC DNA;GERMLINE;HEMICELLULOSE;HEPATITIS A VIRUS;HEPATOSPLENOMEGALY;HIGH-RESOLUTION COMPUTED TOMOGRAPHY;HODGKIN LYMPHOMA;HUMAN GENETICS;HYDROLYZED PROTEIN;HYPERVARIABLE REGION;IMMUNE DYSREGULATION;IMMUNOGLOBULIN E;INFLIXIMAB;INJURY PREVENTION;JUVENILE DERMATOMYOSITIS;KETONE BODIES;KETOROLAC;MAGNETIZATION TRANSFER;METASTASIS;MONOCLONAL ANTIBODY;MULTICENTER STUDY;MYOCLONIC EPILEPSY;NEURORADIOLOGY;OFFSPRING;OPHTHALMOPARESIS;OPTIC NEURITIS;PALIVIZUMAB;PEPTIC;PET THERAPY;PLACEBO;PLASMID;PROLACTIN;REAL-TIME POLYMERASE CHAIN REACTION;REFLUX;RELATIVE RISK;RENAL ARTERY;RENOVASCULAR HYPERTENSION;RICKETS;ROTAVIRUS;SKINFOLD THICKNESS;SOMATIC CELL;SPUTUM;STAPHYLOCOCCUS AUREUS;T CELL;TANDEM MASS SPECTROMETRY;THORACENTESIS;THYMIDINE;THYMIDINE PHOSPHORYLASE;THYMINE;THYROID CANCER;THYROID CARCINOMA;TISSUE TRANSGLUTAMINASE;TRANSAMINASE;TRAUMA CENTER;TYPE 2 DIABETES;TYROSINEMIA;URACIL;VERBASCOSIDE;VIRAL LOAD;WHEEZE","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANAPHYLACTIC REACTION;ANAPHYLACTIC REACTIONS;ANIMAL-ASSISTED THERAPY;ANTI-NUCLEAR ANTIBODY;ANTIRETROVIRAL THERAPY;ASPARTATE TRANSAMINASE;BURKHOLDERIA CENOCEPACIA;BURKHOLDERIA CEPACIA COMPLEX;COGNITIVE DEFICIT;CYTOGENETICS;DNA EXTRACTION;GENE MUTATION;GERD;HAPLOTYPE;HEPACIVIRUS;IL-2 RECEPTOR;KETOACIDOSIS;KETOROLAC TROMETHAMINE;LOW COPY NUMBER;MICROSATELLITE;MILK ALLERGY;MITOCHONDRIAL DISEASE;MONOCLONAL;ORAL ALLERGY SYNDROME;ORAL FOOD CHALLENGE;PEDIATRIC TRAUMA;RENAL ARTERY STENOSIS;RNA SPLICING;URIDINE;VIRAL QUASISPECIES","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;CHILD;ADOLESCENT;MALE;CHILD, PRESCHOOL;HEPATITIS C;BRAIN NEOPLASMS;INFANT;ITALY;ADULT;TREATMENT OUTCOME;DIABETES MELLITUS, TYPE 1;ECTROMELIA;ASTHMA;DERMATITIS, ATOPIC;DNA VIRUS INFECTIONS;MUTATION;RHINITIS, ALLERGIC, SEASONAL","36;27;26;20;17;17;13;10;9;9;9;8;8;7;7;6;6;6;6;6","HEPATITIS C INFECTION AND TREATMENT;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;DISEASES RELATED TO BLOOD GROUP VARIANTS;EPILEPSY AND SEIZURES;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES;GENOMIC ANALYSIS OF ANCIENT DNA;GLIOMAS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PROVISION AND ASSESSMENT OF NUTRITION SUPPORT THERAPY;REAL-TIME POLYMERASE CHAIN REACTION;SURGICAL SUTURE MATERIALS AND TECHNIQUES;ACOUSTIC METAMATERIALS AND PHONONIC CRYSTALS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;AMOEBIASIS: PATHOGENESIS AND CLINICAL MANAGEMENT;ASTHMA;ATTENTION-DEFICIT/HYPERACTIVITY DISORDER;BODY COMPOSITION ASSESSMENT AND ANALYSIS;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;CHEMISTRY AND HEALTH EFFECTS OF OLIVE OIL;CHILDREN'S LITERATURE AND ITS IMPACT","4;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1","DNA BARCODING;ENVIRONMENTAL DNA;TREATMENT;COLLOID CYST;CONTINUOUS GLUCOSE MONITORING;DIABETES;ETIOLOGY;FORENSIC GENETICS;GASTROINTESTINAL DISORDERS;HEPATITIS C;HEPATITIS C VIRUS;INTESTINAL FAILURE;REFRACTORY (PLANETARY SCIENCE);TYPE 1 DIABETES;WOUND HEALING;ACUTE CARE;ADHD;ADULT CONGENITAL HEART DISEASE;AFFECT (LINGUISTICS);ALANINE","4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","ACIDITY INHIBITORS;COLITIS SPECTRUM;COLLOID CYSTS;COOPERATIVE STUDY;GASTRIC ACIDITY;INCIDENCE AETIOLOGY;INTESTINAL FAILURE;ITALIAN NEUROENDOSCOPY;MULTICENTER STUDY;MULTICENTRE STUDY;NEONATAL AGE;TYPE DIABETES;ULCERATIVE COLITIS;ABERRANT MRNA;ACTIVE ANTIRETROVIRAL;ACUTE METABOLIC;ACUTE PANCREATITIS;ADJUVANT TREATMENT;ADVANCED THYROID;AGGRESSIVE NUTRITION;ALANINE TRANSAMINASE;AMYLASE DETECTION;ANAPHYLACTIC REACTION;ANIMALASSISTED ACTIVITY;ANTERIOR PITUITARY;ANTI ENDOMISIUM;ANTINEOPLASTIC CHEMOTHERAPY;ANTIRETROVIRAL THERAPY;ANTITRANSGLUTAMINASE NEGATIVE;ARTERY STENOSIS","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHILDRENS HOSPITAL;CONGENITAL CARDIAC;FIGUREDOWNLOAD POWERPOINTFIGURE;LA SPEZIA;LEFT VENTRICLE;AB MDM;ANDREA HOSPITAL;ANNA MEYER;CARDIOLOGY FATEBENEFRATELLI;CARDIOLOGY OPERATIVE;ED OFTALMICO;FATEBENEFRATELLI ED;FLORENCE AB;FLORENCE ANNA;HOSPITAL FLORENCE;HOSPITAL LA;HOSPITAL MILANO;MEYER CHILDRENS;MILANO SG;OFTALMICO HOSPITAL;OPERATIVE UNIT;PB DEPARTMENT;PEDIATRICS UNIVERSITY;SG ITALY;TUBEROUS SCLEROSIS;VENTRICLE RV;BLOOD HB;CARDIAC RHABDOMYOMA;CARDIAC TUMOR;CARDIAC TUMORS","7;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4",6,0.09,5.25,2,1,0,0,0,1,0,1,2.75,0,0,1.75,0,1,1,0,1,0,0,0,57.25,57.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2007,61,9.22950819672131,2.9672131147541,0.426229508196721,0.40983606557377,0.524590163934426,1.38461538461538,1.3,1.04166666666667,1.23076923076923,0.229508196721311,2,33,14,7,4,0.54,0.23,0.11,0.07,40.39,0.765375351623255,NA,0.311475409836066,0.901639344262295,0.415,0.284,0.22,0.281,"MARIA ALICE DONATI;ROBERTO CAPUTO;LUCA FILIPPI;MAURIZIO DE MARTINO;GIUSEPPE INDOLFI;ELENA PROCOPIO;MAURIZIO GENUARDI;CHIARA AZZARI;MARIA SERENELLA PIGNOTTI;CHIARA POGGI;MARCO PEZZATI;MASSIMO RESTI;IVANA PELA;F. CIANI;AMELIA MORRONE;M. PASTORELLI;A. AUTERI;GIOVANNI BATTISTA FERRERO;RENZO GUERRINI;MARIA MORIONDO","6;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","MARIA SERENELLA PIGNOTTI;LUCA FILIPPI;MARIA ALICE DONATI;M. MORTILLA;CHIARA POGGI;MARCO PEZZATI;ANDREA MESSERI;GIOVANNI TACCETTI;FILIPPO FESTINI;MAURIZIO GENUARDI;ROBERTO CAPUTO;MAURIZIO DE MARTINO;NICOLA DE STEFANO;P BUSONI;IVANA PELA;U. RICCI;ELENA PROCOPIO;FRANCA RUSCONI;GIUSEPPE INDOLFI;CHIARA AZZARI","2.05;0.9;0.75;0.7;0.7;0.7;0.7;0.58;0.58;0.55;0.55;0.51;0.5;0.5;0.5;0.45;0.42;0.42;0.4;0.4","MARIA ALICE DONATI;ROBERTO CAPUTO;LUCA FILIPPI;MAURIZIO DE MARTINO;GIUSEPPE INDOLFI;ELENA PROCOPIO;MAURIZIO GENUARDI;CHIARA AZZARI;MARIA SERENELLA PIGNOTTI;CHIARA POGGI;MARCO PEZZATI;MASSIMO RESTI;IVANA PELA;F. CIANI;AMELIA MORRONE;RENZO GUERRINI;MARIA MORIONDO;R. BERNARDINI;ALICE DONATI;M. MORTILLA","6;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","MARIA SERENELLA PIGNOTTI;LUCA FILIPPI;MARIA ALICE DONATI;M. MORTILLA;CHIARA POGGI;MARCO PEZZATI;ANDREA MESSERI;GIOVANNI TACCETTI;MAURIZIO GENUARDI;ROBERTO CAPUTO;MAURIZIO DE MARTINO;P BUSONI;IVANA PELA;U. RICCI;ELENA PROCOPIO;FRANCA RUSCONI;GIUSEPPE INDOLFI;CHIARA AZZARI;MASSIMO RESTI;BRUNO MURZI","2.05;0.9;0.75;0.7;0.7;0.7;0.7;0.58;0.55;0.55;0.51;0.5;0.5;0.45;0.42;0.42;0.4;0.4;0.4;0.37","ORSETTA ZUFFARDI;ROBERTO CICCONE;ELEONORA GAMBINERI;GIOVANNI BATTISTA FERRERO;ALICE DONATI;ADRIANA ZATTERALE;ALBERT SCHINZEL;ALDO BONFANTE;ALESSANDRA FERLINI;ALESSANDRA TURCI;ANNALISA VETRO;C. PREVIDERÈ;CECILIA ANICHINI;CORRADO ROMANO;ELENA ROSSI;ELISA FAZZI;EMANUELA MENEGHELLI;FAUSTINA LALATTA;FORTUNATO LONARDO;FRANCA BERNARDI","316;316;301;295;283;278;278;278;278;278;278;278;278;278;278;278;278;278;278;278","ELEONORA GAMBINERI;ALICE DONATI;SABRINA GIGLIO;DANIELA BUTI;RENZO GUERRINI;ELENA PROCOPIO;DAVIDE MEI;FEDERICO SICCA;MARIA ALICE DONATI;ROBERTO CAPUTO;LUCA FILIPPI;ANDREA MESSERI;IVANA PELA;FRANCESCA ANASTASI;MARIANA SCOLLO ABETI;SIMONA CAPRILLI;CHIARA POGGI;MAURIZIO DE MARTINO;MASSIMO RESTI;LUCIANA CAMPA","301;283;278;224;224;220;174;174;137;119;115;114;113;109;109;109;107;87;86;83","MARIA ALICE DONATI;ROBERTO CAPUTO;ELENA PROCOPIO;F. CIANI;IVANA PELA;LUCA FILIPPI;MARIA SERENELLA PIGNOTTI;MASSIMO RESTI;MAURIZIO DE MARTINO;MAURIZIO GENUARDI;ALICE DONATI;AMELIA MORRONE;ANDREA MESSERI;CHIARA AZZARI;CHIARA POGGI;CINZIA DE LIBERO;CRISTINA MASSAI;DANIELA BUTI;ELEONORA GAMBINERI;ELIO NOVEMBRE","6;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;PHILOSOPHY;MATERIALS SCIENCE;PSYCHOLOGY;ENGINEERING;GEOGRAPHY;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY","51;34;6;5;4;4;3;3;2;2;2;2;2","INTERNAL MEDICINE;GENETICS;SURGERY;PEDIATRICS;ENDOCRINOLOGY;BIOCHEMISTRY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;GASTROENTEROLOGY;MOLECULAR BIOLOGY;NEUROSCIENCE;PATHOLOGY;PSYCHIATRY;ANESTHESIA;CARDIOLOGY;OPHTHALMOLOGY;OPTICS;CELL BIOLOGY;EMERGENCY MEDICINE;OBSTETRICS;PHYSICAL THERAPY;RADIOLOGY;VIROLOGY","31;28;15;14;9;8;7;6;6;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3","GENE;PREGNANCY;POPULATION;DISEASE;ASTHMA;BACTERIA;CYSTIC FIBROSIS;DOPAMINE;ENZYME;EPILEPSY;RESPIRATORY SYSTEM;RETROSPECTIVE COHORT STUDY;ANTIBODY;BINOCULAR VISION;BLOOD PRESSURE;CHEMOTHERAPY;CHOLESTEROL;CONFIDENCE INTERVAL;CRANIOSYNOSTOSIS;DIABETES MELLITUS;DNA;HORMONE;IMMUNE SYSTEM;INTENSIVE CARE;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;RANDOMIZED CONTROLLED TRIAL;RENAL FUNCTION;RESUSCITATION;TRANSMISSION (TELECOMMUNICATIONS);VACCINATION","18;8;6;5;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MUTATION;ALLELE;MUTANT;PHENOTYPE;EXON;GENE EXPRESSION;NEONATOLOGY;OFFSPRING;APOLIPOPROTEIN B;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;CRANIOSYNOSTOSES;ENDOCRINE SYSTEM;FABRY DISEASE;FETUS;GESTATION;HEK 293 CELLS;LIPOPROTEIN;LOCUS (GENETICS);PSEUDOMONAS AERUGINOSA;SPIROMETRY","8;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","COMPOUND HETEROZYGOSITY;MISSENSE MUTATION;BREAKPOINT;EXHALED NITRIC OXIDE;KARYOTYPE;LDL RECEPTOR;MICROSATELLITE;PROBAND;ANISOMETROPIA;BRADYCARDIA;CAVEOLIN 3;CD146;CENTRAL RETINAL VEIN OCCLUSION;COMPLEMENTATION;CREB;CYTOGENETICS;DNA METHYLATION;DNA MICROARRAY;EOSINOPHIL CATIONIC PROTEIN;FABRY'S DISEASE;FUSIDIC ACID;GENE MUTATION;GERMLINE MOSAICISM;GLYCOGEN STORAGE DISEASE TYPE II;HAPLOTYPE;HOMOVANILLIC ACID;HOUSE DUST MITE;HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE;IL-2 RECEPTOR;IMPAIRED GLUCOSE TOLERANCE;IN UTERO;MICROARRAY;MICROCHIMERISM;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MULTIPOTENT STEM CELL;NULL ALLELE;PRENATAL DIAGNOSIS;PROMOTER;RASBURICASE;RNA SPLICING;RUBELLA;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL FOR GESTATIONAL AGE;TYROSINE 3-MONOOXYGENASE;UREA CYCLE","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;INFANT, NEWBORN;CHILD, PRESCHOOL;CHILD;INFANT;ITALY;ADOLESCENT;ADULT;;MUTATION;PREGNANCY;HYPERCHOLESTEROLEMIA;CYCLOSPORINE;IMMUNOSUPPRESSIVE AGENTS;METABOLISM, INBORN ERRORS;CORONARY ARTERY DISEASE;FETAL DISEASES;HEART FAILURE","51;35;28;19;15;14;13;13;12;11;10;9;9;8;7;7;7;6;6;6","METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;DIAGNOSIS AND MANAGEMENT OF FETAL AND NEONATAL TUMORS;ETHICAL CONSIDERATIONS IN PEDIATRIC MEDICAL DECISION-MAKING;GENETICS AND DEVELOPMENT OF CRANIOFACIAL ABNORMALITIES;IMMUNOLOGICAL MECHANISMS IN ATHEROSCLEROSIS DEVELOPMENT;ALARM FATIGUE IN CLINICAL MONITORING SYSTEMS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;BIOLOGICAL ROLE OF CAVEOLAE IN CELLULAR PROCESSES;BRAIN-COMPUTER INTERFACES IN NEUROSCIENCE AND MEDICINE;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;COMPREHENSIVE APPROACH TO SCHOOL HEALTH PROMOTION;CONGENITAL CORONARY ARTERY ANOMALIES AND THEIR MANAGEMENT;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPILEPSY AND SEIZURES;GENETIC AND DEVELOPMENTAL STUDIES OF LIMB MALFORMATIONS","4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","INBORN ERRORS OF METABOLISM;PRETERM INFANTS;TREATMENT;COMPOUND HETEROZYGOSITY;NEONATOLOGY;BREAKPOINT;CONGENITAL HIGH AIRWAY OBSTRUCTION SYNDROME;CRANIOSYNOSTOSES;CRANIOSYNOSTOSIS;CYSTIC FIBROSIS;END-OF-LIFE DECISIONS;EPILEPSY;FORENSIC GENETICS;HEK 293 CELLS;PAIN MEASUREMENT;PEDIATRIC PAIN;PROBAND;;ABNORMALITY;ACHROMOBACTER XYLOSOXIDANS","4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1","CYSTIC FIBROSIS;ENDOCRINE EFFECTS;GENE EXPRESSION;PROSPECTIVE STUDY;RESPIRATORY PATHOGENS;ACTIVITIES RESULTS;ACUTE LYMPHOBLASTIC;ACUTE RENAL;ACUTE SCROTUM;ADENOSINE MONOPHOSPHATE;ADIPOSE TISSUE;ADRENAL HEMORRHAGE;AGE WEEKS;AIR POLLUTION;AIRWAY INFLAMMATION;ALARM TRACES;ALLA INTERRUZIONE;ALLERGEN EXPOSURE-RELATED;ALTERNATIVA ALLA;ANDERSON-FABRY DISEASE;ANISOMETROPIC AMBLYOPIA;ANTITHROMBOTIC ACTIONS;ARTERY ANOMALY;ATRIOVENTRICULAR BLOCK;ATTRITION BIAS;AUTOIMMUNE DISEASES;AUTOMATED MOLECULAR;BALANCED RECIPROCAL;BASED HEALTH;BCSL GENE","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;PERIPHERAL BLOOD;POLYENDOCRINOPATHY ENTEROPATHY;DYSREGULATION POLYENDOCRINOPATHY;IMMUNE DYSREGULATION;IPEX SYNDROME;PATIENT IV;CD CD;ENTEROPATHY X-LINKED;OCHS HD;FOXP GENE;GENET -CROSSREF;AUTOIMMUNE ENTEROPATHY;BLOOD LYMPHOCYTES;BLOOD MONONUCLEAR;COMPLEX III;COWS MILK;MONONUCLEAR CELL;X-LINKED SYNDROME;BONE MARROW;CDCD REGULATORY;CELL INFECTION;DE NOVO;FOXP MUTATION;IMMUNOL -CROSSREF;MRNA LEVELS;PATIENTS IV;PERINATAL TRANSMISSION;REAL-TIME PCR","32;26;15;13;12;12;11;10;9;9;8;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5",12,0.2,3.72,2.25,0,1,0,0,1,0,1,2.25,0,0,1,0,2,1,1,0,0,0.25,0,92.25,92.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,4,60,1.59,0,0,2.5,0,0,0,0,1,0,1,0,0,1,0,0,0,0,0,0,0,2,0,0,1,1,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY","2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;PATIENT SAFETY","2;1;1;1","CONGENITAL;INFECTION","1;1","6.1 PHARMACEUTICALS","2",NA,NA,NA,NA,1,9883259,318814.81,5,31,13,1,1,63762.9612903226,0.956668240708859,"BIOCODEX (FRANCE);CF CONSULTING FINANZIAMENTI UNIONE EUROPEA;CHARITÉ - UNIVERSITY MEDICINE BERLIN;EPILEPSY IRELAND;FONDAZIONE ISTITUTO NEUROLOGICO NAZIONALE CASIMIRO MONDINO;HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ;HUNGARIAN ACADEMY OF SCIENCES;INNSBRUCK MEDICAL UNIVERSITY;INSERM;ISTANBUL UNIVERSITY;ISTITUTO GIANNINA GASLINI;ISTITUTO NEUROLOGICO CARLO BESTA;JOHANNES GUTENBERG UNIVERSITY OF MAINZ;LUND UNIVERSITY;MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH;MEYER CHILDREN'S HOSPITAL;NSGENE (DENMARK);OZ BIOSCIENCES (FRANCE);PHILIPPS UNIVERSITY OF MARBURG;UNIVERSITY COLLEGE LONDON","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","FP6-2005-LIFESCIHEALTH-6 (CALL FOR PROPOSAL);FP6-LIFESCIHEALTH - LIFE SCIENCES, GENOMICS AND BIOTECHNOLOGY FOR HEALTH: THEMATIC PRIORITY 1 UNDER THE FOCUSING AND INTEGRATING COMMUNITY RESEARCH PROGRAMME 2002-2006. (PROGRAMME);IP - INTEGRATED PROJECT (FUNDING SCHEME)","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3209 NEUROSCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","1;1;1","BRAIN DISORDERS;EPILEPSY;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;RARE DISEASES","1;1;1;1;1;1","NEUROLOGICAL","1","1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1;1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2008,113,8.86725663716814,2.73451327433628,0.451327433628319,0.424778761061947,0.495575221238938,1.93125,1.275,1.84615384615385,1.30232558139535,0.380530973451327,1,51,38,12,9,0.45,0.34,0.11,0.08,29.92,0.545276725709811,NA,0.292035398230089,0.84070796460177,0.45,0.399,0.474,0.441,"RENZO GUERRINI;MAURIZIO ARICÒ;CHIARA AZZARI;MASSIMO RESTI;ROLANDO CIMAZ;MARIA MORIONDO;MARIA ALICE DONATI;LUCA FILIPPI;ENRICO ZAMMARCHI;ELISA BARTOLINI;GIUSEPPE INDOLFI;PAOLO LIONETTI;AMELIA MORRONE;GIANCARLO LA MARCA;GIUSEPPE BASSO;SABRINA MALVAGIA;MAURIZIO DE MARTINO;ANNA MARIA BUCCOLIERO;GIAN LUIGI TADDEI;PATRIZIO FIORINI","15;10;9;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","RENZO GUERRINI;MARIA SERENELLA PIGNOTTI;CHIARA AZZARI;MAURIZIO ARICÒ;PIERCARLO BALLO;ARIANNA BOCELLI;LUCA FILIPPI;MASSIMO RESTI;ELISA BARTOLINI;CHIARA POGGI;MARIA MORIONDO;GIUSEPPE INDOLFI;MARIA ALICE DONATI;ENRICO ZAMMARCHI;SERGIO MONDILLO;RICHARD J. LEVENTER;WILLIAM B. DOBYNS;CLAUDIO FONDA;ROLANDO CIMAZ;MAURIZIO DE MARTINO","2.52;1.5;1.34;1.29;1.28;1.28;1.15;1.13;0.99;0.92;0.87;0.82;0.79;0.79;0.78;0.76;0.76;0.75;0.75;0.73","RENZO GUERRINI;MAURIZIO ARICÒ;CHIARA AZZARI;MASSIMO RESTI;ROLANDO CIMAZ;MARIA MORIONDO;MARIA ALICE DONATI;LUCA FILIPPI;ENRICO ZAMMARCHI;ELISA BARTOLINI;GIUSEPPE INDOLFI;PAOLO LIONETTI;AMELIA MORRONE;GIANCARLO LA MARCA;SABRINA MALVAGIA;MAURIZIO DE MARTINO;PATRIZIO FIORINI;IACOPO SARDI;LAURA BECCIOLINI;ARIANNA BOCELLI","15;10;9;7;7;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4","RENZO GUERRINI;MARIA SERENELLA PIGNOTTI;CHIARA AZZARI;MAURIZIO ARICÒ;ARIANNA BOCELLI;LUCA FILIPPI;MASSIMO RESTI;ELISA BARTOLINI;CHIARA POGGI;MARIA MORIONDO;GIUSEPPE INDOLFI;MARIA ALICE DONATI;ENRICO ZAMMARCHI;CLAUDIO FONDA;ROLANDO CIMAZ;MAURIZIO DE MARTINO;PAOLO LIONETTI;PATRIZIO FIORINI;GIANCARLO LA MARCA;LAURA BECCIOLINI","2.52;1.5;1.34;1.29;1.28;1.15;1.13;0.99;0.92;0.87;0.82;0.79;0.79;0.75;0.75;0.73;0.71;0.65;0.65;0.62","RENZO GUERRINI;RICHARD J. LEVENTER;WILLIAM B. DOBYNS;MAURIZIO ARICÒ;ROLANDO CIMAZ;CHIARA AZZARI;GIANCARLO LA MARCA;PIER LUIGI MERONI;SABRINA MALVAGIA;BLAŽ ROZMAN;RICARD CERVERA;TADEJ AVČIN;ALBERTO MARTINI;ANGELO RAVELLI;CLAUDIA SAAD‐MAGALHÃES;CLÓVIS A. SILVA;DONATO RIGANTE;EARL D. SILVERMAN;FLÁVIO SZTAJNBOK;LÚCIA MARIA ARRUDA CAMPOS","841;419;419;397;378;372;294;267;243;239;239;239;226;226;226;226;226;226;226;226","RENZO GUERRINI;MAURIZIO ARICÒ;ROLANDO CIMAZ;CHIARA AZZARI;GIANCARLO LA MARCA;SABRINA MALVAGIA;SONIA TONI;ELEONORA GAMBINERI;LUCIA BIANCHI;MARIA ALICE DONATI;ALICE DONATI;MAURIZIO DE MARTINO;MARIA MORIONDO;LUCA FILIPPI;PATRIZIO FIORINI;GIUSEPPE INDOLFI;MASSIMO RESTI;ELISABETTA PASQUINI;LAURA BECCIOLINI;AMELIA MORRONE","831;397;378;372;294;243;220;218;218;208;178;166;151;127;127;126;126;123;123;115","RENZO GUERRINI;MAURIZIO ARICÒ;CHIARA AZZARI;MASSIMO RESTI;ROLANDO CIMAZ;LUCA FILIPPI;MARIA MORIONDO;ELISA BARTOLINI;MARIA ALICE DONATI;MAURIZIO DE MARTINO;PATRIZIO FIORINI;AMELIA MORRONE;GIANCARLO LA MARCA;GIUSEPPE INDOLFI;PAOLO LIONETTI;SABRINA MALVAGIA;ANNA CACIOTTI;ARIANNA BOCELLI;LAURA BECCIOLINI;MARINELLA VELTRONI","14;10;9;7;7;6;6;6;6;6;5;5;5;5;5;5;4;4;4;3","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;MATHEMATICS;PHILOSOPHY;POLITICAL SCIENCE;SOCIOLOGY;ART;ECONOMICS","100;50;10;7;5;5;4;4;3;3;3;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;PEDIATRICS;GASTROENTEROLOGY;IMMUNOLOGY;SURGERY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;CARDIOLOGY;PSYCHIATRY;RADIOLOGY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;CHROMATOGRAPHY;MOLECULAR BIOLOGY;ANESTHESIA;FAMILY MEDICINE;ANATOMY;DERMATOLOGY;VIROLOGY","63;37;22;21;16;16;16;13;10;10;10;10;9;9;7;7;6;6;5;5;5","GENE;DISEASE;EPILEPSY;POPULATION;CYSTIC FIBROSIS;MAGNETIC RESONANCE IMAGING;COHORT;FLOW CYTOMETRY;IMMUNE SYSTEM;INTENSIVE CARE;LEUKEMIA;RHEUMATOLOGY;ALLERGY;CHEMOTHERAPY;HEART FAILURE;IMMUNOHISTOCHEMISTRY;MASS SPECTROMETRY;NEONATAL INTENSIVE CARE UNIT;VIRUS;ALTERNATIVE MEDICINE;ANTIBODY;ASTHMA;CANCER;CONFIDENCE INTERVAL;CONTEXT (ARCHAEOLOGY);CYTOKINE;DETECTION LIMIT;DRIED BLOOD SPOT;HEMATOLOGY;IN VITRO;INTENSIVE CARE UNIT;LUNG;OSTEOPOROSIS;RETROSPECTIVE COHORT STUDY;STEM CELL;TRANSPLANTATION;TUBEROUS SCLEROSIS","29;16;9;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MUTATION;PHENOTYPE;LISSENCEPHALY;LYMPHOBLASTIC LEUKEMIA;BONE MINERAL;CD34;CHROMOSOME;CORTICAL DYSPLASIA;EXON;FABRY DISEASE;GENE DUPLICATION;GENE EXPRESSION;GENOME;GENOTYPE;MESSENGER RNA;POLYMICROGYRIA;RNA;SCHIZENCEPHALY;TANDEM MASS SPECTROMETRY;TOPIRAMATE","9;7;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HAPLOINSUFFICIENCY;ACUTE LYMPHOCYTIC LEUKEMIA;DUAL-ENERGY X-RAY ABSORPTIOMETRY;PROBAND;ALPHA-GALACTOSIDASE;COMPARATIVE GENOMIC HYBRIDIZATION;DUAL ENERGY;RNA SPLICING;ALLELE FREQUENCY;ALTERNATIVE SPLICING;ANAPHYLACTIC REACTION;ANAPHYLACTIC REACTIONS;ANTIRETROVIRAL THERAPY;ATHETOSIS;BETA-GALACTOSIDASE;BINGE-EATING DISORDER;BREAKPOINT;BURKHOLDERIA CEPACIA COMPLEX;CADASIL;CARMUSTINE;CASPOFUNGIN;CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME;CD38;CENTRAL RETINAL VEIN OCCLUSION;CHEMICAL CHAPERONE;CMIN;CONGENITAL NEPHROTIC SYNDROME;COPY-NUMBER VARIATION;CORONAVIRUS DISEASE 2019 (COVID-19);CTL*;CUMULUS OOPHORUS;DOPPLER IMAGING;FILGRASTIM;FUSIDIC ACID;GANGLIONEUROMA;GENE EXPRESSION PROFILING;GENE MUTATION;GENOTYPING;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;HEMIMEGALENCEPHALY;HOMEOBOX;HOX GENE;IL-2 RECEPTOR;LEUKAPHERESIS;MATRIX-ASSISTED LASER DESORPTION/IONIZATION;MICRODELETION SYNDROME;MICROSATELLITE;MILK ALLERGY;MISSENSE MUTATION;MITOCHONDRIAL DISEASE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MULTIPLEX POLYMERASE CHAIN REACTION;OSTEOPENIA;PACHYGYRIA;PARADOXICAL EMBOLISM;PENETRANCE;PNEUMOCOCCAL DISEASE;PRIMARY CILIARY DYSKINESIA;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;RIBONUCLEOTIDE REDUCTASE;SELECTED REACTION MONITORING;SEXUAL TRANSMISSION;SPECIES COMPLEX;SUBEPENDYMAL GIANT CELL ASTROCYTOMA;SUBLINGUAL IMMUNOTHERAPY;SUBTELOMERE;SYNOVIAL FLUID;SYSTOLE;T-CELL RECEPTOR;TERATOCARCINOMA;TRANSPOSABLE ELEMENT;VINCRISTINE;VIRAL EVOLUTION","4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;MALE;FEMALE;CHILD;CHILD, PRESCHOOL;ITALY;ADOLESCENT;INFANT;INFANT, NEWBORN;ANTIPHOSPHOLIPID SYNDROME;MUTATION;TREATMENT OUTCOME;ADULT;ALLERGENS;INTESTINAL DISEASES;LATEX HYPERSENSITIVITY;MAGNETIC RESONANCE IMAGING;ALPHA-GALACTOSIDASE;BRAIN","68;43;40;33;31;21;20;19;19;14;12;11;10;9;9;9;9;9;8;8","EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPILEPSY AND SEIZURES;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HEPATITIS C INFECTION AND TREATMENT;INFANT CRYING AND COLIC STUDIES;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;TUBEROUS SCLEROSIS COMPLEX AND RELATED DISORDERS;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;GENOMIC ANALYSIS OF ANCIENT DNA;GLIOMAS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;OSTEOPOROSIS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;SARCOMA RESEARCH AND TREATMENT","6;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","HAPLOINSUFFICIENCY;ACUTE LYMPHOCYTIC LEUKEMIA;CEREBELLAR MALFORMATIONS;CRY ANALYSIS;CYSTIC FIBROSIS;DRIED BLOOD SPOT;DUAL-ENERGY X-RAY ABSORPTIOMETRY;HEMATOLOGY;INFANT CRYING;POLYMICROGYRIA;PROBAND;SCHIZENCEPHALY;TREATMENT OUTCOMES;;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ALPHA-GALACTOSIDASE;ANTIPHOSPHOLIPID SYNDROME;BONE MINERAL DENSITY;CEREBRAL DEVELOPMENT;CHEMOTHERAPY REGIMEN","4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","ACUTE LYMPHOBLASTIC;LYMPHOBLASTIC LEUKEMIA;CYSTIC FIBROSIS;INTENSIVE CARE;ANTIPHOSPHOLIPID SYNDROME;BLOOD SPOTS;BONE MINERAL;BORN ALIVE;CF PATIENTS;CHROMATOGRAPHY-TANDEM MASS;CORTICAL DEVELOPMENT;DRIED BLOOD;EXPANDED NEWBORN;FATHER PREDICTS;FIBROSIS PATIENTS;ITALIAN ASSOCIATION;ITALIAN CHILDREN;LATEX ALLERGY;LIQUID CHROMATOGRAPHY-TANDEM;MASS SPECTROMETRIC;MULTIDISCIPLINARY APPROACH;NATURAL RUBBER;NEWBORN INFANTS;NEWBORN SCREENING;NUTRITIONAL STATUS;ONCOLOGY AIEOP;PATIENTS FIBROBLASTS;PEDIATRIC HEMATOLOGY;PERINATAL TRANSMISSION;PRETERM NEWBORN","5;5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MALATTIE METABOLICHE;METABOLICHE IRCCS;CF PATIENTS;HEART FAILURE;BURLO GAROFOLO;DI MALATTIE;DIAGNOSI PRE-POSTNATALE;GENOVA ITALYSEARCH;GGASLINI GENOVA;IRCCS BURLO;IRCCS GGASLINI;PRE-POSTNATALE MALATTIE;UNITÀ DI;IPEX SYNDROME;PROTEIN EXPRESSION;GAROFOLO TRIESTESEARCH;LABORATORIO DIAGNOSI;BIVENTRICULAR PACING;INFLAMMATORY NEUROPATHY;CHRONIC HEART;FOXP PROTEIN;GROWTH CHARTS;ITALIAN CF;NORMAL SUBJECTS;PATIENTS TREATED;PULSED TD;ANTI-NEURONAL ANTIBODIES;BLOOD OXYGENATION;CURRENT ASTHMA;FRUCTOSE INTOLERANCE","20;18;14;14;10;10;10;10;10;10;10;10;10;9;9;8;8;7;7;6;6;6;6;6;6;6;5;5;5;5",16,0.14,6,2.25,1,1,1,1,3,0,1,2.25,0,1,1.5,0,1,1,1,1,1,0,0,77.25,77.25,1,0,2,0,0,0,0,0,0,0,0,0,2,0,0,0,4,2.59,1,0,0,2,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CERDA BLAS;CHERKASSKIY ALEX;LA MARCA, GIANCARLO;LI YIJUN","2;2;2;2","INDIVIDUAL;PERKINELMER HEALTH SERVICES INC","1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","4;2",NA,NA,NA,NA,"A61K31/185;A61K31/41;B01L99/00","2;2;2","A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833;Y10T436/201666;Y10T436/24;Y10T436/2525","2;2;2;2;2;2;2;2;2;2",4,15.33,327,2.58,0,0,54,0,0,1,0,0,0,1,2,0,1,2,0,0,0,0,0,0,4,0,0,3,1,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","4;2;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ARTHRITIS;AUTOIMMUNE DISEASE;CANCER;PATIENT SAFETY;PEDIATRIC CANCER","3;3;3;2;1;1;1;1;1","CANCER;CONGENITAL;INFLAMMATORY AND IMMUNE SYSTEM","1;1;1","6.1 PHARMACEUTICALS","2","SARCOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2009,90,9.51111111111111,2.61111111111111,0.433333333333333,0.3,0.488888888888889,1.68840579710145,1.05405405405405,1.22727272727273,1.12820512820513,0.355555555555556,3,39,27,10,10,0.43,0.3,0.11,0.11,43.97,0.950482206982693,NA,0.4,0.888888888888889,0.427,0.425,0.408,0.383,"MAURIZIO ARICÒ;RENZO GUERRINI;ROLANDO CIMAZ;LORENZO GENITORI;GIANCARLO LA MARCA;SABRINA MALVAGIA;IACOPO SARDI;GIUSEPPE BASSO;LUCA FILIPPI;U. RICCI;GIUSEPPE MASERA;VALENTINO CONTER;PAOLO LIONETTI;GABRIELE SIMONINI;CHIARA AZZARI;FRANCO LOCATELLI;LUCA LO NIGRO;MARIA ALICE DONATI;DANIELA SILVESTRI;VALENTINA CETICA","10;9;8;8;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4","ROLANDO CIMAZ;RENZO GUERRINI;MAURIZIO ARICÒ;ALESSANDRO BUFALINI;MS PIGNOTTI;DONATI MA;LORENZO GENITORI;GIANCARLO LA MARCA;U. RICCI;SABRINA MALVAGIA;LUCA FILIPPI;ILARIA CARBONI;PATRIZIO FIORINI;MAURIZIO DE MARTINO;IACOPO SARDI;FLAVIO GIORDANO;FRANCESCA MORI;ELIO NOVEMBRE;NERI PUCCI;ANNA MARIA BUCCOLIERO","1.47;1.37;1.05;1;1;1;1;0.99;0.93;0.89;0.75;0.6;0.58;0.58;0.57;0.54;0.53;0.53;0.53;0.52","MAURIZIO ARICÒ;RENZO GUERRINI;ROLANDO CIMAZ;LORENZO GENITORI;GIANCARLO LA MARCA;SABRINA MALVAGIA;IACOPO SARDI;GIUSEPPE BASSO;LUCA FILIPPI;U. RICCI;GIUSEPPE MASERA;VALENTINO CONTER;PAOLO LIONETTI;GABRIELE SIMONINI;CHIARA AZZARI;MARIA ALICE DONATI;DANIELA SILVESTRI;ANDREA BIONDI;SONIA TONI;FLAVIO GIORDANO","10;9;8;8;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4","ROLANDO CIMAZ;RENZO GUERRINI;MAURIZIO ARICÒ;ALESSANDRO BUFALINI;MS PIGNOTTI;DONATI MA;LORENZO GENITORI;GIANCARLO LA MARCA;U. RICCI;SABRINA MALVAGIA;LUCA FILIPPI;ILARIA CARBONI;PATRIZIO FIORINI;MAURIZIO DE MARTINO;IACOPO SARDI;FLAVIO GIORDANO;FRANCESCA MORI;ELIO NOVEMBRE;NERI PUCCI;GABRIELE CENTINI","1.47;1.37;1.05;1;1;1;1;0.99;0.93;0.89;0.75;0.6;0.58;0.58;0.57;0.54;0.53;0.53;0.53;0.5","RENZO GUERRINI;MAURIZIO ARICÒ;GIUSEPPE MASERA;INGRID E. SCHEFFER;SAMUEL F. BERKOVIC;GIUSEPPE BASSO;ANDREA BIONDI;DANIELA SILVESTRI;MARIA GRAZIA VALSECCHI;VALENTINO CONTER;PAOLO LIONETTI;ROLANDO CIMAZ;MARIA ALICE DONATI;GIANCARLO LA MARCA;SABRINA MALVAGIA;MAURIZIO DE MARTINO;ALBENA JORDANOVA;ALBERTO SALVO‐VARGAS;ARVID SULS;BERTEN CEULEMANS","829;533;495;450;450;434;433;433;433;433;432;370;363;361;344;307;287;287;287;287","RENZO GUERRINI;MAURIZIO ARICÒ;PAOLO LIONETTI;ROLANDO CIMAZ;MARIA ALICE DONATI;GIANCARLO LA MARCA;SABRINA MALVAGIA;MARINELLA VELTRONI;ALESSANDRA BENETELLO;ANDREA BIONDI;BARBARA BULDINI;DANIELA SILVESTRI;GIUSEPPE BASSO;GIUSEPPE GAIPA;GIUSEPPE MASERA;MARIA GRAZIA VALSECCHI;MICHAEL DWORZAK;OSCAR MAGLIA;RICHARD RATEI;VALENTINO CONTER","829;533;431;370;363;361;344;269;268;268;268;268;268;268;268;268;268;268;268;268","MAURIZIO ARICÒ;RENZO GUERRINI;ROLANDO CIMAZ;GIANCARLO LA MARCA;SABRINA MALVAGIA;LORENZO GENITORI;U. RICCI;CHIARA AZZARI;MARIA ALICE DONATI;FLAVIO GIORDANO;MAURIZIO DE MARTINO;ELEONORA GAMBINERI;MARIA MORIONDO;AMELIA MORRONE;CATIA CAVICCHI;DAVIDE MEI;ELIO NOVEMBRE;ENRICO ZAMMARCHI;FEDERICO MUSSA;GABRIELE SIMONINI","10;9;8;7;6;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PHILOSOPHY;ECONOMICS;ENGINEERING;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;SOCIOLOGY","80;40;9;9;6;5;4;3;2;2;2;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;PEDIATRICS;SURGERY;IMMUNOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;GASTROENTEROLOGY;PSYCHIATRY;DERMATOLOGY;RADIOLOGY;ANESTHESIA;ENVIRONMENTAL HEALTH;ONCOLOGY;CANCER RESEARCH;MOLECULAR BIOLOGY;NEUROSCIENCE;OPTICS;ANATOMY;INTENSIVE CARE MEDICINE","54;29;19;18;18;15;11;9;9;9;8;7;6;6;6;5;5;5;5;4;4","GENE;DISEASE;CANCER;POPULATION;EPILEPSY;ENZYME;LEUKEMIA;ANTIBODY;ARTHRITIS;DIABETES MELLITUS;IMMUNE SYSTEM;RHEUMATOLOGY;TRANSPLANTATION;ALLERGY;BONE MARROW;CHEMOTHERAPY;COGNITION;CYSTIC FIBROSIS;CYTOKINE;ELECTROCARDIOGRAPHY;INCIDENCE (GEOMETRY);INSULIN;JUVENILE;NEWBORN SCREENING;PREGNANCY;RECEPTOR;RESPIRATORY SYSTEM;TEST (BIOLOGY)","21;15;7;7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MUTATION;MINIMAL RESIDUAL DISEASE;PHENOTYPE;ALLELE;EXON;LYMPHOBLASTIC LEUKEMIA;FETUS;FOXP3;GENOME;INTERLEUKIN 17;TYPE 1 DIABETES;ARGININE;AUTOIMMUNITY;BLOOD CANCER;BREAST CANCER;COLORECTAL CANCER;CYCLOOXYGENASE;DIABETIC KETOACIDOSIS;FABRY DISEASE;FAMILIAL MEDITERRANEAN FEVER;FOOD ALLERGY;GENE DUPLICATION;GENOTYPE;GLUCOKINASE;HEART BLOCK;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HISTIOCYTOSIS;LANGERHANS CELL HISTIOCYTOSIS;LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY;LOCUS (GENETICS);MESENTERIC CYST;METHYLMALONIC ACID;NEUROPSYCHOLOGY;POLYMERASE CHAIN REACTION;TANDEM MASS SPECTROMETRY;TOLERABILITY;TYPE 2 DIABETES","9;5;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ACUTE LYMPHOCYTIC LEUKEMIA;GENE MUTATION;MISSENSE MUTATION;ASPARAGINASE;COMPARATIVE GENOMIC HYBRIDIZATION;COPY-NUMBER VARIATION;COX-2 INHIBITOR;HAPLOTYPE;KETOACIDOSIS;MICROSATELLITE;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;ABSOLUTE NEUTROPHIL COUNT;ADJUVANT CHEMOTHERAPY;ALLELE FREQUENCY;ALPHA-GALACTOSIDASE;ANTI-THYROID AUTOANTIBODIES;AUTOIMMUNE THYROIDITIS;BLINDSIGHT;CASPOFUNGIN;CHORDEE;CITRULLINE;CLADE;COLONOSCOPY;CTGF;DIABETES MANAGEMENT;DNA MISMATCH REPAIR;ENOXAPARIN SODIUM;FEBRILE NEUTROPENIA;FILGRASTIM;FRAMESHIFT MUTATION;GENETIC HETEROGENEITY;GLUT1;GROWTH HORMONE DEFICIENCY;HAPLOINSUFFICIENCY;HENOCH-SCHONLEIN PURPURA;HISTIOCYTOSIS X;HYDROPS FETALIS;IL-2 RECEPTOR;IMPAIRED GLUCOSE TOLERANCE;IN SITU HYBRIDIZATION;INSULIN PUMP;INTERFERON Γ;INTERLEUKIN 12;INTERLEUKIN 23;INTRACRANIAL THROMBOSIS;LATENT TUBERCULOSIS;LYMPHEDEMA;MATURITY ONSET DIABETES OF THE YOUNG;MEATAL STENOSIS;MECONIUM;METHYLMALONIC ACIDURIA;MICAFUNGIN;MILK ALLERGY;MUCOPOLYSACCHARIDOSIS TYPE II;MULTIPLEX POLYMERASE CHAIN REACTION;MUTANT PROTEIN;NEUROENDOCRINE DIFFERENTIATION;NEUROEPITHELIAL CELL;NEUROPSYCHOLOGICAL ASSESSMENT;NEUROPSYCHOLOGICAL TEST;NULL ALLELE;ORNITHINE;PRENATAL DIAGNOSIS;PROBAND;RESPIRATORY ALLERGY;SEROTONIN TRANSPORTER;SPATIAL MEMORY;SYNBIOTICS;SYNOVIAL FLUID;SYSTEMIC VASCULITIS;TUBERCULOSIS DIAGNOSIS;UNDERWEIGHT;UREA CYCLE;VINCRISTINE;WECHSLER INTELLIGENCE SCALE FOR CHILDREN","4;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;ITALY;INFANT;INFANT, NEWBORN;;ARTHRITIS, JUVENILE;MUTATION;TREATMENT OUTCOME;EPILEPSY;BRAIN;BRAIN NEOPLASMS;ATRIOVENTRICULAR BLOCK;GROWTH DISORDERS;DNA;PROPIONIC ACIDEMIA","77;48;46;37;25;21;20;16;15;13;13;13;13;12;11;11;10;10;8;8","EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;GENOMIC ANALYSIS OF ANCIENT DNA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR CHARACTERIZATION OF COLORECTAL CANCER;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ASTHMA;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;INFECTION CONTROL IN HEALTHCARE SETTINGS;PANCREATIC ISLET DYSFUNCTION AND REGENERATION;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;CATHETER ABLATION OF CARDIAC ARRHYTHMIAS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF CEREBRAL VEIN THROMBOSIS","4;4;4;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1","MINIMAL RESIDUAL DISEASE;ACUTE LYMPHOBLASTIC LEUKEMIA;ACUTE LYMPHOCYTIC LEUKEMIA;INBORN ERRORS OF METABOLISM;JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;ADOLESCENT AND YOUNG ADULT ONCOLOGY;ASPARAGINASE;BLOOD CANCER;CHILDHOOD CANCER SURVIVOR STUDY;COMPARATIVE GENOMIC HYBRIDIZATION;COX-2 INHIBITOR;DIABETIC KETOACIDOSIS;DIAGNOSIS;DRIED BLOOD;DRIED BLOOD SPOT;EPILEPSY;FOOD ALLERGY;GLUCOKINASE;GLYCEMIC CONTROL","5;4;4;4;4;4;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ACUTE LYMPHOBLASTIC;LYMPHOBLASTIC LEUKEMIA;CHILDHOOD ACUTE;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;OBSERVATIONAL STUDY;CALCIFIED CYSTIC;CD CELLS;CYSTIC FIBROSIS;CYSTIC LYMPHANGIOMA;GROWTH HORMONE;HAND HYGIENE;JUVENILE POLYPOSIS;POLYPOSIS SYNDROME;POOR PROGNOSIS;TYPE DIABETES;ABSCESSES DUE;ABSENCE EPILEPSY;ABUNDANT NEUROPIL;ACCUMULATION DISEASES;ACTIVATING MUTATION;ACUTE EFFECTS;ACUTE ONSET;ADOLESCENTS SCREENING;AGED DNA;AIEOP STUDIES;AIEOP TRIALS;ALKYLATION DAMAGE;ALLERGIC SYMPTOMS;ALTERING VALIDITY","5;5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PUBMED SCOPUS;CROSSREF PUBMED;GWA STUDIES;GENET -CROSSREF;SUSCEPTIBILITY LOCI;GENOME-WIDE ASSOCIATION;ILIL PATHWAY;INFLAMMATORY BOWEL;CD SUSCEPTIBILITY;COX- INHIBITORS;GENOMIC CONTROL;GWA STUDY;SUSCEPTIBILITY GENES;ALGENOME-WIDE ASSOCIATION;BRANT SR;CHILDRENS HOSPITAL;CHO JH;DISEASENAT GENET;DUERR RH;NICOLAE DL;RIOUX JD;SILVERBERG MS;TAYLOR KD;ASSOCIATION DEFINES;BARMADA MM;CROHNS DISEASENAT;DISTINCT SUSCEPTIBILITY;DL CHO;GWA DATA;HAMARTOMATOUS POLYPS","43;38;21;16;12;11;11;9;8;8;8;8;8;7;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6",17,0.19,9,5,0,1,0,1,7.5,0,1,5,0,1,1,0,3,0,2,1,2.5,0,0,82,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,10,207,2.33,1,0.33,37.67,0,0,1,0,2,0,0,0,0,3,0,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","3;3;2;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;STEM CELL RESEARCH;ARTHRITIS;AUTOIMMUNE DISEASE;BIOTECHNOLOGY;PATIENT SAFETY;PEDIATRIC RESEARCH INITIATIVE","3;2;2;2;2;2;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM","2;1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","3;2","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LUNG CANCER;SARCOMA","2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2010,112,10.5535714285714,2.57142857142857,0.383928571428571,0.303571428571429,0.401785714285714,1.6551724137931,1.13157894736842,1.25925925925926,1.15384615384615,0.455357142857143,4,49,38,17,6,0.44,0.34,0.15,0.05,118.5,2.62222711627888,NA,0.375,0.919642857142857,0.468,0.466,0.461,0.468,"ROLANDO CIMAZ;RENZO GUERRINI;CHIARA AZZARI;GIANCARLO LA MARCA;GABRIELE SIMONINI;IACOPO SARDI;ELIO NOVEMBRE;MAURIZIO ARICÒ;MAURIZIO DE MARTINO;GIOVANNI TACCETTI;FRANCESCA MORI;LUCA FILIPPI;ELEONORA GAMBINERI;LORENZO GENITORI;NERI PUCCI;CRISTINA MASSAI;FRANCO BAMBI;PATRIZIO FIORINI;PINA FORTUNATO;ALESSANDRO FRANCHI","12;11;11;9;8;7;6;6;6;5;5;5;5;5;5;4;4;4;3;3","RENZO GUERRINI;CHIARA AZZARI;GIANCARLO LA MARCA;MARIA SERENELLA PIGNOTTI;ROLANDO CIMAZ;B ABBATE;GIANPAOLO DONZELLI;GABRIELE SIMONINI;ELIO NOVEMBRE;MAURIZIO DE MARTINO;FRANCESCA MORI;NERI PUCCI;IACOPO SARDI;GIOVANNI TACCETTI;ELEONORA GAMBINERI;MAURIZIO ARICÒ;SOFIA MORATTI;S VIERUCCI;CRISTIANO RIZZO;A VIERUCCI","2.17;1.6;1.54;1.5;1.43;1;1;0.86;0.85;0.77;0.73;0.73;0.69;0.67;0.59;0.54;0.5;0.5;0.5;0.5","ROLANDO CIMAZ;RENZO GUERRINI;CHIARA AZZARI;GIANCARLO LA MARCA;GABRIELE SIMONINI;IACOPO SARDI;ELIO NOVEMBRE;MAURIZIO ARICÒ;MAURIZIO DE MARTINO;GIOVANNI TACCETTI;FRANCESCA MORI;LUCA FILIPPI;ELEONORA GAMBINERI;LORENZO GENITORI;NERI PUCCI;CRISTINA MASSAI;FRANCO BAMBI;PATRIZIO FIORINI;PINA FORTUNATO;ROBERTO CAPUTO","12;11;11;9;8;7;6;6;6;5;5;5;5;5;5;4;4;4;3;3","RENZO GUERRINI;CHIARA AZZARI;GIANCARLO LA MARCA;MARIA SERENELLA PIGNOTTI;ROLANDO CIMAZ;B ABBATE;GIANPAOLO DONZELLI;GABRIELE SIMONINI;ELIO NOVEMBRE;MAURIZIO DE MARTINO;FRANCESCA MORI;NERI PUCCI;IACOPO SARDI;GIOVANNI TACCETTI;ELEONORA GAMBINERI;MAURIZIO ARICÒ;S VIERUCCI;A VIERUCCI;LUCA FILIPPI;LORENZO GENITORI","2.17;1.6;1.54;1.5;1.43;1;1;0.86;0.85;0.77;0.73;0.73;0.69;0.67;0.59;0.54;0.5;0.5;0.49;0.47","CARLOTTA DE FILIPPO;DUCCIO CAVALIERI;MONICA DI PAOLA;PAOLO LIONETTI;GIUSEPPE PIERACCINI;J.B. POULLET;MATTEO RAMAZZOTTI;SILVIA COLLINI;SÉBASTIEN MASSART;RENZO GUERRINI;A. JAMES BARKOVICH;ALBERT J. BECKER;ALFONSO REPRESA;ANDREAS SCHULZE‐BONHAGE;ANDRÉ PALMINI;ANNAMARIA VEZZANI;CARLOS CEPEDA;CHARLES RAYBAUD;DAWNA D. ARMSTRONG;ELEONORA ARONICA","5028;5028;5028;5028;4997;4997;4997;4997;4997;1871;1588;1588;1588;1588;1588;1588;1588;1588;1588;1588","PAOLO LIONETTI;MONICA DI PAOLA;SILVIA COLLINI;RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO ARICÒ;GABRIELE SIMONINI;BIAGIO OLIVITO;MARIA ALICE DONATI;FRANCO BAMBI;CLAUDIO PROFETI;IACOPO SARDI;MAURIZIO DE MARTINO;CLAUDIO FONDA;CHIARA AZZARI;ROBERTO CAPUTO;CINZIA DE LIBERO;GIANCARLO LA MARCA;LUCA FILIPPI;ANTONIO FRASSOLDATI","5028;4997;4997;1871;1071;802;560;470;399;308;303;294;286;277;275;270;262;258;258;239","RENZO GUERRINI;ROLANDO CIMAZ;CHIARA AZZARI;GABRIELE SIMONINI;GIANCARLO LA MARCA;IACOPO SARDI;GIOVANNI TACCETTI;MAURIZIO DE MARTINO;MAURIZIO ARICÒ;FRANCO BAMBI;LUCA FILIPPI;NERI PUCCI;ELIO NOVEMBRE;LORENZO GENITORI;C. BRAGGION;CARLA MARINI;CLEMENTINA CANESSA;DAVIDE MEI;ELEONORA GAMBINERI;ELISABETTA LAPI","11;9;7;6;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;ENGINEERING;POLITICAL SCIENCE;ECONOMICS;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS;SOCIOLOGY;BUSINESS","103;52;11;9;9;5;5;3;2;2;2;2;1","INTERNAL MEDICINE;GENETICS;IMMUNOLOGY;PATHOLOGY;SURGERY;PEDIATRICS;ENDOCRINOLOGY;PSYCHIATRY;BIOCHEMISTRY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;MICROBIOLOGY;ENVIRONMENTAL HEALTH;CANCER RESEARCH;NEUROSCIENCE;ANESTHESIA;DERMATOLOGY;NURSING;ONCOLOGY;PHARMACOLOGY;PHYSICAL THERAPY","67;37;25;25;24;23;14;11;10;10;10;10;8;7;7;6;6;6;6;6;6","GENE;DISEASE;PREGNANCY;COHORT;EPILEPSY;ANTIBIOTICS;IMMUNE SYSTEM;POPULATION;ARTHRITIS;CHEMOTHERAPY;CYSTIC FIBROSIS;ALTERNATIVE MEDICINE;ANTIBODY;BACTERIA;CANCER;PROSPECTIVE COHORT STUDY;REGIMEN;ADVERSE EFFECT;ASTHMA;DIABETES MELLITUS;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;RECEPTOR","28;14;10;9;9;8;8;8;7;7;6;5;5;5;5;5;5;4;4;4;4;4;4","PHENOTYPE;GENOTYPE;MUTATION;GESTATIONAL AGE;ALLELE;FOXP3;CHROMOSOME;CLARITHROMYCIN;FETUS;INFLIXIMAB;LYMPHOBLASTIC LEUKEMIA;POLYMERASE CHAIN REACTION;PROVOCATION TEST;PSEUDOMONAS AERUGINOSA;AMOXICILLIN;ASTROCYTOMA;AUTOIMMUNITY;BONE MINERAL;CHEMOTHERAPY REGIMEN;CYCLOPHOSPHAMIDE;DOWNREGULATION AND UPREGULATION;ETOPOSIDE;EXON;FABRY DISEASE;GENE DUPLICATION;IMMUNE DYSREGULATION;IMMUNITY;INNATE IMMUNE SYSTEM;KAWASAKI DISEASE;LISSENCEPHALY;MANNAN-BINDING LECTIN;NEUROPSYCHOLOGY;PATIENT SAFETY;POLYMICROGYRIA;PSORIATIC ARTHRITIS;RETINOPATHY;SPIROMETRY;T CELL;TANDEM MASS SPECTROMETRY;TRANSCRIPTION FACTOR;WEST SYNDROME","9;8;8;7;6;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MISSENSE MUTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;ACUTE LYMPHOCYTIC LEUKEMIA;CHROMOSOME 22;ENTHESITIS;GENE MUTATION;IL-2 RECEPTOR;MUCOSAL IMMUNITY;RETINOPATHY OF PREMATURITY;VINCRISTINE;ABATACEPT;ALLELE FREQUENCY;AMNIOTIC FLUID;ARTEMISININ;AUTOIMMUNE THYROIDITIS;BACTEROIDETES;BLOOD–RETINAL BARRIER;BRONCHODILATION;CD90;CEFPODOXIME;CEFTAZIDIME;CHROMOSOME 17 (HUMAN);COGNITIVE DECLINE;COMPARATIVE GENOMIC HYBRIDIZATION;CORONAVIRUS DISEASE 2019 (COVID-19);CYPROTERONE ACETATE;CYTOGENETICS;DELETION SYNDROME;DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;DIFFUSING CAPACITY;DOPPLER IMAGING;DOUBLECORTIN;DOXORUBICIN HYDROCHLORIDE;EDINBURGH POSTNATAL DEPRESSION SCALE;EXECUTIVE DYSFUNCTION;EXHALED NITRIC OXIDE;FICOLL;FIRMICUTES;FLUORESCENCE IN SITU HYBRIDIZATION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENOTYPING;GERMLINE MOSAICISM;GLOBAL DEVELOPMENTAL DELAY;GLOMERULOSCLEROSIS;GONADOTROPIN-RELEASING HORMONE;GROWTH HORMONE DEFICIENCY;HAPLOINSUFFICIENCY;HAPLOTYPE;HEAD AND NECK SQUAMOUS-CELL CARCINOMA;HENOCH-SCHONLEIN PURPURA;HEREDITARY SPASTIC PARAPLEGIA;HIPPOCAMPAL SCLEROSIS;HOLOPROSENCEPHALY;HOMEOBOX;HOMOVANILLIC ACID;IDIOPATHIC SHORT STATURE;IFOSFAMIDE;JURKAT CELLS;LOSS FUNCTION;MERLIN (PROTEIN);MEROPENEM;MICROSATELLITE;MILK ALLERGY;MULTIPLEX POLYMERASE CHAIN REACTION;OLIGOARTHRITIS;OLIGODENDROGLIOMA;OSTEOCALCIN;PACHYGYRIA;PERFORIN;PILOCYTIC ASTROCYTOMA;PNEUMOCOCCAL DISEASE;PODOCYTE;POLYARTERITIS NODOSA;POLYMORPHISM (COMPUTER SCIENCE);PROBAND;PROGENITOR;RESPIRATORY RATE;RIBAVIRIN;RUBELLA;SYSTEMIC VASCULITIS;TAKAYASU ARTERITIS;TAQMAN;TESTICULAR VOLUME;TOBRAMYCIN;TUMOR NECROSIS FACTOR RECEPTOR 1;TYROSINE 3-MONOOXYGENASE;UBIQUITIN LIGASE;VARICOCELE;WISCONSIN CARD SORTING TEST","4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ADULT;INFANT;EPILEPSY;ITALY;ARTHRITIS, JUVENILE;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;CYSTIC FIBROSIS;INFANT, NEWBORN;FORKHEAD TRANSCRIPTION FACTORS;MUTATION;TREATMENT OUTCOME;YOUNG ADULT;CROSS INFECTION;MIDDLE AGED","102;67;66;58;39;38;23;23;18;17;16;15;15;14;13;13;13;13;12;12","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;EPILEPSY AND SEIZURES;GLIOMAS;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND TREATMENT OF RETINOPATHY OF PREMATURITY;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;IMPACT OF CHILD CARE ON INFECTIOUS DISEASES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MULTIPOTENT MESENCHYMAL STEM CELLS;REGULATORY T CELL DEVELOPMENT AND FUNCTION;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;BODY CONTOURING TECHNIQUES AND PROCEDURES;CHEMICAL GLYCOBIOLOGY AND THERAPEUTIC APPLICATIONS;CHOLESTEROL-LOWERING TREATMENT","6;5;5;4;4;4;4;2;2;2;2;2;2;2;2;2;1;1;1;1","REGIMEN;JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT;CYSTIC FIBROSIS;INBORN ERRORS OF METABOLISM;INFLAMMATION;RADIOTHERAPY;ACUTE LYMPHOCYTIC LEUKEMIA;BREASTFEEDING SUPPORT;CANCER THERAPY;CHEMOTHERAPY REGIMEN;DISCONTINUATION;EPENDYMOMA;EPILEPSY;ETIOLOGY;EWING'S SARCOMA;FABRY DISEASE;GOLD STANDARD (TEST);HYPOTHERMIA TREATMENT","5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","CYSTIC FIBROSIS;PSEUDOMONAS AERUGINOSA;UPPER AIRWAYS;AERUGINOSA INFECTION;BONE MASS;COMPARATIVE STUDY;GROWTH HORMONE;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;KAWASAKI DISEASE;LEUKEMIA RESULTS;LYMPHOBLASTIC LEUKEMIA;MASS SPECTROMETRIC;OXIDATIVE STRESS;STEM CELL;SUSCEPTIBILITY TESTING;TESTING JUSTIFIED;TUMOR NECROSIS;ABATACEPT IMPROVES;ABSENCE EPILEPSY;ACCREDITED TRAINING;ACTIVATION DIFFERENTIALLY;ACUTE BCELL;ACUTE KAWASAKI;ACUTE LYMPHOBLASTIC;ACUTE NON-LYMPHOBLASTIC;ACYLCOA DEHYDROGENASE;AD HOC;ADALIMUMAB VERSUS;ADC MAPS","5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","FCD TYPE;BONE MASS;HYDROXYLASE DEFICIENCY;TYROSINE HYDROXYLASE;LUNG FUNCTION;SIGNIFICANT DIFFERENCES;MAGNETIC RESONANCE;CEREBROSPINAL FLUID;DISEASE ONSET;MEDIAN AGE;PERISYLVIAN POLYMICROGYRIA;SPINE BMAD;BONE MINERAL;CHILDREN LIVING;ENTHESITIS-RELATED ARTHRITIS;GESTATIONAL AGE;IDIOPATHIC ARTHRITIS;RENAL PROGENITORS;RESONANCE IMAGING;SHORT-TERM OUTCOME;SIGNIFICANTLY LOWER;STATISTICALLY SIGNIFICANT;VEGF-A PATHWAY;ADVERSE EFFECTS;AFFECTED MALE;BILATERAL PERISYLVIAN;BILATERAL RB;CDCDFOXP TREG;CF PATIENTS;CLASSIFICATION SYSTEM","9;8;8;8;7;7;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3",28,0.25,3.44,3,3.25,10.5,0,19,3.5,1,1,3,2,1.5,2.75,7,2,3,5.5,2.5,1.5,0,0,106.75,106.75,1,0,3,0,0,0,0,0,0,0,0,0,3,0,0,7,3.33333333333333,3.47,1,0,0,2,0,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,"CERDA BLAS;CHERKASSKIY ALEX;LI YIJUN;ALEX CHERKASSKIY;BLAS CERDA;LA MARCA GIANCARLO;YIJUN LI","2;2;2;1;1;1;1","PERKINELMER HEALTH SCIENCES INC","3","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","6;3",NA,NA,NA,NA,"A61K31/185;A61K31/41;B01L99/00;G01N33/68","3;3;3;2","A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833;Y10T436/201666;Y10T436/24;Y10T436/2525","3;3;3;3;3;3;3;3;3;3",9,4.14,932.29,5.56,2,0.22,21.56,0,0,3,1,3,0,0,2,0,6,1,0,0,0,0,0,0,9,0,0,5,2,0,2,0,0,0,0,0,0,"Germany;Italy;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3213 PAEDIATRICS;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;39 EDUCATION;3904 SPECIALIST STUDIES IN EDUCATION","9;5;1;1;1;1;1;1","PEDIATRIC;RARE DISEASES;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;NEUROSCIENCES;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;BIOTECHNOLOGY;BRAIN DISORDERS;CANCER;CEREBRAL PALSY;COMPLEMENTARY AND INTEGRATIVE HEALTH;CYSTIC FIBROSIS;DIGESTIVE DISEASES;EYE DISEASE AND DISORDERS OF VISION;HEMATOLOGY;INFANT MORTALITY;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LUNG;NEURODEGENERATIVE;NUTRITION","5;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","REPRODUCTIVE HEALTH AND CHILDBIRTH;CANCER;CONGENITAL;EYE;NEUROLOGICAL;STROKE","2;1;1;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","3;1;1","LEUKEMIA / LEUKAEMIA","1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2011,117,12.1794871794872,2.72649572649573,0.324786324786325,0.299145299145299,0.401709401709402,1.74725274725275,1.2258064516129,1.59090909090909,1.27027027027027,0.555555555555556,1,59,31,14,5,0.5,0.26,0.12,0.04,44.44,1.04470770742072,NA,0.401709401709402,0.931623931623932,0.421,0.436,0.534,0.512,"RENZO GUERRINI;MAURIZIO ARICÒ;GIANCARLO LA MARCA;ROLANDO CIMAZ;MASSIMO RESTI;GABRIELE SIMONINI;MARIA ALICE DONATI;AMELIA MORRONE;LUCA FILIPPI;SABRINA MALVAGIA;ROSSELLA PARINI;ANTONELLA MELONI;ALESSIA PEPE;CHIARA AZZARI;TOMMASO CASINI;LUISA GALLI;SABRINA GIGLIO;LUCA CANTARINI;MASSIMO LOMBARDI;SERENA GASPERINI","17;14;11;10;8;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4","RENZO GUERRINI;GIANCARLO LA MARCA;MASSIMO RESTI;MAURIZIO ARICÒ;PAOLA ROMAGNANI;LUCA FILIPPI;ROLANDO CIMAZ;PATRIZIO FIORINI;GIANPAOLO DONZELLI;CHIARA AZZARI;GABRIELE SIMONINI;MARTA DANIOTTI;MARIA ALICE DONATI;SABRINA MALVAGIA;RICHARD KRAEMER;SABINA GALLATI;LUISA GALLI;FÁBIO C. TUCCI;MAURIZIO DE MARTINO;ELENA CHIAPPINI","1.8;1.53;1.31;1.21;1.14;0.97;0.91;0.88;0.71;0.67;0.63;0.58;0.52;0.52;0.5;0.5;0.48;0.46;0.44;0.43","RENZO GUERRINI;MAURIZIO ARICÒ;GIANCARLO LA MARCA;ROLANDO CIMAZ;MASSIMO RESTI;GABRIELE SIMONINI;MARIA ALICE DONATI;AMELIA MORRONE;LUCA FILIPPI;SABRINA MALVAGIA;CHIARA AZZARI;TOMMASO CASINI;LUISA GALLI;SABRINA GIGLIO;SERENA GASPERINI;SILVIA FUNGHINI;CARLA MARINI;MAURIZIO DE MARTINO;PATRIZIO FIORINI;IACOPO SARDI","17;14;11;10;8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;3","RENZO GUERRINI;GIANCARLO LA MARCA;MASSIMO RESTI;MAURIZIO ARICÒ;PAOLA ROMAGNANI;LUCA FILIPPI;ROLANDO CIMAZ;PATRIZIO FIORINI;GIANPAOLO DONZELLI;CHIARA AZZARI;GABRIELE SIMONINI;MARTA DANIOTTI;MARIA ALICE DONATI;SABRINA MALVAGIA;SABINA GALLATI;LUISA GALLI;FÁBIO C. TUCCI;MAURIZIO DE MARTINO;ELENA CHIAPPINI;CARLA MARINI","1.8;1.53;1.31;1.21;1.14;0.97;0.91;0.88;0.71;0.67;0.63;0.58;0.52;0.52;0.5;0.48;0.46;0.44;0.43;0.42","MAURIZIO ARICÒ;HELMUT GADNER;RENZO GUERRINI;GRITTA JANKA;JAN‐INGE HENTER;ANNACARIN HORNE;HELENA TROTTESTAM;GIANCARLO LA MARCA;ALEXANDRA H. FILIPOVICH;DAVID WEBB;R. MAARTEN EGELER;SHINSAKU IMASHUKU;STEPHAN LADISCH;MARIA GRAZIA VALSECCHI;FRANCO LOCATELLI;CHIARA MESSINA;THOMAS KLINGEBIEL;ROSSELLA PARINI;MARIA ALICE DONATI;ELISABETTA LAPI","1334;962;845;744;744;658;658;615;572;572;572;572;572;475;467;433;433;410;404;402","MAURIZIO ARICÒ;RENZO GUERRINI;GIANCARLO LA MARCA;ELISABETTA LAPI;MARIA ALICE DONATI;SERENA GASPERINI;SERENA MATERAZZI;LAURA LEGA;ELENA PROCOPIO;SABRINA MALVAGIA;MASSIMO RESTI;LUCA FILIPPI;SABRINA GIGLIO;ELENA SIENI;CARMEN GUIDO;LORENZO FERRI;MARCO MATERASSI;CARLA MARINI;CHIARA AZZARI;PATRIZIO FIORINI","1322;829;598;402;378;313;261;239;224;223;217;214;210;172;171;171;163;160;156;155","RENZO GUERRINI;MAURIZIO ARICÒ;GIANCARLO LA MARCA;ROLANDO CIMAZ;GABRIELE SIMONINI;MASSIMO RESTI;LUCA FILIPPI;SABRINA MALVAGIA;CHIARA AZZARI;MARIA ALICE DONATI;SILVIA FUNGHINI;TOMMASO CASINI;SERENA GASPERINI;AMELIA MORRONE;CARLA MARINI;DAVIDE MEI;ELENA CHIAPPINI;ELEONORA GAMBINERI;ELISABETTA LAPI;G VENERUSO","16;13;10;9;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;ENGINEERING;GEOGRAPHY;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;COMPUTER SCIENCE;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOLOGY","105;54;13;10;8;3;3;3;2;2;2;2;1;1;1;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;IMMUNOLOGY;SURGERY;BIOCHEMISTRY;PATHOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;PSYCHIATRY;RADIOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;NEUROSCIENCE;ANESTHESIA;MICROBIOLOGY;CARDIOLOGY;ONCOLOGY;OPTICS;ANATOMY;CANCER RESEARCH;CHROMATOGRAPHY;NUCLEAR MEDICINE;PHARMACOLOGY;QUANTUM MECHANICS","80;40;36;20;19;17;16;14;12;12;12;11;8;8;7;7;6;6;6;4;4;4;4;4;4","GENE;DISEASE;EPILEPSY;CHEMOTHERAPY;IMMUNE SYSTEM;CANCER;POPULATION;RHEUMATOLOGY;ANTIBIOTICS;MAGNETIC RESONANCE IMAGING;CYSTIC FIBROSIS;ENZYME;PREGNANCY;STEM CELL;INCIDENCE (GEOMETRY);TRANSPLANTATION;ASTHMA;BACTERIA;COHORT;AMINO ACID;ANTIBODY;ASYMPTOMATIC;CELL;CENTRAL NERVOUS SYSTEM;CLINICAL TRIAL;DIABETES MELLITUS;DRIED BLOOD SPOT;DYSPLASIA;ELECTROENCEPHALOGRAPHY;ENCEPHALOPATHY;EPIDEMIOLOGY;HEART FAILURE;KIDNEY;LEUKEMIA;LUNG;ODDS RATIO;PNEUMONIA;POWER (PHYSICS);REFRACTORY (PLANETARY SCIENCE);URINARY SYSTEM;UVEITIS","29;21;10;9;9;8;8;8;7;7;6;6;6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MUTATION;PHENOTYPE;ALLELE;FETUS;GENOTYPE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;NEUTROPENIA;T CELL;CHROMOSOME;EXON;LYMPHOBLASTIC LEUKEMIA;PEDIATRIC ONCOLOGY;RELIABILITY (SEMICONDUCTOR);STREPTOCOCCUS PNEUMONIAE;ARGININE;BLOOD CANCER;BRONCHODILATOR;CARCINOGENESIS;CARDIAC FUNCTION CURVE;CARDIOMYOPATHY;CD34;CHILDHOOD CANCER;CHROMOSOMAL TRANSLOCATION;CORTICAL DYSPLASIA;ENZYME REPLACEMENT THERAPY;ETANERCEPT;FABRY DISEASE;FOXP3;GENE DUPLICATION;GENE EXPRESSION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HYPOGLYCEMIA;IMMUNE DYSREGULATION;IMMUNODEFICIENCY;KAWASAKI DISEASE;PROGENITOR CELL;PROTEINURIA;PSEUDOMONAS AERUGINOSA;TANDEM MASS SPECTROMETRY;TYROSINEMIA;VASCULITIS","14;11;5;4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MISSENSE MUTATION;HAPLOINSUFFICIENCY;COMPOUND HETEROZYGOSITY;FRAMESHIFT MUTATION;PROBAND;PNEUMOCOCCAL CONJUGATE VACCINE;PNEUMOCOCCAL DISEASE;PNEUMOCOCCAL INFECTIONS;SANGER SEQUENCING;SYSTEMIC VASCULITIS;T-CELL RECEPTOR;UREA CYCLE;ACUTE LYMPHOCYTIC LEUKEMIA;ACYL COA DEHYDROGENASE;ADENOSINE DEAMINASE DEFICIENCY;ADIPOKINE;ALPHA (FINANCE);ALPHA-GALACTOSIDASE;BREAKPOINT;CALPROTECTIN;CENTROSOME;CHEMOIMMUNOTHERAPY;COMPARATIVE GENOMIC HYBRIDIZATION;COMPLEMENTATION;CONJUGATE VACCINE;COPY-NUMBER VARIATION;CORTICOSPINAL TRACT;DIASTOLIC FUNCTION;DNA METHYLATION;EMPERIPOLESIS;EPILEPSIA PARTIALIS CONTINUA;FEBRILE NEUTROPENIA;FILAMIN;FILGRASTIM;FLUORESCENCE IN SITU HYBRIDIZATION;GANGLIONEUROMA;GENE MUTATION;GENETIC HETEROGENEITY;GLOBOTRIAOSYLCERAMIDE;GLOMERULOSCLEROSIS;HAPLOTYPE;HEMATOPOIETIC STEM CELL;HETEROZYGOTE ADVANTAGE;HOMEOBOX;HYPERINSULINEMIC HYPOGLYCEMIA;IMATINIB MESYLATE;INSULIN PUMP;JURKAT CELLS;KARYOTYPE;KETOACIDOSIS;KIDNEY DEVELOPMENT;KRAS;LEUKAPHERESIS;LEVODOPA;LOSS FUNCTION;LOSS OF HETEROZYGOSITY;MEFLOQUINE;MEROPENEM;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MICROANGIOPATHIC HEMOLYTIC ANEMIA;MOLECULAR EPIDEMIOLOGY;MULTILOCUS SEQUENCE TYPING;NOD2;ORAL FOOD CHALLENGE;PATHERGY;PERFORIN;PERIPHERAL TOLERANCE;PHILADELPHIA CHROMOSOME;PLEOMORPHIC XANTHOASTROCYTOMA;PNEUMOCOCCAL VACCINE;PRENATAL DIAGNOSIS;PROTOCADHERIN;RENAL STEM CELL;SALMONELLA ENTERITIDIS;SALMONELLA INFECTION;SYNOVIAL FLUID;TUMOR SUPPRESSOR GENE;TYROSINE AMINOTRANSFERASE;VACCINATION SCHEDULE;VENTRICULOMEGALY;WWOX","9;4;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;CHILD, PRESCHOOL;CHILD;INFANT;ADOLESCENT;INFANT, NEWBORN;ITALY;ADULT;LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC;MUTATION;YOUNG ADULT;KIDNEY;INTELLECTUAL DISABILITY;MIDDLE AGED;TANDEM MASS SPECTROMETRY;EPILEPSY;MAGNETIC RESONANCE IMAGING","80;52;51;37;34;33;32;25;21;21;20;17;12;12;11;10;10;10;9;9","METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;PEDIATRIC CANCER AND QUALITY OF LIFE;ASTHMA;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;EPILEPSY AND SEIZURES;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC BASIS OF NEUTROPENIA DISORDERS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE","9;6;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","INBORN ERRORS OF METABOLISM;ADOLESCENT AND YOUNG ADULT ONCOLOGY;FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HAPLOINSUFFICIENCY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;COMPOUND HETEROZYGOSITY;CYSTIC FIBROSIS;DRIED BLOOD SPOT;NEUTROPENIC PATIENTS;NONSENSE MUTATION;PEDIATRIC ONCOLOGY;REFRACTORY (PLANETARY SCIENCE);BLOOD CANCER;CHILDHOOD CANCER;CHILDHOOD CANCER SURVIVOR STUDY;CONSENSUS CONFERENCE;CONTINUOUS GLUCOSE MONITORING;CREATINE KINASE;DIABETES;ENTEROCOLITIS","5;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","CYSTIC FIBROSIS;ACUTE LYMPHOBLASTIC;BLOOD SPOT;DRIED BLOOD;HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;LYMPHOBLASTIC LEUKEMIA;RISK FACTORS;CIRCULATING LEVELS;DISEASE ACTIVITY;FABRY DISEASE;FEASIBILITY REPRODUCIBILITY;HEMATOPOIETIC STEM;IDIOPATHIC ARTHRITIS;IPEX SYNDROME;IRON EVALUATION;ITALIAN REGISTRY;JUVENILE IDIOPATHIC;KAWASAKI DISEASE;MASS SPECTROMETRY;NECROTIZING ENTEROCOLITIS;PNEUMOCOCCAL CONJUGATE;PSEUDOMONAS AERUGINOSA;STEM CELL;THALASSEMIA MAJOR;TYROSINEMIA TYPE;ACCESSING PEDIATRIC;ACQUIRED NEUTROPENIAS;ACTION MYOCLONUS;ACUTE EFFECTS;ACUTE GASTROENTERITIS","5;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1","POTENTIAL ANKYRIN;RECEPTOR POTENTIAL;TRANSIENT RECEPTOR;NEWBORN SCREENING;IMMUNOLOGICAL SYNAPSE;CF PATIENTS;GM GANGLIOSIDOSIS;IMMUNE SYSTEM;INCREASED RISK;INKT CELLS;LUNG CANCER;TR CELLS;UREA CYCLE;VLBW INFANTS;ACTIVE JOINTS;CHAGAS DISEASE;CONTROL SUBJECTS;DBS SAMPLES;DRIED BLOOD;MASS SPECTROMETRY;MAX FRC;PERIPHERAL BLOOD;PULMONARY FUNCTION;AMINO ACID;BLOOD SPOT;CALCITONIN GENE-RELATED;CARGLUMIC ACID;CONFIDENCE INTERVAL;CONFIDENCE LIMIT;CYTOLYTIC CELLS","11;11;11;8;7;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4",34,0.29,7.13,3,2,1,1,1,4.5,0,1,3,0,1,4,0,2.5,1,1,2.25,2.5,0,0,116.25,116.25,2,0,0,2,0,0,0,0,1,0,0,0,3,0,0,3.33333333333333,3,2.83,3.33333333333333,0,3,2,0,0,1,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"AZZARI CHIARA;RESTI MASSIMO;MORIONDO MARIA;LA MARCA GIANCARLO","3;3;2;1","AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZZARI CHIARA;RESTI MASSIMO;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;LA MARCA GIANCARLO;MORIONDO MARIA","3;2;2;1;1;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3105 GENETICS;3202 CLINICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","3;3;2;1;1;1","LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA;GENETICS","2;2;2;1",NA,NA,"C12Q1/68;G01N33/66","2;1","C12Q1/689;G01N33/492;G01N33/66;H01J49/005;H01J49/0459","2;1;1;1;1",7,5.25,390.25,4.05,2,0.29,30.57,0,0,2,0,3,0,1,1,0,6,0,0,0,0,0,0,0,7,0,0,5,1,0,0,1,0,0,0,0,0,"Italy","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3207 MEDICAL MICROBIOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","7;3;2;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BRAIN DISORDERS;CANCER;NEUROSCIENCES;PEDIATRIC RESEARCH INITIATIVE;PREVENTION;RARE DISEASES;DIABETES;DIGESTIVE DISEASES;EPILEPSY;NEUROBLASTOMA;NEURODEGENERATIVE;NUTRITION;PATIENT SAFETY;PEDIATRIC CANCER","6;6;4;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CANCER;CONGENITAL;INFECTION;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL","2;1;1;1;1","6.1 PHARMACEUTICALS;6.4 SURGERY","6;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;NEUROBLASTOMA;SARCOMA","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2012,123,13.0325203252033,2.86178861788618,0.373983739837398,0.373983739837398,0.414634146341463,1.80927835051546,1.17948717948718,1.64285714285714,1.18604651162791,0.552845528455285,1,61,42,16,2,0.5,0.34,0.13,0.02,51.9,1.2426264834329,5.68979591836735,0.455284552845528,0.886178861788618,0.428,0.463,0.487,0.466,"RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO ARICÒ;ELENA CHIAPPINI;GABRIELE SIMONINI;LUISA GALLI;GIANCARLO LA MARCA;DESIRÉE CASELLI;DAVIDE MEI;LORENZO GENITORI;CARLA MARINI;MAURIZIO DE MARTINO;MAURIZIO DE MARTINO;IACOPO SARDI;FRANCESCO MANNELLI;LUCA FILIPPI;ANTONIO MESSINEO;SARA SAVELLI;FRANCESCA BONSIGNORI;SERENA CATARZI","18;14;9;8;7;7;6;6;6;6;6;6;6;5;5;5;5;5;4;4","RENZO GUERRINI;ROLANDO CIMAZ;ALESSANDRO BUFALINI;DESIRÉE CASELLI;ANTONIO MESSINEO;GABRIELE SIMONINI;LUISA GALLI;MAURIZIO ARICÒ;MASSIMO RESTI;SARA SAVELLI;OLIVIA PAOLICCHI;DAVIDE MEI;ELENA CHIAPPINI;MAURIZIO DE MARTINO;LORENZO GENITORI;GIUSEPPE INDOLFI;ANDREA MESSERI;LUCA FILIPPI;ILARIA PAGNINI;FERRONI TOMMASO","1.71;1.69;1;0.97;0.88;0.83;0.76;0.74;0.66;0.65;0.64;0.63;0.62;0.61;0.56;0.56;0.54;0.54;0.52;0.5","RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO ARICÒ;ELENA CHIAPPINI;GABRIELE SIMONINI;LUISA GALLI;GIANCARLO LA MARCA;DESIRÉE CASELLI;DAVIDE MEI;LORENZO GENITORI;CARLA MARINI;MAURIZIO DE MARTINO;MAURIZIO DE MARTINO;IACOPO SARDI;FRANCESCO MANNELLI;LUCA FILIPPI;ANTONIO MESSINEO;SARA SAVELLI;FRANCESCA BONSIGNORI;CHIARA AZZARI","18;14;9;8;7;7;6;6;6;6;6;6;6;5;5;5;5;5;4;4","RENZO GUERRINI;ROLANDO CIMAZ;ALESSANDRO BUFALINI;DESIRÉE CASELLI;ANTONIO MESSINEO;GABRIELE SIMONINI;LUISA GALLI;MAURIZIO ARICÒ;MASSIMO RESTI;SARA SAVELLI;OLIVIA PAOLICCHI;DAVIDE MEI;ELENA CHIAPPINI;MAURIZIO DE MARTINO;LORENZO GENITORI;GIUSEPPE INDOLFI;ANDREA MESSERI;LUCA FILIPPI;ILARIA PAGNINI;FERRONI TOMMASO","1.71;1.69;1;0.97;0.88;0.83;0.76;0.74;0.66;0.65;0.64;0.63;0.62;0.61;0.56;0.56;0.54;0.54;0.52;0.5","ROLANDO CIMAZ;RENZO GUERRINI;SEZA ÖZEN;STEFANIA VIOLA;MAURIZIO ARICÒ;CARINE WOUTERS;PIERRE QUARTIER;ALBERTO MARTINI;ALEXEI A. GROM;BERIT FLATØ;BO MAGNUSSON;DANIEL J. LOVELL;DENNIS KIM;FLÁVIO SZTAJNBOK;GERD HORNEFF;HERMINE I. BRUNNER;INMACULADA CALVO;ISABELLE KONÉ‐PAUT;K. LHERITIER;KENNETH ABRAMS","1485;843;806;798;761;717;717;648;648;648;648;648;648;648;648;648;648;648;648;648","ROLANDO CIMAZ;MAURIZIO ARICÒ;RENZO GUERRINI;CARLA MARINI;PAOLA ROMAGNANI;PAOLO LIONETTI;GABRIELE SIMONINI;MAURIZIO DE MARTINO;DAVIDE MEI;MONICA DI PAOLA;ELISABETTA PASQUINI;SALVATORE DE MASI;ELENA CHIAPPINI;TIZIANA PISANO;BIAGIO OLIVITO;LUISA GALLI;ILARIA PAGNINI;ROBERTO CAPUTO;FRANCESCO MANNELLI;MARIA ELISABETTA ZANNIN","1485;761;693;434;421;393;321;306;275;271;250;250;248;212;186;184;164;157;154;150","RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO ARICÒ;MAURIZIO DE MARTINO;ELENA CHIAPPINI;GABRIELE SIMONINI;DESIRÉE CASELLI;ANTONIO MESSINEO;CARLA MARINI;DAVIDE MEI;FRANCESCO MANNELLI;IACOPO SARDI;LUISA GALLI;CHIARA AZZARI;ILARIA PAGNINI;LAURA GIUNTI;LORENZO GENITORI;SARA SAVELLI;SARA SOLLAI;TIZIANA PISANO","16;14;9;8;7;7;6;5;5;5;5;5;5;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;POLITICAL SCIENCE;ENGINEERING;SOCIOLOGY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY","108;63;10;9;7;6;5;4;3;3;2;1;1","INTERNAL MEDICINE;GENETICS;SURGERY;PATHOLOGY;PEDIATRICS;IMMUNOLOGY;BIOCHEMISTRY;PSYCHIATRY;ANESTHESIA;INTENSIVE CARE MEDICINE;NEUROSCIENCE;RADIOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;OPTICS;PHYSICAL THERAPY;ENDOCRINOLOGY;LAW","70;38;30;28;28;23;21;13;10;10;10;10;9;8;8;8;7;7;7;6;6","GENE;DISEASE;EPILEPSY;IMMUNE SYSTEM;CHEMOTHERAPY;POPULATION;PREGNANCY;ARTHRITIS;CANCER;COHORT;INCIDENCE (GEOMETRY);ANTIBIOTICS;ANTIBODY;COHORT STUDY;CONFIDENCE INTERVAL;CYSTIC FIBROSIS;IMMUNOHISTOCHEMISTRY;MAGNETIC RESONANCE IMAGING;MEDLINE;RECEPTOR","33;15;14;10;9;8;7;6;6;6;6;5;5;5;5;5;5;5;5;5","MUTATION;GENOTYPE;PHENOTYPE;ALLELE;GESTATIONAL AGE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;CD8;GENOME;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;ICTAL;LYMPHOBLASTIC LEUKEMIA;POLYMERASE CHAIN REACTION;T CELL;ANAKINRA;AUTOIMMUNITY;BIRTH WEIGHT;CANCER STEM CELL;CELLULAR DIFFERENTIATION;CHEMOTHERAPY REGIMEN;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;CORTICAL DYSPLASIA;CROHN'S DISEASE;DRAVET SYNDROME;FOXP3;HEART RATE;HEDGEHOG;HEDGEHOG SIGNALING PATHWAY;HYPOXIC ISCHEMIC ENCEPHALOPATHY;IMATINIB;INDUCTION CHEMOTHERAPY;INFLAMMATORY BOWEL DISEASE;JUVENILE MYOCLONIC EPILEPSY;MONOCLONAL ANTIBODY;MYCOBACTERIUM TUBERCULOSIS;NEUTROPENIA;NUSS PROCEDURE;POLYARTHRITIS;PROGENITOR CELL;SPIROMETRY;TRANSCRIPTION FACTOR","13;7;7;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PROBAND;RETINOPATHY OF PREMATURITY;SANGER SEQUENCING;BRADYCARDIA;CALPROTECTIN;CANAKINUMAB;CYCLOPAMINE;GLI1;HAPLOINSUFFICIENCY;IDH1;LATENT TUBERCULOSIS;OLIGOARTHRITIS;PENETRANCE;PERFORIN;SMOOTHENED;ACTIVE TUBERCULOSIS;ACUTE LYMPHOCYTIC LEUKEMIA;ACYL COA DEHYDROGENASE;ADENOSINE DEAMINASE DEFICIENCY;ADENOSINE RECEPTOR;ADIPOKINE;ADIPONECTIN;AMPLICON;ANTI-NUCLEAR ANTIBODY;ANTIRETROVIRAL THERAPY;ANTIVIRAL THERAPY;BRONCHOPULMONARY DYSPLASIA;CASPOFUNGIN;CD24;CD28;CD3;CHEMOKINE RECEPTOR;CHILDHOOD LEUKEMIA;CHROMOSOME 15;CHROMOSOME 21;CLAVULANIC ACID;CLINICAL PHENOTYPE;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;CONGENITAL NEUTROPENIA;CONGENITAL SYPHILIS;CONJUGATE VACCINE;CORNEAL NEOVASCULARIZATION;CROHN DISEASE;DNA METHYLATION;DYSKINESIA;ELISPOT;ENDOVASCULAR COILING;ENTHESITIS;EXHALED NITRIC OXIDE;EXOME SEQUENCING;FABRY'S DISEASE;FEBRILE NEUTROPENIA;FILAMIN;FILGRASTIM;FIRST TRIMESTER;FLUORESCENCE IN SITU HYBRIDIZATION;FRAMESHIFT MUTATION;FRUCTOSE-BISPHOSPHATE ALDOLASE;GENE MUTATION;GENOMICS;GENOTYPING;GLI2;GLUT1;HAPLOTYPE;HYPERGLYCINEMIA;IL-2 RECEPTOR;IMATINIB MESYLATE;INDUCED PLURIPOTENT STEM CELL;JURKAT CELLS;KARYOTYPE;LEUKAPHERESIS;MENINGOCOCCAL DISEASE;MENINGOCOCCAL VACCINE;MICROSATELLITE;MIGRAINE WITH AURA;MISSENSE MUTATION;MITOCHONDRIAL MYOPATHY;MOLECULAR MEDICINE;MUCOPOLYSACCHARIDOSIS I;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;MULTIPLEX POLYMERASE CHAIN REACTION;MUTATION TESTING;NODULAR SCLEROSIS;NONSYNONYMOUS SUBSTITUTION;ONCOGENE;ORPHAN RECEPTOR;PACHYGYRIA;PHILADELPHIA CHROMOSOME;PILOCYTIC ASTROCYTOMA;PODOCYTE;PRIMARY TUMOR;PROGENITOR;PROTOCADHERIN;PTEN;PULSELESS ELECTRICAL ACTIVITY;RAR-RELATED ORPHAN RECEPTOR GAMMA;RENAL STEM CELL;RIBAVIRIN;SERUM AMYLOID A PROTEIN;SINGLE-NUCLEOTIDE POLYMORPHISM;SOD2;SOX2;TELOMERASE REVERSE TRANSCRIPTASE;THROAT CULTURE;TUMOR INITIATION;VANCOMYCIN;VARIANTS OF PCR;WILD TYPE","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;CHILD, PRESCHOOL;ADOLESCENT;;INFANT;ITALY;ADULT;YOUNG ADULT;ARTHRITIS, JUVENILE;MUTATION;INFANT, NEWBORN;INFLAMMATION;RETROSPECTIVE STUDIES;MALFORMATIONS OF CORTICAL DEVELOPMENT;BRAIN NEOPLASMS;PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC","92;66;58;50;43;33;29;27;23;20;16;15;15;14;14;14;12;11;11;10","EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;GLIOMAS;MINIMALLY INVASIVE REPAIR OF PECTUS EXCAVATUM;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;CLINICAL CHARACTERISTICS AND MANAGEMENT OF SARCOIDOSIS;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;DIAGNOSIS AND TREATMENT OF RETINOPATHY OF PREMATURITY;EPIDEMIOLOGY AND TREATMENT OF CHILDHOOD LEUKEMIA;ESOPHAGEAL INTERVENTION TECHNIQUES;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;HEDGEHOG SIGNALING IN DEVELOPMENT AND CANCER;HEMATOPOIETIC STEM CELL BIOLOGY;MANAGEMENT OF FEBRILE NEUTROPENIA IN CANCER PATIENTS;NEONATAL BRAIN INJURY AND DEVELOPMENTAL CONSEQUENCES;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT","5;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2","INBORN ERRORS OF METABOLISM;EPILEPSY;JUVENILE IDIOPATHIC ARTHRITIS;PAIN ASSESSMENT TOOLS;PECTUS EXCAVATUM;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT;CHEST WALL DEFORMITIES;CYSTIC FIBROSIS;EWING'S SARCOMA;FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HYPOTHERMIA TREATMENT;PAIN MANAGEMENT;PEDIATRIC PAIN;PRETERM INFANTS;PROBAND;REGIMEN;SANGER SEQUENCING;AIRWAY STENOSIS","5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2","DI CHIRURGIA;IDIOPATHIC ARTHRITIS;ITALIANA DI;JUVENILE IDIOPATHIC;PECTUS EXCAVATUM;SOCIETÀ ITALIANA;ACUTE LYMPHOBLASTIC;CYSTIC FIBROSIS;FAMILIAL HEMOPHAGOCYTIC;COHORT STUDY;DISEASE ACTIVITY;DISEASE PATIENTS;FOCAL CORTICAL;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;LATENT TUBERCULOSIS;LYMPHOBLASTIC LEUKEMIA;MOLECULAR FEATURES;MULTICENTER STUDY;NEWBORN SCREENING;PROSPECTIVE STUDY;REDUCE PAIN;TUMOR NECROSIS;TUSCANY ITALY;ACCESS PORTS;ACID ORPHAN;ACID SUSPENSION;ACOI SOCIETÀ;ACQUIRED APLASTIC;ACTIVITY ASSESSMENT;ACTIVITY SCORE","4;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","AMINOTRANSFERASE LEVELS;CF PATIENTS;SERUM AMINOTRANSFERASE;ACUTE LYMPHOBLASTIC;RAISED SERUM;STEM CELL;ACTIVE JOINTS;CDCDCD CELLS;SIGNIFICANTLY LOWER;EVENT-FREE SURVIVAL;JOINTS RHO;JUVENILE IDIOPATHIC;MINIMAL RESIDUAL;RESIDUAL DISEASE;STRUCTURAL VARIANTS;TREG CELLS;ACUTE MYELOID;DIFFERENTIAL DIAGNOSIS;DISEASE ACTIVITY;FEBRILE SEIZURES;IDIOPATHIC ARTHRITIS;NEWBORN SCREENING;PATHOGENIC STRUCTURAL;PINE NUT;RS PMETA;ACTIVE TB;ANTIFUNGAL THERAPY;CELL LINES;CHILDREN AGED;CRANIAL NEUROSURGERY","13;12;11;8;8;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4",52,0.42,6.12,5.25,1,1,1.75,1,3,1,1,6,0,1,5,1,2,1,3,5,1,0,0,92.75,92.75,4,0,3,3,0,2,0,0,0,0,0,0,4,2,2,6,3.5,7.98,1.75,0,6,6,0,0,3,1,0,1,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,1,0,1,0,2,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"LA MARCA GIANCARLO;CERDA BLAS;CHERKASSKIY ALEX;LI YIJUN;AZZARI CHIARA;RESTI MASSIMO;AZZARI, CHIARA;MORIONDO MARIA;MORIONDO, MARIA;RESTI, MASSIMO","6;4;4;4;3;3;1;1;1;1","AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO UNIVERSITARIA MEYER DI FIRENZE;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;PERKINELMER HEALTH SCI INC;PERKINELMER HEALTH SCIENCES INC","4;4;2;2;2","34 CHEMICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3207 MEDICAL MICROBIOLOGY","11;6;6;1;1;1","GENETICS;LUNG;PNEUMONIA;PNEUMONIA & INFLUENZA","2;2;2;2",NA,NA,"B01L99/00;A61K31/185;A61K31/41;G01N33/68;C12Q1/68;G01N33/48;G01N33/66;H01J49/26","4;3;3;3;2;1;1;1","A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833;Y10T436/201666;Y10T436/24;Y10T436/2525","4;4;4;4;4;4;4;4;4;4",2,7,605,1.14,0,0,75,0,0,0,0,2,0,0,0,0,1,0,0,0,0,0,0,0,2,0,0,1,1,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3107 MICROBIOLOGY","2;2;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EPILEPSY;NEURODEGENERATIVE;NEUROSCIENCES;PEDIATRIC;PREVENTION","1;1;1;1;1;1;1;1","CONGENITAL;INFECTION","1;1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2013,147,12.2517006802721,2.84353741496599,0.45578231292517,0.346938775510204,0.45578231292517,2.22340425531915,1.24074074074074,1.64516129032258,1.31372549019608,0.54421768707483,3,64,54,7,10,0.44,0.37,0.05,0.07,38.94,1.11596197802109,5.80170940170941,0.408163265306122,0.931972789115646,0.512,0.516,0.476,0.514,"RENZO GUERRINI;ROLANDO CIMAZ;LUCA CANTARINI;GABRIELE SIMONINI;GIANCARLO LA MARCA;MARIA ALICE DONATI;LUISA GALLI;ELENA CHIAPPINI;MAURIZIO DE MARTINO;MAURIZIO ARICÒ;AMELIA MORRONE;ORSO MARIA LUCHERINI;LAURA OBICI;SABRINA MALVAGIA;FRANCA RUSCONI;JORDI ANTÓN;GIAMPAOLO MERLINI;CHIARA AZZARI;ILARIA PAGNINI;STEFANO STAGI","25;24;14;13;11;10;10;10;10;9;8;8;8;7;7;6;6;5;5;5","MARIA SERENELLA PIGNOTTI;ROLANDO CIMAZ;RENZO GUERRINI;ELENA CHIAPPINI;MAURIZIO DE MARTINO;GABRIELE SIMONINI;LUISA GALLI;GIANCARLO LA MARCA;LUCA CANTARINI;STEFANO STAGI;MARIA ALICE DONATI;AMELIA MORRONE;FRANCA RUSCONI;MASSIMO RESTI;CHIARA AZZARI;PATRIZIO FIORINI;ILARIA PAGNINI;MARIA LUISA BRANDI;MAURIZIO ARICÒ;SABRINA MALVAGIA","3.33;2.92;2.27;1.92;1.86;1.77;1.42;1.25;1.18;1.12;0.92;0.89;0.83;0.82;0.74;0.74;0.74;0.72;0.7;0.7","RENZO GUERRINI;ROLANDO CIMAZ;GABRIELE SIMONINI;GIANCARLO LA MARCA;MARIA ALICE DONATI;LUISA GALLI;ELENA CHIAPPINI;MAURIZIO DE MARTINO;MAURIZIO ARICÒ;AMELIA MORRONE;SABRINA MALVAGIA;FRANCA RUSCONI;CHIARA AZZARI;ILARIA PAGNINI;STEFANO STAGI;DAVIDE MEI;MASSIMO RESTI;SILVIA FUNGHINI;PAOLO LIONETTI;TERESA GIANI","25;24;13;11;10;10;10;10;9;8;7;7;5;5;5;5;5;5;4;4","MARIA SERENELLA PIGNOTTI;ROLANDO CIMAZ;RENZO GUERRINI;ELENA CHIAPPINI;MAURIZIO DE MARTINO;GABRIELE SIMONINI;LUISA GALLI;GIANCARLO LA MARCA;STEFANO STAGI;MARIA ALICE DONATI;AMELIA MORRONE;FRANCA RUSCONI;MASSIMO RESTI;CHIARA AZZARI;PATRIZIO FIORINI;ILARIA PAGNINI;MAURIZIO ARICÒ;SABRINA MALVAGIA;ANTONIO MESSINEO;ENRICO LOMBARDI","3.33;2.92;2.27;1.92;1.86;1.77;1.42;1.25;1.12;0.92;0.89;0.83;0.82;0.74;0.74;0.74;0.7;0.7;0.67;0.61","RENZO GUERRINI;MAURIZIO ARICÒ;ROLANDO CIMAZ;FRANCESCA DARRA;LUCA CANTARINI;ELENA PARRINI;PASQUALE STRIANO;ANNIE ANDRIEUX;BENJAMIN SAINT PIERRE;BERNARDO DALLA BERNADINA;CLAUDE CANCÈS;CYRIL GITIAUX;CÉCILE BOSCHERON;CÉCILE MASSON;DAVID GENEVIÈVE;DIANA ZÉLÉNIKA;DIDIER LACOMBE;DOMINIQUE BONNEAU;ELENA FONTANA;FIONA FRANCIS","1312;757;649;564;544;541;490;448;448;448;448;448;448;448;448;448;448;448;448;448","RENZO GUERRINI;MAURIZIO ARICÒ;ROLANDO CIMAZ;ELENA PARRINI;ELEONORA GAMBINERI;PAOLO LIONETTI;MARIA ALICE DONATI;MAURIZIO DE MARTINO;DAVIDE MEI;GIANCARLO LA MARCA;GABRIELE SIMONINI;CARLA MARINI;MARINA VIGNOLI;SARA CIULLINI MANNURITA;AMELIA MORRONE;LUCA FILIPPI;FRANCO BAMBI;MICHELE SACCHINI;MARIA LUISA DELLA BONA;LUISA GALLI","780;678;649;541;420;378;300;269;263;235;227;225;220;220;186;185;175;173;159;155","ROLANDO CIMAZ;RENZO GUERRINI;MAURIZIO DE MARTINO;GABRIELE SIMONINI;ELENA CHIAPPINI;MARIA ALICE DONATI;GIANCARLO LA MARCA;LUISA GALLI;MAURIZIO ARICÒ;AMELIA MORRONE;FRANCA RUSCONI;SABRINA MALVAGIA;MASSIMO RESTI;SILVIA FUNGHINI;STEFANO STAGI;DAVIDE MEI;CHIARA AZZARI;ELISABETTA VENTURINI;ENRICO LOMBARDI;LORENZO FERRI","22;22;12;11;10;10;10;9;7;7;6;6;5;5;5;5;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;ENGINEERING;POLITICAL SCIENCE;SOCIOLOGY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;HISTORY;MATERIALS SCIENCE;PHILOSOPHY","135;73;18;13;12;5;5;5;3;3;2;2;2;2","INTERNAL MEDICINE;GENETICS;PEDIATRICS;IMMUNOLOGY;PATHOLOGY;SURGERY;ENVIRONMENTAL HEALTH;PSYCHIATRY;ENDOCRINOLOGY;BIOCHEMISTRY;NEUROSCIENCE;INTENSIVE CARE MEDICINE;OPTICS;DERMATOLOGY;PHYSICAL THERAPY;BIOINFORMATICS;CHROMATOGRAPHY;FAMILY MEDICINE;GASTROENTEROLOGY;RADIOLOGY","92;59;52;22;19;18;16;16;14;13;13;12;9;7;7;6;6;6;6;6","GENE;DISEASE;EPILEPSY;COHORT;POPULATION;PREGNANCY;RHEUMATOLOGY;INCIDENCE (GEOMETRY);PNEUMONIA;RETROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;MASS SPECTROMETRY;FAMILY HISTORY;NEWBORN SCREENING;REGIMEN;TUMOR NECROSIS FACTOR ALPHA;UVEITIS;ADVERSE EFFECT;ANTIBIOTICS;ARTHRITIS;CANCER;CENTRAL NERVOUS SYSTEM;EPIDEMIOLOGY;IMMUNE SYSTEM;LUNG;OSTEOPOROSIS;VIRUS","42;33;16;14;14;14;14;8;7;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","MUTATION;PHENOTYPE;TANDEM MASS SPECTROMETRY;GESTATIONAL AGE;INFLIXIMAB;ADALIMUMAB;ANAKINRA;BEHCET'S DISEASE;EXON;MICRORNA;MITOCHONDRIAL DNA;VASCULITIS;BONE MASS;CD8;COMMUNITY-ACQUIRED PNEUMONIA;CUMULATIVE INCIDENCE;DRAVET SYNDROME;ENZYME REPLACEMENT THERAPY;ETANERCEPT;FABRY DISEASE;GENE EXPRESSION;GENOTYPE;LIQUID CHROMATOGRAPHY–MASS SPECTROMETRY;PROGRAMMED CELL DEATH;RELATIVE RISK","18;12;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","MISSENSE MUTATION;PENETRANCE;MITOCHONDRIAL DISEASE;MITOCHONDRIAL ENCEPHALOMYOPATHY;POINT MUTATION;RETINAL VASCULITIS;CLINICAL PHENOTYPE;COPY-NUMBER VARIATION;ESOPHAGITIS;FAS RECEPTOR;GERMLINE MUTATION;HETEROPLASMY;MICROARRAY;PEAK BONE MASS;PERFORIN;RETINOPATHY OF PREMATURITY;SINGLE-NUCLEOTIDE POLYMORPHISM;ABATACEPT;ADENOSINE DEAMINASE DEFICIENCY;ADIPOKINE;ADIPONECTIN;ALTERNATIVE SPLICING;ANTERIOR TEMPORAL LOBECTOMY;ANTIRETROVIRAL THERAPY;BONE HEALTH;BRADYCARDIA;BRONCHOPULMONARY DYSPLASIA;CANAKINUMAB;CASPASE;CD40;CHROMATIN REMODELING;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);DNA FRAGMENTATION;DUP;EXOME SEQUENCING;FILAMIN;FRAMESHIFT MUTATION;GANGLIONIC EMINENCE;GENETIC HETEROGENEITY;GLOBUS PALLIDUS;HAPLOINSUFFICIENCY;HAPLOTYPE;HBSAG;HEMIMEGALENCEPHALY;HEMOPHAGOCYTOSIS;HIPPOCAMPAL SCLEROSIS;HYDRANENCEPHALY;HYPERTRIGLYCERIDEMIA;IL-2 RECEPTOR;INTRAUTERINE GROWTH RESTRICTION;INTRAVENTRICULAR HEMORRHAGE;ISOTYPE;KEARNS–SAYRE SYNDROME;KETOACIDOSIS;KRABBE DISEASE;KRAS;LOSS FUNCTION;MALE INFERTILITY;MATURITY ONSET DIABETES OF THE YOUNG;MENINGOCOCCAL DISEASE;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MIGRAINE WITH AURA;MITOCHONDRIAL MYOPATHY;MUCOPOLYSACCHARIDOSIS I;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NEONATAL DEATH;NOD2;NON-MENDELIAN INHERITANCE;ONCOGENE;OSTEOCALCIN;PERIVENTRICULAR LEUKOMALACIA;PNEUMOCOCCAL CONJUGATE VACCINE;PNEUMOCOCCAL PNEUMONIA;PREMATURE BIRTH;PROBAND;RESPIRATORY ALLERGY;SELECTED REACTION MONITORING;SEMEN ANALYSIS;SIDA;SKIN INFECTION;SMALL FOR GESTATIONAL AGE;STAPHYLOCOCCAL INFECTIONS;STEREOELECTROENCEPHALOGRAPHY;TRANSCRIPTOME;UREA CYCLE;VASCULAR ENDOTHELIAL GROWTH FACTOR A;VIRAL ENCEPHALITIS;VISUAL SHORT-TERM MEMORY;ZONISAMIDE","5;5;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;CHILD;;ADOLESCENT;CHILD, PRESCHOOL;ITALY;ADULT;INFANT;YOUNG ADULT;MIDDLE AGED;MUTATION;RETROSPECTIVE STUDIES;INFANT, NEWBORN;MEMBRANE PROTEINS;BRAIN;COMMUNITY-ACQUIRED INFECTIONS;HEREDITARY AUTOINFLAMMATORY DISEASES;MAGNETIC RESONANCE IMAGING","94;64;64;53;52;40;31;31;30;25;22;19;18;16;15;15;11;11;11;11","EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;CLASSIFICATION AND INTERVENTIONS FOR CEREBRAL PALSY;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;AUTISM SPECTRUM DISORDERS;CLINICAL CHARACTERISTICS AND MANAGEMENT OF SARCOIDOSIS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORS;VITAMIN D AND HEALTH OUTCOMES;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;BREASTFEEDING: EPIDEMIOLOGY, MECHANISMS, AND HEALTH OUTCOMES","6;6;6;5;5;5;5;4;4;3;3;2;2;2;2;2;2;1;1;1","INBORN ERRORS OF METABOLISM;PRETERM INFANTS;CHILDHOOD PNEUMONIA;NEWBORN SCREENING;REGIMEN;TREATMENT;AUTISM;PENETRANCE;SEIZURES;COMMUNITY-ACQUIRED PNEUMONIA;CROSS-SECTIONAL STUDY;DEEP LEARNING FOR EEG;DRAVET SYNDROME;DRIED BLOOD SPOT;EEG ANALYSIS;EPILEPSY DETECTION;INFLAMMATION;JUVENILE IDIOPATHIC ARTHRITIS;MITOCHONDRIAL DISEASE;MITOCHONDRIAL ENCEPHALOMYOPATHY","6;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","CIRCULATING MICRORNAS;SYNDROME TRAPS;BEHCETS DISEASE;BONE MASS;FACTOR RECEPTOR-ASSOCIATED;GROWTH FACTOR;NECROSIS FACTOR;PED-BD COHORT;PEDIATRIC PATIENTS;PERIODIC SYNDROME;RECEPTOR-ASSOCIATED PERIODIC;AMBULANT BOYS;ANDERSONFABRY DISEASE;CANCER RISK;CHILDREN BORN;CHRONIC UVEITIS;CLINICAL FEATURES;COHORT EXPERT;COHORT STUDY;COMMUNITYACQUIRED PNEUMONIA;CONSENSUS CLASSIFICATION;DEFINE BEHCETS;DISEASES TREATED;DRAVET SYNDROME;DRIED BLOOD;DUCHENNE MUSCULAR;EDITORIAL HOT;ENCEPHALOMYOPATHY DUE;ENDOTHELIAL GROWTH;EXPERT CONSENSUS","4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;DE NOVO;GENET -CROSSREF;EXOME SEQUENCING;INTELLECTUAL DISABILITY;DRAVET SYNDROME;FABRY DISEASE;MACROCYTIC ANEMIA;AFFECTED INDIVIDUALS;MYOCLONIC SEIZURES;AUTISM SPECTRUM;NODULAR HETEROTOPIA;NOVO MUTATIONS;PERIVENTRICULAR NODULAR;RED BLOOD;BLOOD CELL;CHD MUTATION;FAST OSCILLATIONS;HUM GENET;MB DELETION;CONFIDENCE INTERVAL;CORNEA VERTICILLATA;GENERALIZED SEIZURES;GENERALIZED TONIC-CLONIC;GENET -ABSTRACT;GROSS MOTOR;INCLUDING CHD;INCLUSION CRITERIA;LACTIC ACIDOSIS","82;61;23;13;12;12;11;10;10;9;9;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6",53,0.36,7.83,6,1.75,1,1.75,2.5,1,1,1,6,0,1,5.25,0,1.25,1,2.5,3.5,1,0,0,108,90,2,0,0,1,0,2,0,0,0,0,0,0,0,2,1,0,3.33333333333333,2.39,1.66666666666667,0,2,3,0,0,1,0,1,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"LA MARCA GIANCARLO;AZZARI CHIARA;RESTI MASSIMO;CERDA BLAS;CHERKASSKIY ALEX;LI YIJUN","3;2;2;1;1;1","AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO UNIVERSITARIA MEYER DI FIRENZE;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;PERKINELMER HEALTH SCIENCES INC","2;1;1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;32 BIOMEDICAL AND CLINICAL SCIENCES","3;2;1",NA,NA,NA,NA,"G01N33/66;A61K31/185;A61K31/41;B01L99/00","2;1;1;1","G01N33/492;G01N33/66;H01J49/005;H01J49/0459;A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777","2;2;2;2;1;1;1;1;1;1",8,3.38,70.86,4.57,2,0.25,12.75,1,1,3,2,0,0,0,1,0,7,0,0,0,0,0,0,0,8,0,0,6,1,0,1,0,0,0,0,0,0,"Belgium;Switzerland;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;3202 CLINICAL SCIENCES;3213 PAEDIATRICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES","8;4;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EYE DISEASE AND DISORDERS OF VISION;PEDIATRIC;RARE DISEASES;INFANT MORTALITY;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;PRETERM, LOW BIRTH WEIGHT AND HEALTH OF THE NEWBORN;PREVENTION;ARTHRITIS;AUTOIMMUNE DISEASE;CANCER;IMMUNIZATION;NEUROBLASTOMA;NEUROSCIENCES;ORPHAN DRUG;PATIENT SAFETY;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;VACCINE RELATED","5;5;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","EYE;INFLAMMATORY AND IMMUNE SYSTEM","2;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","4;2","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BRAIN TUMOR;NEUROBLASTOMA;SARCOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"PUBLIC LIBRARY OF SCIENCE","8","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3202 CLINICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;3105 GENETICS;3204 IMMUNOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;49 MATHEMATICAL SCIENCES;4904 PURE MATHEMATICS","11;3;3;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;BIOTECHNOLOGY;CANCER;GENETICS","2;1;1;1","CANCER","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS","2;1","BIOMEDICAL","2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","4;1","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_MEYER",2014,172,13.6860465116279,2.83720930232558,0.395348837209302,0.331395348837209,0.5,2.06779661016949,1.30769230769231,1.46153846153846,1.40983606557377,0.622093023255814,5,92,44,9,16,0.53,0.26,0.05,0.09,43.44,1.14935409832858,6.05735294117647,0.406976744186047,0.924418604651163,0.485,0.476,0.501,0.462,"RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;SABRINA GIGLIO;CHIARA AZZARI;STEFANO STAGI;MARIA ALICE DONATI;GIANCARLO LA MARCA;IACOPO SARDI;GABRIELE SIMONINI;FLAVIO GIORDANO;LAURA GIUNTI;TERESA GIANI;MAURIZIO ARICÒ;ANGELA TAMBURINI;MAURIZIO DE MARTINO;PAOLO LIONETTI;RICCARDO CICCHI;SURESH ANAND;FRANCESCO S. PAVONE","22;16;14;12;10;10;9;8;7;7;7;7;6;6;6;6;5;5;5;5","RENZO GUERRINI;MAURIZIO DE MARTINO;ROLANDO CIMAZ;STEFANO STAGI;MARCO GHIONZOLI;CHIARA AZZARI;MARIA SERENELLA PIGNOTTI;MARCO DE LUCA;F TONDI;GIANPAOLO DONZELLI;MAURIZIO DE MARTINO;SABRINA GIGLIO;GABRIELE SIMONINI;FLAVIO GIORDANO;TERESA GIANI;ILARIA PAGNINI;GIANCARLO LA MARCA;IACOPO SARDI;GIUSEPPE INDOLFI;FERNANDA FALCINI","2.1;1.76;1.64;1.49;1.49;1.3;1;1;1;1;0.93;0.92;0.91;0.75;0.73;0.72;0.64;0.63;0.62;0.61","RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;SABRINA GIGLIO;CHIARA AZZARI;STEFANO STAGI;MARIA ALICE DONATI;GIANCARLO LA MARCA;IACOPO SARDI;GABRIELE SIMONINI;FLAVIO GIORDANO;LAURA GIUNTI;TERESA GIANI;MAURIZIO ARICÒ;ANGELA TAMBURINI;MAURIZIO DE MARTINO;PAOLO LIONETTI;RICCARDO CICCHI;S. CARDELLICCHIO;ANNA MARIA BUCCOLIERO","22;16;14;12;10;10;9;8;7;7;7;7;6;6;6;6;5;5;5;5","RENZO GUERRINI;MAURIZIO DE MARTINO;ROLANDO CIMAZ;STEFANO STAGI;MARCO GHIONZOLI;CHIARA AZZARI;MARIA SERENELLA PIGNOTTI;MARCO DE LUCA;F TONDI;GIANPAOLO DONZELLI;MAURIZIO DE MARTINO;SABRINA GIGLIO;GABRIELE SIMONINI;FLAVIO GIORDANO;TERESA GIANI;ILARIA PAGNINI;GIANCARLO LA MARCA;IACOPO SARDI;GIUSEPPE INDOLFI;RICCARDO CICCHI","2.1;1.76;1.64;1.49;1.49;1.3;1;1;1;1;0.93;0.92;0.91;0.75;0.73;0.72;0.64;0.63;0.62;0.58","PAOLO LIONETTI;A. BARABINO;ERASMO MIELE;FRANK M. RUEMMELE;JORGE AMIL DIAS;RENZO GUERRINI;ABRAHAM R. ELIAKIM;ANDERS PÆRREGAARD;ANNE M. GRIFFITHS;ARIE LEVINE;AXEL DIGNAß;B. WEIß;CHRISTIAN BRAEGGER;DAN TURNER;DANIELA ELENA SERBAN;DAVID C. WILSON;GIGI VEEREMAN;GÁBOR VERES;HARLAND S. WINTER;JAROSŁAW KIERKUŚ","1181;1068;1068;1048;1048;1045;940;940;940;940;940;940;940;940;940;940;940;940;940;940","PAOLO LIONETTI;RENZO GUERRINI;ROLANDO CIMAZ;ELENA PARRINI;MARIA ALICE DONATI;P. CATASTINI;CHIARA AZZARI;ANGELA TAMBURINI;MAURIZIO DE MARTINO;MICHELE SACCHINI;CARMEN BARBA;GIANCARLO LA MARCA;FRANCO BAMBI;SABRINA GIGLIO;ANNA MARIA BUCCOLIERO;BARBARA ATZORI;IACOPO SARDI;STEFANO STAGI;SIMONA CAPRILLI;MARCO MATERASSI","1181;939;725;494;490;443;414;359;330;312;297;250;204;203;182;168;152;148;141;140","RENZO GUERRINI;MAURIZIO DE MARTINO;ROLANDO CIMAZ;CHIARA AZZARI;MARIA ALICE DONATI;SABRINA GIGLIO;STEFANO STAGI;IACOPO SARDI;GIANCARLO LA MARCA;GABRIELE SIMONINI;ANGELA TAMBURINI;LAURA GIUNTI;TERESA GIANI;ILARIA PAGNINI;FLAVIO GIORDANO;CARMEN BARBA;PAOLO LIONETTI;ANNA MARIA BUCCOLIERO;FRANCA RUSCONI;MAURIZIO ARICÒ","18;17;16;10;9;8;8;7;7;7;6;6;6;6;6;5;5;5;5;5","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;SOCIOLOGY;ECONOMICS;POLITICAL SCIENCE;ENGINEERING;ART;BUSINESS;HISTORY","157;76;19;14;11;7;7;7;5;5;4;4;2;1;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;PATHOLOGY;SURGERY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;NEUROSCIENCE;ONCOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;OPTICS;CANCER RESEARCH;INTENSIVE CARE MEDICINE;RADIOLOGY;PHYSICAL THERAPY;ENDOCRINOLOGY;MICROBIOLOGY;CLINICAL PSYCHOLOGY","104;56;48;37;32;30;19;15;15;15;13;13;12;11;11;11;10;9;8;7","GENE;DISEASE;RHEUMATOLOGY;CHEMOTHERAPY;POPULATION;EPILEPSY;CANCER;ARTHRITIS;COHORT;PREGNANCY;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;JUVENILE;ANTIBIOTICS;ANTIBODY;ANXIETY;CENTRAL NERVOUS SYSTEM;CLINICAL TRIAL;CONFIDENCE INTERVAL;CYSTIC FIBROSIS;EPIDEMIOLOGY;FLUORESCENCE;RAMAN SPECTROSCOPY;RANDOMIZED CONTROLLED TRIAL;VACCINATION","42;32;17;14;13;12;11;10;10;9;7;7;6;5;5;5;5;5;5;5;5;5;5;5;5","MUTATION;PHENOTYPE;CISPLATIN;CLINICAL ENDPOINT;GENOTYPE;FLUORESCENCE SPECTROSCOPY;GENOME;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;STREPTOCOCCUS PNEUMONIAE;CORTICAL DYSPLASIA;CRONBACH'S ALPHA;CYTOTOXICITY;DOWNREGULATION AND UPREGULATION;DOXORUBICIN;ETOPOSIDE;EXON;GENE DUPLICATION;GESTATIONAL AGE;IMMUNIZATION;INFLAMMATORY BOWEL DISEASE;JUVENILE RHEUMATOID ARTHRITIS;KAWASAKI DISEASE","15;13;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","MISSENSE MUTATION;PNEUMOCOCCAL CONJUGATE VACCINE;SINGLE-NUCLEOTIDE POLYMORPHISM;COPY-NUMBER VARIATION;FRAMESHIFT MUTATION;HAPLOINSUFFICIENCY;ENTHESITIS;FANCONI ANEMIA;GENETIC HETEROGENEITY;HEMOPHAGOCYTOSIS;IFOSFAMIDE;NIMOTUZUMAB;P-GLYCOPROTEIN;PROBAND;RETINOPATHY OF PREMATURITY;SANGER SEQUENCING;VINORELBINE;ADULT STEM CELL;ALLELE FREQUENCY;ALTERNATIVE SPLICING;ANDROGEN DEPRIVATION THERAPY;ATP-BINDING CASSETTE TRANSPORTER;BONE MARROW FAILURE;BOOSTER DOSE;BRONCHOPULMONARY DYSPLASIA;CARBOPLATIN;CHILDHOOD LEUKEMIA;CHORIOAMNIONITIS;COLONOSCOPY;CONGENITAL NEUTROPENIA;COW'S MILK ALLERGY;CYTOLYSIS;DESMIN;DISCRIMINANT VALIDITY;DISEASE MANAGEMENT;DOMESTIC VIOLENCE;DYSKINESIA;EGG ALLERGY;FETAL TISSUE TRANSPLANTATION;FILGRASTIM;GENE DOSAGE;GENE MUTATION;GENOME INSTABILITY;GENOTYPING;GERMLINE MUTATION;GLOBUS PALLIDUS;GROWTH HORMONE DEFICIENCY;HEMATOPOIETIC GROWTH FACTOR;HEMIMEGALENCEPHALY;HERITABILITY OF AUTISM;HISTONE DEACETYLASE;HYPERINSULINISM;IL-2 RECEPTOR;IMPAIRED GLUCOSE TOLERANCE;INDUCED PLURIPOTENT STEM CELL;INSULIN PUMP;INTERFACE (MATTER);INTRAVENTRICULAR HEMORRHAGE;KERATAN SULFATE;MILK ALLERGY;MITOCHONDRIAL DISEASE;MUCOPOLYSACCHARIDOSIS TYPE II;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NEOADJUVANT THERAPY;NKG2D;ORAL FOOD CHALLENGE;PDGFRA;PERFORIN;PERIVENTRICULAR LEUKOMALACIA;PERTUSSIS VACCINE;PILOCYTIC ASTROCYTOMA;PNEUMOCOCCAL DISEASE;PNEUMOCOCCAL INFECTIONS;PNEUMOCOCCAL PNEUMONIA;PRENATAL DIAGNOSIS;PTEN;PURINE NUCLEOSIDE PHOSPHORYLASE;PYRIMETHAMINE;RAMAN MICROSCOPE;RENAL STEM CELL;RIBAVIRIN;RIGHT CORONARY ARTERY;RNA INTERFERENCE;RUBELLA;RYANODINE RECEPTOR 2;SOX2;SPIRAMYCIN;STRUCTURAL VARIATION;SYSTEMIC VASCULITIS;T-CELL RECEPTOR;THIOTEPA;TRANSLATION (BIOLOGY);UREA CYCLE;VACCINATION SCHEDULE;VILLOUS ATROPHY;WILD TYPE;ZONISAMIDE","5;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;;CHILD;ADOLESCENT;CHILD, PRESCHOOL;INFANT;ADULT;ITALY;EPILEPSY;MUTATION;YOUNG ADULT;INFANT, NEWBORN;MIDDLE AGED;TREATMENT OUTCOME;MAGNETIC RESONANCE IMAGING;ANIMALS;PHENOTYPE;RETROSPECTIVE STUDIES","108;81;73;61;56;44;43;33;31;28;23;23;21;20;18;16;14;12;12;12","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;EPILEPSY AND SEIZURES;GLIOMAS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;MOLECULAR MECHANISMS OF CARDIAC DEVELOPMENT AND REGENERATION;MOLECULAR MECHANISMS OF MUSCLE REGENERATION AND ATROPHY;SARCOMA RESEARCH AND TREATMENT;VITAMIN D AND HEALTH OUTCOMES;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;CLOSTRIDIUM DIFFICILE INFECTION AND TREATMENT;DIAGNOSIS AND TREATMENT OF RETINOPATHY OF PREMATURITY;EPIDEMIOLOGY AND PATHOGENESIS OF BACTERIAL MENINGITIS","9;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2","JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT;CLINICAL ENDPOINT;PAIN ASSESSMENT TOOLS;PAIN MEASUREMENT;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;PNEUMOCOCCAL CONJUGATE VACCINE;RAMAN SPECTROSCOPY;TISSUE DIAGNOSIS;VITAMIN D;AUTISM;BRAIN DEVELOPMENT;FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HAPLOINSUFFICIENCY;JUVENILE RHEUMATOID ARTHRITIS;KAWASAKI DISEASE;MEDICATION ADHERENCE;NEUROIMAGING;NONSENSE MUTATION","9;9;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;ITALIAN SOCIETY;LUPUS ERYTHEMATOSUS;CYSTIC FIBROSIS;DELETION SYNDROME;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;ITALIAN ASSOCIATION;JUVENILE SYSTEMIC;MOLECULAR ANALYSIS;SYSTEMIC LUPUS;ACTIVATION SYNDROME;ANTI-PSEUDOMONAS AERUGINOSA;ARTHRITIS JIA;BONE MARROW;BONE MASS;BOWEL DISEASE;BRAIN TUMORS;CANCER RISK;CHRONIC NEUTROPENIA;COELIAC DISEASE;DIFFUSE PONTINE;DRIED BLOOD;ENZYME REPLACEMENT;ERYTHEMATOSUS JSLE;FAILURE STUDY;FANCONI ANEMIA;FIBER PROBE;FIXED SAMPLES;FORMALIN FIXED","8;8;6;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;STEM CELLS;CROSSREF PUBMED;STEM CELL;NEPHROL -CROSSREF;SOC NEPHROL;LUNG INFECTION;POST-INFECTION COMPARED;RENAL PROGENITORS;S-IGY TREATED;EPITHELIAL CELLS;SIGNIFICANTLY REDUCED;CHRONIC DISEASES;COMPUTED TOMOGRAPHY;KIDNEY REGENERATION;MINUTE WALK;SIGNIFICANT DIFFERENCE;WALK TEST;CLINICAL SCORE;FANCONI ANEMIA;HEALTHY CONTROLS;MEDIAN AGE;PA LUNG;SAP EXPRESSION;SYSTEMIC JIA;TREATED MICE;BRAIN TUMORS;CELL BIOL;DISEASE ACTIVITY;IDIOPATHIC ARTHRITIS","43;35;33;27;15;13;12;12;12;12;11;10;9;9;9;9;9;9;8;8;8;8;8;8;8;8;7;7;7;7",69,0.4,8.75,7,2,1.75,0,2,3.5,1,1,8,0,1,5,0,4,1,1.25,4,2,0,0,91,91,3,0,1,0,0,2,0,0,0,0,0,0,1,2,0,0,3.33333333333333,2.05,2,0,3,2,2,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CERDA BLAS;CHERKASSKIY ALEX;LA MARCA GIANCARLO;LI YIJUN;AZZARI CHIARA;RESTI MASSIMO","2;2;2;2;1;1","AZIENDA OSPEDALIERO UNIVERSITARIA MEYER DI FIRENZE;AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;PERKINELMER HEALTH SCIENCES INC;PERKINELMER HEALTH SERVICES INC","2;1;1;1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;32 BIOMEDICAL AND CLINICAL SCIENCES;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS","6;3;2;1","CLINICAL RESEARCH;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD","1;1;1",NA,NA,"A61K31/185;A61K31/41;B01L99/00;G01N33/66","2;2;2;1","A61P3/00;G01N2800/04;G01N2800/50;G01N33/492;G01N33/64;G01N33/66;G01N33/6848;H01J49/005;H01J49/0459;Y10T436/147777","1;1;1;1;1;1;1;1;1;1",4,4.25,294.33,1.8,3,0.75,32.5,0,0,0,1,2,0,0,1,0,2,1,0,0,0,0,0,0,4,0,0,3,1,0,0,0,0,0,0,0,0,"Belgium;Canada;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;49 MATHEMATICAL SCIENCES","4;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CYSTIC FIBROSIS;HEMATOLOGY;LUNG;PEDIATRIC","2;2;2;1;1;1;1","BLOOD;CONGENITAL","1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","2;1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_MEYER",2015,182,13.2362637362637,2.89010989010989,0.357142857142857,0.335164835164835,0.461538461538462,2.02316602316602,1.2037037037037,1.69444444444444,1.35483870967742,0.554945054945055,4,95,46,15,15,0.52,0.25,0.08,0.08,30.48,0.817802188934986,5.87323943661972,0.434065934065934,0.945054945054945,0.496,0.469,0.442,0.444,"RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;GIANCARLO LA MARCA;GABRIELE SIMONINI;PAOLO LIONETTI;AMELIA MORRONE;LORENZO GENITORI;CHIARA AZZARI;SIMONA BARNI;LUISA GALLI;SABRINA GIGLIO;FLAVIO GIORDANO;CARLA MARINI;IACOPO SARDI;SABRINA BECCIANI;GIOVANNI TACCETTI;FRANCESCA MORI;ALESSIO MENGONI;SIMONE CESARO","28;17;14;10;9;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5","RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;GIANCARLO LA MARCA;SIMONA BARNI;MARIO MASCALCHI;GABRIELE SIMONINI;FRANCESCA MORI;ANDREA BASSI;PATRIZIO FIORINI;DIDIER MUSSO;LORENZO GENITORI;LUISA GALLI;MAURIZIO DE MARTINO;FLAVIO GIORDANO;STEFANO STAGI;ELIO NOVEMBRE;AMELIA MORRONE;ANTONELLA GRECO;ELENA CHIAPPINI","2.59;2.07;1.93;1.67;1.28;1.25;1.17;1.16;1.03;1.03;1;0.93;0.91;0.85;0.81;0.8;0.78;0.77;0.74;0.72","RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;GIANCARLO LA MARCA;GABRIELE SIMONINI;PAOLO LIONETTI;AMELIA MORRONE;LORENZO GENITORI;CHIARA AZZARI;SIMONA BARNI;LUISA GALLI;SABRINA GIGLIO;FLAVIO GIORDANO;CARLA MARINI;IACOPO SARDI;SABRINA BECCIANI;GIOVANNI TACCETTI;FRANCESCA MORI;ROBERTO CAPUTO;STEFANO STAGI","28;17;14;10;9;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5","RENZO GUERRINI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;GIANCARLO LA MARCA;SIMONA BARNI;MARIO MASCALCHI;GABRIELE SIMONINI;FRANCESCA MORI;ANDREA BASSI;PATRIZIO FIORINI;DIDIER MUSSO;LORENZO GENITORI;LUISA GALLI;MAURIZIO DE MARTINO;FLAVIO GIORDANO;STEFANO STAGI;ELIO NOVEMBRE;AMELIA MORRONE;ANTONELLA GRECO;ELENA CHIAPPINI","2.59;2.07;1.93;1.67;1.28;1.25;1.17;1.16;1.03;1.03;1;0.93;0.91;0.85;0.81;0.8;0.78;0.77;0.74;0.72","RENZO GUERRINI;CARLA MARINI;ROLANDO CIMAZ;SONIA TONI;INGRID E. SCHEFFER;DARIO IAFUSCO;GIULIO MALTONI;GIUSEPPE D’ANNUNZIO;STEFANO TUMINI;STEFANO ZUCCHINI;VITTORIA CAUVIN;CARMEN BARBA;SARAH WECKHUYSEN;ANDREA E. SCARAMUZZA;ANNA PAOLA FRONGIA;FRANCESCA CARDELLA;GIOVANNI CHIARI;IPPOLITA PATRIZIA PATERA;IVANA RABBONE;PIETRO BUONO","1127;517;502;376;369;343;343;343;343;343;343;337;330;329;329;329;329;329;329;329","RENZO GUERRINI;CARLA MARINI;ROLANDO CIMAZ;SONIA TONI;CARMEN BARBA;TIZIANA PISANO;MAURIZIO DE MARTINO;VALERIO CONTI;ELIO NOVEMBRE;SIMONA BARNI;CHIARA AZZARI;FRANCESCA BECHERUCCI;PAOLA ROMAGNANI;ELENA SIENI;GIANCARLO LA MARCA;FRANCESCA MORI;VALENTINA CETICA;NERI PUCCI;PAOLO LIONETTI;FRANCA RUSCONI","1112;517;502;376;337;298;269;268;256;256;245;203;203;195;188;176;171;168;163;142","RENZO GUERRINI;MAURIZIO DE MARTINO;ROLANDO CIMAZ;GIANCARLO LA MARCA;GABRIELE SIMONINI;PAOLO LIONETTI;CARLA MARINI;AMELIA MORRONE;ANNA MARIA BUCCOLIERO;LUISA GALLI;ELIO NOVEMBRE;FRANCA RUSCONI;FRANCESCA MORI;GIOVANNI TACCETTI;IACOPO SARDI;SIMONA BARNI;ANDREA BASSI;CHIARA AZZARI;ALESSIA STIVAL;ANTONELLA GRECO","26;18;16;9;7;7;6;6;6;6;5;5;5;5;5;5;5;5;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;POLITICAL SCIENCE;ECONOMICS;MATERIALS SCIENCE;SOCIOLOGY;ENGINEERING;PHILOSOPHY;ART;BUSINESS;GEOGRAPHY;HISTORY","165;78;16;14;13;10;9;6;4;4;4;3;3;1;1;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;PATHOLOGY;SURGERY;IMMUNOLOGY;PSYCHIATRY;RADIOLOGY;INTENSIVE CARE MEDICINE;BIOCHEMISTRY;DERMATOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;ANESTHESIA;GASTROENTEROLOGY;MICROBIOLOGY;NEUROSCIENCE;FAMILY MEDICINE;ANATOMY;CARDIOLOGY;CELL BIOLOGY","104;62;51;38;36;25;24;18;17;16;15;14;12;10;10;10;10;9;8;8;8","GENE;DISEASE;EPILEPSY;COHORT;PREGNANCY;CHEMOTHERAPY;BACTERIA;CONFIDENCE INTERVAL;MAGNETIC RESONANCE IMAGING;POPULATION;ALTERNATIVE MEDICINE;ADVERSE EFFECT;RETROSPECTIVE COHORT STUDY;ALLERGY;ANTIBIOTICS;ANTIBODY;CELL;CYSTIC FIBROSIS;STEM CELL;TRANSPLANTATION","33;31;19;14;11;10;9;9;9;9;8;7;7;6;6;6;6;6;6;6","MUTATION;GENOTYPE;PROGENITOR CELL;FETUS;GENOME;GESTATION;GESTATIONAL AGE;PHENOTYPE;ADALIMUMAB;ALLELE;CHROMOSOME;CROHN'S DISEASE;CYCLOPHOSPHAMIDE;DIFFUSION MRI;DOXORUBICIN;ESCHERICHIA COLI;EXON;FOOD ALLERGY;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEPATITIS C VIRUS;PLACEBO","13;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","PRENATAL DIAGNOSIS;PROBAND;PROGENITOR;SINGLE-NUCLEOTIDE POLYMORPHISM;BREAKPOINT;CAULOBACTER CRESCENTUS;COPY-NUMBER VARIATION;ENTEROBACTERIACEAE;FRACTIONAL ANISOTROPY;IFOSFAMIDE;METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;MISSENSE MUTATION;SINORHIZOBIUM MELILOTI;ACANTHOSIS NIGRICANS;ADENOSINE KINASE;ADRENOLEUKODYSTROPHY;ALPHAPROTEOBACTERIA;ALTERNATIVE SPLICING;ANAGRELIDE;ANAPLASTIC ASTROCYTOMA;ANTERIOR TEMPORAL LOBECTOMY;ANTIRETROVIRAL THERAPY;AORTIC ARCH SYNDROME;ATHETOSIS;ATP-BINDING CASSETTE TRANSPORTER;BENZYLPENICILLIN;BRADYCARDIA;BRONCHOPULMONARY DYSPLASIA;BURKHOLDERIA CEPACIA COMPLEX;BUSULFAN;CALCIFEDIOL;CANAKINUMAB;CAREGIVER BURDEN;CD3;CEREBRAL VASCULITIS;CHEMOKINE RECEPTOR;CHILDHOOD OBESITY;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS;COLONOSCOPY;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;CORONAVIRUS DISEASE 2019 (COVID-19);CROSSOVER STUDY;CYTOLYSIS;DIABETIC FOOT ULCER;DNA METHYLATION;DYSGRAPHIA;EXOME SEQUENCING;FILAMIN;FLUORESCENCE IN SITU HYBRIDIZATION;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENE DOSAGE;GENETIC HETEROGENEITY;GENOMICS;GENOTYPING;GERMLINE MUTATION;GLOBAL DEVELOPMENTAL DELAY;GLOMERULOSCLEROSIS;GLYCOGEN STORAGE DISEASE TYPE II;HEMATOPOIETIC STEM CELL;HEME OXYGENASE;HERPESVIRIDAE;HETEROPLASMY;HIPPOCAMPAL SCLEROSIS;HYPERINSULINISM;INDUCED PLURIPOTENT STEM CELL;INTERFACE (MATTER);INTERMEDIATE UVEITIS;INTRACRANIAL ARTERIOVENOUS MALFORMATIONS;JAK2 V617F;KETOACIDOSIS;KLEBSIELLA PNEUMONIAE;LEUKAPHERESIS;LIGHT SHEET FLUORESCENCE MICROSCOPY;LOSS OF HETEROZYGOSITY;MITOCHONDRIAL ENCEPHALOMYOPATHY;MITOCHONDRIAL MYOPATHY;MULTILOCUS SEQUENCE TYPING;MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION;NATURAL KILLER CELL;NEUROACTIVE STEROID;NOD2;ORAL FOOD CHALLENGE;ORPHAN RECEPTOR;P-GLYCOPROTEIN;PEMPHIGOID;PERFORIN;PODOCYTE;POINT MUTATION;POLYARTERITIS NODOSA;PREMATURE BIRTH;PRETERM DELIVERY;PROTOCADHERIN;PTERIN;PURINE NUCLEOSIDE PHOSPHORYLASE;RAR-RELATED ORPHAN RECEPTOR GAMMA;RESPIRATORY ALLERGY;RESTRICTION FRAGMENT LENGTH POLYMORPHISM;RNA SPLICING;RYR1;SERRATIA MARCESCENS;SHELLFISH;SMALL FOR GESTATIONAL AGE;SODIUM CHANNEL BLOCKER;STEREOELECTROENCEPHALOGRAPHY;TELOMERASE REVERSE TRANSCRIPTASE;TETRAHYDROBIOPTERIN;TOLL-LIKE RECEPTOR;VACCINATION SCHEDULE;VINCRISTINE;VIRIDANS STREPTOCOCCI;WHOLE GENOME SEQUENCING","3;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ITALY;ADULT;INFANT;YOUNG ADULT;EPILEPSY;MUTATION;INFANT, NEWBORN;MIDDLE AGED;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;RISK FACTORS;COHORT STUDIES;EPILEPSIES, MYOCLONIC","120;88;85;58;58;56;46;41;37;37;26;23;21;20;18;18;14;12;11;11","EPILEPSY AND SEIZURES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;CLINICAL CHARACTERISTICS AND MANAGEMENT OF SARCOIDOSIS;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HEMATOPOIETIC STEM CELL BIOLOGY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;PATHOGENESIS AND TREATMENT OF SYSTEMIC SCLEROSIS;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;DIFFUSION MAGNETIC RESONANCE IMAGING;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENETICS AND PATHOGENESIS OF TYPE 1 DIABETES","8;7;6;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","EPILEPSY;ETIOLOGY;REGIMEN;ANTIEPILEPTIC DRUGS;CYSTIC FIBROSIS;DIABETES;DIAGNOSIS;DIFFUSION MRI;DRY EYE DISEASE;FOOD ALLERGY;HEPATITIS C;IDENTIFICATION (BIOLOGY);IRON OVERLOAD;NEWBORN SCREENING;PROBAND;SKIN SENSITIZATION;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;TREATMENT;UVEITIS;","6;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","AORTIC ARCH;COHORT STUDY;CYSTIC FIBROSIS;DE NOVO;HEMATOPOIETIC STEM;ITALIAN PEDIATRIC;NEWBORN SCREENING;PULMONARY FUNCTION;STEM CELL;ABSENCE EPILEPSY;AK PROTECTS;ASTATIC EPILEPSY;BEHÇETS DISEASE;CELL CYCLE;CELL DEVELOPMENT;CELL TRANSPLANTATION;COMBINED RAMAN;COMPARATIVE STUDY;CYCLE CONTROL;DRIED BLOOD;DYSGENESISASSOCIATED AK;FABRY DISEASE;FIBER PROBE;FLUORESCENCE SPECTROSCOPY;INFLAMMATORY BOWEL;ITALIAN ASSOCIATION;ITALIAN CHILDREN;ITALIAN REGISTRY;JUVENILE SYSTEMIC;KAWASAKI DISEASE","3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MGG DW;GESTATIONAL AGE;CELL CYCLE;IRON OVERLOAD;LUNG FUNCTION;MRI LIC;LOW BIRTHWEIGHT;MGG NA;NK CELLS;SYSTEMIC SCLEROSIS;TEMPORAL LOBE;CF PATIENTS;FRENCH POLYNESIA;MAGNETIC RESONANCE;RENAL PROGENITORS;TAZ GENE;ABSENCE EPILEPSY;ATAXIA TYPE;DIAGNOSTIC WORKUP;DISEASE PROGRESSION;DS SUBJECTS;LIC VALUES;LOBE EPILEPSY;PANCREATIC CANCER;PRETERM DELIVERY;PSYCHOSOCIAL CARE;RESONANCE IMAGING;RISK FACTORS;SIGNIFICANT DIFFERENCES;SPINOCEREBELLAR ATAXIA","18;12;11;10;10;9;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6;6",95,0.52,9.62,7.5,2.25,1.5,1,3,2,0,1,9,0,1,6,0,1,1.25,2,5,3,0,0,80.5,80.5,2,1,0,2,0,1,0,0,0,0,0,0,3,1,0,1,3.25,2.48,1.25,0,1,3,1,1,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,0,0,"LASAGNI LAURA;LAZZERI ELENA;ROMAGNANI PAOLA;CERDA BLAS;CHERKASSKIY ALEX;LA MARCA GIANCARLO;LI YIJUN","3;3;3;1;1;1;1","AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO UNIV MEYER DI FIRENZE;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;PERKINELMER HEALTH SCIENCES INC","2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","6;3;2;1","KIDNEY DISEASE;STEM CELL RESEARCH","3;3",NA,NA,"C12N5/071;A61K31/185;A61K31/41;B01L99/00","3;1;1;1","C12N2501/12;C12N2501/50;C12N5/0684;C12N5/0686;C12N5/0687;G01N2333/70596;G01N2800/347;G01N33/5014;G01N33/5044;G01N33/56966","3;3;3;3;3;3;3;3;3;3",10,4,455.67,4.08,3,0.3,27.8,0,0,4,0,2,0,1,3,0,4,2,0,0,0,0,0,0,10,0,0,6,4,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS","10;6;2;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;CYSTIC FIBROSIS;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;LIVER DISEASE;LUNG;PEDIATRIC;ANTIMICROBIAL RESISTANCE;BRAIN CANCER;BRAIN DISORDERS;CHRONIC LIVER DISEASE AND CIRRHOSIS;EYE DISEASE AND DISORDERS OF VISION;HEMATOLOGY;HEPATITIS;HEPATITIS - C;INFANT MORTALITY;INFECTIOUS DISEASES","7;5;5;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","CONGENITAL;EYE;CANCER;CARDIOVASCULAR;INFECTION","2;2;1;1;1","6.1 PHARMACEUTICALS","6","BRAIN TUMOR;LIVER CANCER","1;1","2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,"PUBLIC LIBRARY OF SCIENCE","14","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3213 PAEDIATRICS;3105 GENETICS;49 MATHEMATICAL SCIENCES;4905 STATISTICS;52 PSYCHOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;33 BUILT ENVIRONMENT AND DESIGN;3303 DESIGN;5202 BIOLOGICAL PSYCHOLOGY","11;5;4;3;3;2;2;1;1;1;1","BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;EPILEPSY;NEURODEGENERATIVE;NEUROSCIENCES;PEDIATRIC;RARE DISEASES","1;1;1;1;1;1;1;1","CARDIOVASCULAR;NEUROLOGICAL","2;1","6.1 PHARMACEUTICALS","1","CLINICAL","2","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","6;1;1",NA,NA,NA,NA
"IRCCS_MEYER",2016,200,15.725,3.19,0.395,0.365,0.495,2.33699633699634,1.36206896551724,1.97297297297297,1.546875,0.61,2,101,41,20,18,0.5,0.2,0.1,0.09,31.22,0.96127175035725,6.15438596491227,0.315,0.915,0.532,0.46,0.439,0.497,"RENZO GUERRINI;IACOPO SARDI;LORENZO GENITORI;ROLANDO CIMAZ;M LUCCHESI;CLAUDIO FAVRE;MILENA GUIDI;CARLA FONTE;LUISA GALLI;FRANCA RUSCONI;SILVIA FARIÑA;MAURIZIO DE MARTINO;CARMEN BARBA;GABRIELE SIMONINI;FRANCO BAMBI;ELENA CHIAPPINI;PAOLO LIONETTI;MARTINA DA ROS;AMELIA MORRONE;GIANCARLO LA MARCA","23;19;18;16;15;15;15;11;10;9;9;9;8;7;7;7;6;6;6;6","ROLANDO CIMAZ;IACOPO SARDI;LORENZO GENITORI;MARTINA DA ROS;M LUCCHESI;MILENA GUIDI;CLAUDIO FAVRE;RENZO GUERRINI;CARLA FONTE;LUISA GALLI;MAURIZIO DE MARTINO;SILVIA FARIÑA;ANNA LISA IORIO;ELENA CHIAPPINI;PAOLA ROMAGNANI;FRANCA RUSCONI;MARIO MASCALCHI;AMELIA MORRONE;ANNA MARIA BUCCOLIERO;GABRIELE SIMONINI","2.56;2.01;1.93;1.92;1.8;1.8;1.79;1.61;1.39;1.29;1.23;1.14;0.92;0.87;0.87;0.82;0.76;0.72;0.69;0.68","RENZO GUERRINI;IACOPO SARDI;LORENZO GENITORI;ROLANDO CIMAZ;M LUCCHESI;CLAUDIO FAVRE;MILENA GUIDI;CARLA FONTE;LUISA GALLI;FRANCA RUSCONI;SILVIA FARIÑA;MAURIZIO DE MARTINO;CARMEN BARBA;GABRIELE SIMONINI;FRANCO BAMBI;ELENA CHIAPPINI;PAOLO LIONETTI;MARTINA DA ROS;AMELIA MORRONE;GIANCARLO LA MARCA","23;19;18;16;15;15;15;11;10;9;9;9;8;7;7;7;6;6;6;6","ROLANDO CIMAZ;IACOPO SARDI;LORENZO GENITORI;MARTINA DA ROS;M LUCCHESI;MILENA GUIDI;CLAUDIO FAVRE;RENZO GUERRINI;CARLA FONTE;LUISA GALLI;MAURIZIO DE MARTINO;SILVIA FARIÑA;ANNA LISA IORIO;ELENA CHIAPPINI;PAOLA ROMAGNANI;FRANCA RUSCONI;MARIO MASCALCHI;AMELIA MORRONE;ANNA MARIA BUCCOLIERO;GABRIELE SIMONINI","2.56;2.01;1.93;1.92;1.8;1.8;1.79;1.61;1.39;1.29;1.23;1.14;0.92;0.87;0.87;0.82;0.76;0.72;0.69;0.68","RENZO GUERRINI;ANNA MARIA BUCCOLIERO;ELEONORA ARONICA;ALAN MACKAY;AMAR GAJJAR;ANDREW S. MOORE;ANDRÉ O. VON BUEREN;ANNE JOUVET;ARIE PERRY;BARBARA C. WORST;BRENT A. ORR;BRET C. MOBLEY;CAMELIA-MARIA MONORANU;CATHERINE KEOHANE;CHRIS JONES;CHRISTEL HEROLD‐MENDE;CHRISTELLE DUFOUR;CHRISTIAN HAGEL;CHRISTIAN KOELSCHE;CHRISTIAN MAWRIN","1389;857;829;775;775;775;775;775;775;775;775;775;775;775;775;775;775;775;775;775","RENZO GUERRINI;ANNA MARIA BUCCOLIERO;PAOLO LIONETTI;ROLANDO CIMAZ;CARMEN BARBA;VALERIO CONTI;CARLA MARINI;DAVIDE MEI;MARIA ALICE DONATI;PAOLA ROMAGNANI;ANNA ROSATI;FRANCO BAMBI;GABRIELE SIMONINI;MAURIZIO DE MARTINO;LUISA GALLI;MONICA DI PAOLA;FRANCESCA BECHERUCCI;MARCO MATERASSI;ROSA MARIA ROPERTO;GIOVANNI TACCETTI","1149;857;495;485;441;396;338;338;330;308;287;283;279;266;256;254;248;245;234;229","RENZO GUERRINI;IACOPO SARDI;CLAUDIO FAVRE;LORENZO GENITORI;M LUCCHESI;MILENA GUIDI;ROLANDO CIMAZ;MAURIZIO DE MARTINO;CARLA FONTE;ANNA MARIA BUCCOLIERO;LUISA GALLI;FRANCA RUSCONI;SILVIA FARIÑA;CARMEN BARBA;GABRIELE SIMONINI;ELENA CHIAPPINI;FRANCO BAMBI;GIANCARLO LA MARCA;MARTINA DA ROS;AMELIA MORRONE","22;19;15;15;15;15;15;13;11;10;10;9;9;8;7;7;7;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;SOCIOLOGY;MATHEMATICS;POLITICAL SCIENCE;ECONOMICS;MATERIALS SCIENCE;ENGINEERING;PHILOSOPHY;ART;BUSINESS;GEOGRAPHY;GEOLOGY;HISTORY","183;77;20;20;15;14;8;6;6;4;4;2;2;1;1;1;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;SURGERY;PATHOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;PSYCHIATRY;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;ENDOCRINOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;PHARMACOLOGY;BIOINFORMATICS;NEUROSCIENCE;NUCLEAR MEDICINE;NURSING;OPTICS","114;58;55;39;36;33;25;25;22;21;19;17;15;13;12;10;10;10;10;10","GENE;DISEASE;POPULATION;MAGNETIC RESONANCE IMAGING;COHORT;ALTERNATIVE MEDICINE;CHEMOTHERAPY;EPILEPSY;RETROSPECTIVE COHORT STUDY;ARTHRITIS;PREGNANCY;ANTIBIOTICS;ANTIBODY;BACTERIA;CANCER;CENTRAL NERVOUS SYSTEM;CLINICAL TRIAL;ADVERSE EFFECT;COHORT STUDY;ENZYME;HORMONE;INCIDENCE (GEOMETRY);LOGISTIC REGRESSION;LYMPHOMA;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;STEM CELL","34;30;20;14;12;11;11;11;11;10;10;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6","MUTATION;GENOTYPE;PHENOTYPE;ALLELE;INFLAMMATORY BOWEL DISEASE;DOXORUBICIN;HYPERINTENSITY;PROTOCOL (SCIENCE);TYPE 1 DIABETES;TYPE 2 DIABETES;BIRTH WEIGHT;CLINICAL ENDPOINT;CORTICAL DYSPLASIA;DNA SEQUENCING;DRAVET SYNDROME;EXON;FLUID-ATTENUATED INVERSION RECOVERY;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PROTEINURIA;RITUXIMAB;STATUS EPILEPTICUS;TOLERABILITY;WHITE MATTER","11;7;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","SINGLE-NUCLEOTIDE POLYMORPHISM;COMPOUND HETEROZYGOSITY;SANGER SEQUENCING;ABATACEPT;ALTERNATIVE SPLICING;FRAMESHIFT MUTATION;INTERNAL CAPSULE;KLEBSIELLA PNEUMONIAE;MENINGOCOCCAL DISEASE;MENINGOCOCCAL VACCINE;MISSENSE MUTATION;OSTEOCALCIN;RNA SPLICING;SYNOVIAL FLUID;ABDUCENS NERVE;ACENOCOUMAROL;ACTIVE TUBERCULOSIS;ADOPTIVE CELL TRANSFER;ALLELE FREQUENCY;ALLELIC HETEROGENEITY;AMPLICON;ANISOMETROPIA;ANTIFOLATE;ANTIRHEUMATIC DRUGS;ASPARAGINASE;BARTONELLA HENSELAE;BASE EXCISION REPAIR;BINOCULAR RIVALRY;BREAKPOINT;BRONCHUS;BROTH MICRODILUTION;CADASIL;CANAKINUMAB;CANCER-ASSOCIATED FIBROBLASTS;CD137;CENTRAL PRECOCIOUS PUBERTY;CHIMERIC ANTIGEN RECEPTOR;CROHN DISEASE;DEEP BRAIN STIMULATION;DEEP SEQUENCING;DIABETES MANAGEMENT;DIFFUSE REFLECTANCE INFRARED FOURIER TRANSFORM;DIFFUSION IMAGING;DNA METHYLATION;DOUBLE AORTIC ARCH;DOUBLE BLIND;EXOME SEQUENCING;EXTRACORPOREAL PHOTOPHERESIS;FIRST TRIMESTER;FRACTIONAL ANISOTROPY;GENE MAPPING;GENETIC HETEROGENEITY;GENOME INSTABILITY;GERMLINE MUTATION;GLOBOTRIAOSYLCERAMIDE;HAPLOTYPE;HEMOPHAGOCYTOSIS;HETEROZYGOTE ADVANTAGE;HYPOTHALAMIC HAMARTOMA;HYPOVITAMINOSIS;IDIOPATHIC NEPHROTIC SYNDROME;IDIOPATHIC SHORT STATURE;INSULIN PUMP;INTERNATIONAL PROGNOSTIC INDEX;INTRAVOXEL INCOHERENT MOTION;KETOACIDOSIS;KRAS;LEUKAPHERESIS;LIVE ATTENUATED INFLUENZA VACCINE;LOSS FUNCTION;LUCIFERASE;MASSIVE PARALLEL SEQUENCING;MATURITY ONSET DIABETES OF THE YOUNG;MECONIUM;MENINGOCOCCAL MENINGITIS;MESALAZINE;METASTASECTOMY;MITOCHONDRIAL FUSION;MITOPHAGY;MONOCULAR DEPRIVATION;MONTREAL COGNITIVE ASSESSMENT;MYCOBACTERIUM ABSCESSUS;NEUROEPITHELIAL CELL;NONRIBOSOMAL PEPTIDE;NUCLEOTIDE EXCISION REPAIR;P-GLYCOPROTEIN;PARVOVIRIDAE;PODOCYTE;PONSETI METHOD;POSACONAZOLE;PRENATAL DIAGNOSIS;PURE TONE AUDIOMETRY;RAR-RELATED ORPHAN RECEPTOR GAMMA;REACTOGENICITY;RENAL STEM CELL;RETINOPATHY OF PREMATURITY;RUPTURE OF MEMBRANES;SERRATIA MARCESCENS;SPIRITUAL CARE;STENOTROPHOMONAS MALTOPHILIA;SUBEPENDYMAL GIANT CELL ASTROCYTOMA;SULFASALAZINE;TOTAL BODY IRRADIATION;TYMPANOMETRY;VASCULAR RING;VINCRISTINE","6;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;;CHILD;ADOLESCENT;CHILD, PRESCHOOL;ITALY;INFANT;ADULT;ARTHRITIS, JUVENILE;YOUNG ADULT;RETROSPECTIVE STUDIES;INFANT, NEWBORN;MIDDLE AGED;ANTICONVULSANTS;BRAIN;MAGNETIC RESONANCE IMAGING;DIABETES MELLITUS, TYPE 1;TREATMENT OUTCOME","120;92;90;79;68;51;49;33;32;25;23;22;21;17;17;15;15;15;14;14","GLIOMAS;EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;NEUROBLASTOMA RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;HEMATOPOIETIC STEM CELL BIOLOGY;IMPACT OF CHRONIC STRESS ON CANCER PROGRESSION;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;EFFECTS OF NOISE POLLUTION ON HEALTH AND WELL-BEING;EPIDEMIOLOGY AND IMPACT OF TRAUMATIC BRAIN INJURY;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND PATHOGENESIS OF BACTERIAL MENINGITIS","9;7;7;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2","EPILEPSY;JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;CONTINUOUS GLUCOSE MONITORING;DIABETES;TYPE 1 DIABETES;COMPOUND HETEROZYGOSITY;NEURO-ONCOLOGY;STATUS EPILEPTICUS;TREATMENT OUTCOMES;CLINICAL ENDPOINT;CYSTIC FIBROSIS;DIAGNOSIS;DRAVET SYNDROME;ETIOLOGY;EXOME SEQUENCING;FLUID-ATTENUATED INVERSION RECOVERY;GLIOBLASTOMA;KAWASAKI DISEASE;MATERNAL EPILEPSY","7;7;7;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3","JUVENILE IDIOPATHIC;IDIOPATHIC ARTHRITIS;CYSTIC FIBROSIS;ITALIAN CHILDREN;BIRTH COHORT;HIGH-GRADE GLIOMAS;MYCOBACTERIUM ABSCESSUS;RETROSPECTIVE STUDY;TYPE DIABETES;ABSCESSUS SUBSP;ARTHRITIS PATIENTS;BRAIN TUMORS;CHILDRENS HOSPITAL;COHORT STUDY;CONGENITAL HEART;DOXORUBICIN UPTAKE;FLORENTINE EXPERIENCE;GROWTH HORMONE;HUMAN GLIOBLASTOMA;KAWASAKI DISEASE;LAND-USE VARIABLES;MEYER CHILDRENS;OBSERVATIONAL STUDY;PEDIATRIC HIGH-GRADE;AIEOP PROTOCOL;AUTOPHAGIC FLUX;BLOOD-BRAIN BARRIER;BONE MINERAL;BOWEL DISEASE;BRAIN INJURY","9;8;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2","JIA PATIENTS;PUBMED SCOPUS;CHILDREN AGED;HEALTHY SUBJECTS;AZIENDA OSPEDALIERO;CROSSREF PUBMED;OSPEDALIERO UNIVERSITARIA;PUBLIC HEALTH;SEVERE ASTHMA;ALZHEIMERS DISEASE;MEDIAN AGE;PANCREATIC CANCER;RISK FACTORS;ADVERSE EVENTS;ARTHRITIS JIA;CLASS III;CYSTIC FIBROSIS;CZECH REPUBLIC;DE NOVO;FOCAL EPILEPSY;IDIOPATHIC ARTHRITIS;IL- INHIBITORS;ITALY DEPARTMENT;ITALY OSPEDALE;JUVENILE IDIOPATHIC;PRETERM NEWBORNS;TMJ INVOLVEMENT;CARGLUMIC ACID;FLUID OVERLOAD;IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMN FONTSTYLEITALICMMLMNMMLMATH","13;11;10;10;9;9;9;9;9;8;8;8;8;7;7;7;7;7;7;7;7;7;7;7;7;7;7;6;6;6",87,0.44,10,8,1,1,1,2.5,3,0,1,9.5,1,1,6.25,0,1,2,2,4.5,3,0,0,90.5,90.5,6,1,1,2,0,2,1,0,2,0,0,0,5,3,1,1.75,3.25,4.08,1.66666666666667,2,5,5,1,0,3,0,0,3,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5,0,0,1,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,"AZZARI CHIARA;RESTI MASSIMO;LA MARCA GIANCARLO;LASAGNI LAURA;LAZZERI ELENA;ROMAGNANI PAOLA;BASCIANO SIMONE;CERDA BLAS;CHERKASSKIY ALEX;FORT ADA","3;3;2;2;2;2;1;1;1;1","AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO UNIV MEYER;AZIENDA OSPEDALIERO UNIV MEYER DI FIRENZE;PERKINELMER HEALTH SCIENCES INC;UNIVERSITÀ DEGLI STUDI DI FIRENZE;UNIVERSITÀ DEGLI STUDI DI SIENA","5;5;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;34 CHEMICAL SCIENCES;3202 CLINICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS","10;4;3;3;1","KIDNEY DISEASE;STEM CELL RESEARCH;PEDIATRIC","2;2;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1","C12N5/071;A61F5/058;A61K31/185;A61K31/41;B01L99/00;C12M1/34;C12Q1/68;G01N33/00;G01N33/49;G01N33/50","2;1;1;1;1;1;1;1;1;1","A61F5/05825;A61F5/05875;C12N2501/12;C12N2501/50;C12N5/0684;C12N5/0686;C12N5/0687;G01N2333/70596;G01N2800/347;G01N33/492","2;2;2;2;2;2;2;2;2;2",8,4.43,292.43,3.02,0,0,4.25,0,0,2,0,2,0,1,3,0,5,2,0,0,0,0,0,0,8,0,0,7,1,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;36 CREATIVE ARTS AND WRITING;3603 MUSIC;41 ENVIRONMENTAL SCIENCES;4102 ECOLOGICAL APPLICATIONS;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","6;3;3;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;RARE DISEASES;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;AUTOIMMUNE DISEASE;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN CANCER;BRAIN DISORDERS;CHRONIC PAIN;COLO-RECTAL CANCER;CYSTIC FIBROSIS;LUNG;NEUROSCIENCES;ORPHAN DRUG;PAIN RESEARCH;PATIENT SAFETY;PEDIATRIC RESEARCH INITIATIVE","5;5;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CONGENITAL;CANCER;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL","2;1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;7.1 INDIVIDUAL CARE NEEDS","5;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BRAIN TUMOR;COLON AND RECTAL CANCER;NOT SITE-SPECIFIC CANCER;SARCOMA","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.1 LOCALIZED THERAPIES - DISCOVERY AND DEVELOPMENT;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","2;1;1",1,1689045,211130.62,2,8,4,1,0,105565.3125,1.8945617197884,"ASSOCIAZIONE DELLA CROCE ROSSA ITALIANA;BAMBINO GESÙ CHILDREN'S HOSPITAL;HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO;ISTITUTO SUPERIORE DI SANITÀ;MEYER CHILDREN'S HOSPITAL;MINISTERO DELLA SALUTE;MINISTRY FOR HEALTH;NATIONAL INSTITUTE OF PUBLIC HEALTH","1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","3RD HEALTH PROGRAMME (PROGRAMME)","1","44 HUMAN SOCIETY;4403 DEMOGRAPHY","1;1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"C22 ANTHROPOLOGY AND DEVELOPMENT STUDIES","1",NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","32 BIOMEDICAL AND CLINICAL SCIENCES;44 HUMAN SOCIETY;49 MATHEMATICAL SCIENCES;3204 IMMUNOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4403 DEMOGRAPHY;4904 PURE MATHEMATICS","3;2;2;1;1;1;1;1","CLINICAL RESEARCH;ACQUIRED COGNITIVE IMPAIRMENT;AGING;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ARTHRITIS;AUTOIMMUNE DISEASE;BRAIN DISORDERS;DEMENTIA;NEURODEGENERATIVE;NEUROSCIENCES;RARE DISEASES","2;1;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION","2;1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","3",NA,NA,NA,NA
"IRCCS_MEYER",2017,204,15.1813725490196,2.9656862745098,0.343137254901961,0.308823529411765,0.426470588235294,2.09342560553633,1.2962962962963,1.96875,1.42622950819672,0.622549019607843,1,93,66,19,13,0.46,0.32,0.09,0.06,27.78,0.942639124029853,5.93013555787278,0.323529411764706,0.931372549019608,0.487,0.381,0.411,0.425,"RENZO GUERRINI;ROLANDO CIMAZ;SABRINA GIGLIO;PAOLO LIONETTI;MARIA ALICE DONATI;GIUSEPPE INDOLFI;FLAVIO GIORDANO;IACOPO SARDI;STEFANO STAGI;MARIO MASCALCHI;ELENA CHIAPPINI;FRANCA RUSCONI;MAURIZIO DE MARTINO;ELENA PROCOPIO;CHIARA AZZARI;ALBERTO VERROTTI;ANTONIO MESSINEO;LORENZO GENITORI;ALICE DONATI;CLAUDIO FAVRE","23;14;13;10;10;9;9;7;7;7;7;7;7;6;6;6;6;6;5;5","RENZO GUERRINI;SABRINA GIGLIO;ROLANDO CIMAZ;LAURA GIUNTI;MILENA GUIDI;ELENA CHIAPPINI;FRANCA RUSCONI;ENRICA ROSSI;ANTONIO MESSINEO;GIUSEPPE INDOLFI;FLAVIO GIORDANO;IACOPO SARDI;MARCO GHIONZOLI;MARIA ALICE DONATI;MAURIZIO DE MARTINO;LUISA GALLI;MAURIZIO DE MARTINO;MARIO MASCALCHI;STEFANO STAGI;SIMONA BARNI","1.93;1.5;1.43;1.3;1.27;1.03;1.03;1;0.92;0.91;0.9;0.89;0.87;0.82;0.81;0.77;0.77;0.72;0.69;0.69","RENZO GUERRINI;ROLANDO CIMAZ;SABRINA GIGLIO;PAOLO LIONETTI;MARIA ALICE DONATI;GIUSEPPE INDOLFI;FLAVIO GIORDANO;IACOPO SARDI;STEFANO STAGI;MARIO MASCALCHI;ELENA CHIAPPINI;FRANCA RUSCONI;MAURIZIO DE MARTINO;ELENA PROCOPIO;CHIARA AZZARI;ANTONIO MESSINEO;LORENZO GENITORI;ALICE DONATI;CLAUDIO FAVRE;SIMONA BARNI","23;14;13;10;10;9;9;7;7;7;7;7;7;6;6;6;6;5;5;5","RENZO GUERRINI;SABRINA GIGLIO;ROLANDO CIMAZ;LAURA GIUNTI;MILENA GUIDI;ELENA CHIAPPINI;FRANCA RUSCONI;ENRICA ROSSI;ANTONIO MESSINEO;GIUSEPPE INDOLFI;FLAVIO GIORDANO;IACOPO SARDI;MARCO GHIONZOLI;MARIA ALICE DONATI;MAURIZIO DE MARTINO;LUISA GALLI;MAURIZIO DE MARTINO;MARIO MASCALCHI;STEFANO STAGI;SIMONA BARNI","1.93;1.5;1.43;1.3;1.27;1.03;1.03;1;0.92;0.91;0.9;0.89;0.87;0.82;0.81;0.77;0.77;0.72;0.69;0.69","RENZO GUERRINI;PAOLO LIONETTI;DANIELE GHEZZI;ALICE DONATI;VALERIA TIRANTI;AGNÈS RÖTIG;ANNE LOMBÈS;ARCANGELA IUSO;BENOÎT FUNALOT;BIRGIT REPP;CATERINA TERRILE;CHRISTIAN MERTES;CHRISTOPH LEONHARDT;CLAUDE JARDEL;DANIEL M. BADER;DIETER GLÄSER;ELISABETH GRAF;ELIŠKA KOŇAŘÍKOVÁ;FELIX DISTELMAIER;GABI KASTENMÜLLER","1166;815;568;544;521;479;479;479;479;479;479;479;479;479;479;479;479;479;479;479","RENZO GUERRINI;PAOLO LIONETTI;ALICE DONATI;MARIO MASCALCHI;MONICA DI PAOLA;EMANUELE BARTOLINI;MATTEO LENGE;ROLANDO CIMAZ;SABRINA GIGLIO;SILVIA RICCI;ELEONORA GAMBINERI;ELENA BANCI;MARIA ALICE DONATI;ELENA PARRINI;FLAVIO GIORDANO;MARTINO MONTOMOLI;GIUSEPPE INDOLFI;FRANCA RUSCONI;MAURIZIO DE MARTINO;TIZIANA PISANO","1158;815;544;471;449;438;431;402;316;285;262;222;219;213;204;202;200;182;180;177","RENZO GUERRINI;ROLANDO CIMAZ;SABRINA GIGLIO;MAURIZIO DE MARTINO;PAOLO LIONETTI;FLAVIO GIORDANO;MARIA ALICE DONATI;GIUSEPPE INDOLFI;ELENA CHIAPPINI;FRANCA RUSCONI;IACOPO SARDI;MARIO MASCALCHI;ELENA PROCOPIO;LORENZO GENITORI;ANTONIO MESSINEO;MASSIMO RESTI;ANNA MARIA BUCCOLIERO;CHIARA AZZARI;CLAUDIO FAVRE;DAVIDE MEI","21;14;13;12;10;9;9;8;7;7;7;7;6;6;6;5;5;5;5;5","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;POLITICAL SCIENCE;SOCIOLOGY;BUSINESS;MATERIALS SCIENCE;ECONOMICS;ENVIRONMENTAL SCIENCE","182;86;24;13;13;12;11;7;4;4;3;3;1;1","INTERNAL MEDICINE;GENETICS;PEDIATRICS;SURGERY;PATHOLOGY;IMMUNOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;BIOCHEMISTRY;INTENSIVE CARE MEDICINE;NEUROSCIENCE;RADIOLOGY;OPTICS;ANESTHESIA;MICROBIOLOGY;ONCOLOGY;PHYSICAL THERAPY;CANCER RESEARCH;QUANTUM MECHANICS","121;62;52;46;35;29;21;19;19;18;16;16;16;15;13;11;10;10;10;9;9","GENE;DISEASE;POPULATION;COHORT;RETROSPECTIVE COHORT STUDY;PREGNANCY;CHEMOTHERAPY;EPILEPSY;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;ODDS RATIO;ANTIBIOTICS;ANTIBODY;COHORT STUDY;CONFIDENCE INTERVAL;DIABETES MELLITUS;ARTHRITIS;CANCER;RADIATION THERAPY;RETINAL;TRANSPLANTATION","41;35;15;13;13;12;11;10;10;10;8;7;7;7;7;7;6;6;6;6;6","MUTATION;PHENOTYPE;GENOTYPE;GESTATIONAL AGE;INFLAMMATORY BOWEL DISEASE;CORTICAL DYSPLASIA;CROHN'S DISEASE;ALLELE;GENOME;NUSS PROCEDURE;TYPE 1 DIABETES;CHRONIC HEPATITIS;ENZYME REPLACEMENT THERAPY;EPILEPSY SURGERY;GENE EXPRESSION;GERMLINE;MITOCHONDRIAL DNA;RITUXIMAB;STREPTOCOCCUS PNEUMONIAE;APOLIPOPROTEIN B;ASTROCYTOMA;AUTOIMMUNE HEPATITIS;AUTOPHAGY;BONE MINERAL;CD34;COGNITIVE IMPAIRMENT;COMMUNITY-ACQUIRED PNEUMONIA;COMPLEMENT SYSTEM;CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;DESENSITIZATION (MEDICINE);DISTAL RENAL TUBULAR ACIDOSIS;ENTERAL ADMINISTRATION;FLUORESCENCE SPECTROSCOPY;FOLEY CATHETER;GENE DUPLICATION;GLYCOGEN STORAGE DISEASE;HAZARD RATIO;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;HUMAN LEUKOCYTE ANTIGEN;HYPOXIC ISCHEMIC ENCEPHALOPATHY;INFLIXIMAB;LEUCINE;MACROPHAGE ACTIVATION SYNDROME;METAGENOMICS;MULTICENTER STUDY;MUSCLE BIOPSY;OFFSPRING;PANCREATIC CANCER;PEDIATRIC GASTROENTEROLOGY;PERIPHERAL NEUROPATHY;PI3K/AKT/MTOR PATHWAY;PLACEBO;POLYMICROGYRIA;PROGENITOR CELL;PSORIATIC ARTHRITIS;PYRIDOXAL;RENAL TUBULAR ACIDOSIS;RETINAL DETACHMENT;RHABDOMYOSARCOMA;STEROL;TEMOZOLOMIDE;THALIDOMIDE;THROMBOTIC MICROANGIOPATHY;THYROIDITIS;TRANSCRIPTION FACTOR;TYPE 2 DIABETES;U87;ULCERATIVE COLITIS;VASCULITIS","20;11;7;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COMPOUND HETEROZYGOSITY;MISSENSE MUTATION;GERMLINE MUTATION;HAPLOINSUFFICIENCY;SINGLE-NUCLEOTIDE POLYMORPHISM;RIBAVIRIN;EXOME SEQUENCING;ATYPICAL HEMOLYTIC UREMIC SYNDROME;AUTOIMMUNE THYROIDITIS;BRONCHOPULMONARY DYSPLASIA;COPY-NUMBER VARIATION;ECULIZUMAB;ENTHESITIS;GENOMICS;GLYCOGEN STORAGE DISEASE TYPE II;MITOCHONDRIAL MYOPATHY;PROBAND;RETINOPATHY OF PREMATURITY;ABATACEPT;AKT1;ALTERNATIVE SPLICING;ALVEOLAR RHABDOMYOSARCOMA;ANAPLASTIC ASTROCYTOMA;ANTIRETROVIRAL THERAPY;ANTIRHEUMATIC DRUGS;BRANCH RETINAL VEIN OCCLUSION;BRONCHUS;CD117;CHOLESTERYL ESTER;CHORDEE;CHROMATIN REMODELING;CITRULLINE;COLONOSCOPY;COMPLEMENTATION;CONGENITAL NEUTROPENIA;CONJUGATE VACCINE;CONTINUOUS GLUCOSE MONITORING;CORDECTOMY;CORONARY ARTERY ANEURYSM;CORONAVIRUS DISEASE 2019 (COVID-19);CROHN DISEASE;DIFFUSE REFLECTANCE INFRARED FOURIER TRANSFORM;DNA MICROARRAY;FLAVIN MONONUCLEOTIDE;FOXP2;FRACTIONAL ANISOTROPY;FRAMESHIFT MUTATION;GENE FAMILY;GENE MUTATION;GLOBAL DEVELOPMENTAL DELAY;GLOBOTRIAOSYLCERAMIDE;GLOBUS PALLIDUS;GRANULOMATOSIS WITH POLYANGIITIS;HAPLOTYPE;HEREDITARY SPASTIC PARAPLEGIA;HOMOCYSTINURIA;HYPERINSULINISM;IMAGE RESTORATION;INSULIN PUMP;INSULIN-LIKE GROWTH FACTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;LACTOBACILLUS RHAMNOSUS;LOSS OF HETEROZYGOSITY;LUCIFERASE;MACULOPATHY;MAPLE SYRUP URINE DISEASE;MATERNAL HEALTH;MATURITY ONSET DIABETES OF THE YOUNG;MEATAL STENOSIS;METHYLENETETRAHYDROFOLATE REDUCTASE;MICROSCOPIC POLYANGIITIS;MILK ALLERGY;MITOCHONDRIAL DISEASE;MITOCHONDRIAL ENCEPHALOMYOPATHY;NALP3;OLIGODENDROGLIOMA;ORAL FOOD CHALLENGE;ORAL IMMUNOTHERAPY;ORPHAN RECEPTOR;OSTEOCALCIN;PACHYGYRIA;PEMPHIGOID;PERFORIN;PERIPHERAL TOLERANCE;PERSISTENT VEGETATIVE STATE;PHYLOTYPE;PNEUMOCOCCAL CONJUGATE VACCINE;PNEUMOCOCCAL INFECTIONS;PNEUMOCOCCAL PNEUMONIA;PNEUMOCOCCAL VACCINE;PONSETI METHOD;PRENATAL DIAGNOSIS;PROGENITOR;PROTEIN PHOSPHATASE 2;PTEN;PYRIDOXAL PHOSPHATE;PYRIN DOMAIN;QUANTITATIVE COMPUTED TOMOGRAPHY;RAR-RELATED ORPHAN RECEPTOR GAMMA;RETINOSCHISIS;SANGER SEQUENCING;SEVERE MALARIA;SPECKLE TRACKING ECHOCARDIOGRAPHY;SPECTRIN;THIOTEPA;TRANSCRIPTOME;TRPV4;TUBERCULIN TEST;UBIQUITIN LIGASE;V600E;VCAM-1;VESICOURETERAL REFLUX;VINCRISTINE;WATCHFUL WAITING;WHOLE GENOME SEQUENCING","6;6;5;5;5;4;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;CHILD;;ADOLESCENT;CHILD, PRESCHOOL;INFANT;ITALY;TREATMENT OUTCOME;RETROSPECTIVE STUDIES;MUTATION;ADULT;INFANT, NEWBORN;INTELLECTUAL DISABILITY;YOUNG ADULT;MIDDLE AGED;FOLLOW-UP STUDIES;ARTHRITIS, JUVENILE;MAGNETIC RESONANCE IMAGING","136;105;104;82;68;57;57;47;44;37;36;27;24;23;19;17;16;15;14;13","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MINIMALLY INVASIVE REPAIR OF PECTUS EXCAVATUM;EPILEPSY AND SEIZURES;GLIOMAS;HEPATITIS C INFECTION AND TREATMENT;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;BIOMEDICAL APPLICATIONS OF SPECTROSCOPY TECHNIQUES;MANAGEMENT AND EPIDEMIOLOGY OF PNEUMONIA;NEONATAL LUNG DEVELOPMENT AND RESPIRATORY MORBIDITY;RNA METHYLATION AND MODIFICATION IN GENE EXPRESSION;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;CLINICAL MANAGEMENT OF TRACHEAL AND AIRWAY DISORDERS;COMPOSITION AND HEALTH EFFECTS OF HUMAN MILK;DIAGNOSIS AND MANAGEMENT OF CONGENITAL DIAPHRAGMATIC HERNIA;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY","7;7;5;5;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2","TREATMENT;INBORN ERRORS OF METABOLISM;COMPOUND HETEROZYGOSITY;ETIOLOGY;HAPLOINSUFFICIENCY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;CONTINUOUS GLUCOSE MONITORING;DIABETES;EPILEPSY;JUVENILE IDIOPATHIC ARTHRITIS;MICROCEPHALY;NUSS PROCEDURE;BRAIN TUMOR EPIDEMIOLOGY;DIFFUSE OPTICAL TOMOGRAPHY;EXOME;FUNCTIONAL NEUROIMAGING;OBESITY-ASSOCIATED MICROBIOME;PEDIATRIC AIRWAY SURGERY;PEGYLATED INTERFERON;RNA METHYLATION","10;8;7;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3","ITALIAN SOCIETY;CHRONIC HEPATITIS;CLINICAL CHARACTERIZATION;CONGENITAL HEART;CROHNS DISEASE;CYSTIC FIBROSIS;DISTAL RENAL;EPILEPSY SURGERY;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;IDIOPATHIC ARTHRITIS;INFLAMMATORY BOWEL;ITALIAN PEDIATRIC;JUVENILE IDIOPATHIC;MULTICENTER RETROSPECTIVE;OXIDASE DEFICIENCY;RECESSIVE MUTATIONS;RENAL TUBULAR;RETROSPECTIVE STUDY;TUBULAR ACIDOSIS;AUTOIMMUNE THYROIDITIS;BIALLELIC MUTATIONS;BOWEL DISEASE;CANCER RISK;CHILDRENS HOSPITAL;CLINICAL SYNDROME;COMMUNITY-ACQUIRED PNEUMONIA;CORTICAL DYSPLASIA;COWS MILK;DEFECTIVE MITOCHONDRIAL;DISEASE PROGRESSION","4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","MEDIAN AGE;MGKG ATLG;RS RS;CLINICAL RESPONSE;CLINICAL REMISSION;MAGNETIC RESONANCE;MUCOSAL HEALING;RISK FACTORS;CORTICAL DYSPLASIA;BOSISIO PARINI;BRAF VE;COMMUNITY-ACQUIRED PNEUMONIA;DE NOVO;INFLAMMATORY BOWEL;INSTITUTE IRCCS;MEDEA BOSISIO;MEDIAN FOLLOW-UP;ODDS RATIO;PEDIATRIC PATIENTS;SCIENTIFIC INSTITUTE;AKT MUTATIONS;CONFIDENCE INTERVAL;CROSSREFGOOGLE SCHOLAR;EUGENIO MEDEA;IRCCS EUGENIO;ITALIAN CHILDREN;PARINI ITALY;PUBMED SCOPUS;RESONANCE IMAGING;SETBP MUTATIONS","18;16;15;12;10;10;10;10;9;8;8;8;8;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7;7;7",108,0.53,6,5,2,1.5,1,2.75,1.5,0,1,5,1,1,4.75,3,1.25,2,1,4,3,0,0,78.75,78.75,2,0,0,2,0,1,0,0,0,0,0,0,1,1,1,2,6,2.98,2,0,3,3,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CARDONA FRANCESCA;CATARZI SERENA;D'ADAMIO GIAMPIERO;GOTI ANDREA;MATASSINI CAMILLA;MORRONE AMELIA;PARMEGGIANI CAMILLA;CERDA BLAS;CHERKASSKIY ALEX;LA MARCA GIANCARLO","2;2;2;2;2;2;2;1;1;1","AZIENDA OSPEDALIERO UNIV MEYER;AZIENDA OSPEDALIERO UNIVERSITARIA MEYER DI FIRENZE;PERKINELMER HEALTH SCIENCES INC;UNIV DEGLI STUDI DI FIRENZE;UNIVERSITA' DEGLI STUDI DI FIRENZE","2;1;1;1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;3405 ORGANIC CHEMISTRY","4;1;1",NA,NA,NA,NA,"A61K31/4192;C07C233/16;C07D403/14;C07D407/12;A61P43/00;B01L99/00;G01N1/28;G01N1/40","2;2;2;2;1;1;1;1","A61P43/00;C07D403/14;C07D407/12;A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833","2;2;2;1;1;1;1;1;1;1",7,4,203.33,2.52,3,0.43,16.86,0,2,2,0,1,0,0,2,0,4,2,0,0,0,0,0,0,7,0,0,6,1,0,0,0,0,0,0,0,0,"United States;Australia;Turkey;Denmark;France;Germany;Italy;Japan;Portugal;Spain;Switzerland;United Kingdom","6;3;2;1;1;1;1;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","6;4;2;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;HEMATOLOGY;HEPATITIS;HEPATITIS - C;INFECTIOUS DISEASES;LIVER DISEASE;LUNG;LYMPHOMA;MENTAL HEALTH;NEUROSCIENCES;ORPHAN DRUG;RARE DISEASES","5;5;3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION;MENTAL HEALTH;NEUROLOGICAL;RESPIRATORY","3;1;1;1;1","6.1 PHARMACEUTICALS;2.4 SURVEILLANCE AND DISTRIBUTION;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES","4;1;1;1","BRAIN TUMOR;HODGKIN'S DISEASE;LIVER CANCER;NON-HODGKIN'S LYMPHOMA;NOT SITE-SPECIFIC CANCER","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER","3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,"PUBLIC LIBRARY OF SCIENCE;TAYLOR & FRANCIS GROUP","6;1","31 BIOLOGICAL SCIENCES;3105 GENETICS;32 BIOMEDICAL AND CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3213 PAEDIATRICS","10;5;2;2;1;1","NEURODEGENERATIVE;BIOTECHNOLOGY;BRAIN DISORDERS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;EPILEPSY;GENETICS;HUMAN GENOME;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);LIVER DISEASE;NEUROSCIENCES;PATIENT SAFETY;PEDIATRIC;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NEUROLOGICAL","2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS","2;1","BIOMEDICAL;CLINICAL","1;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","3;1;1",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_MEYER",2018,255,15.2901960784314,2.72941176470588,0.333333333333333,0.286274509803922,0.431372549019608,2.24516129032258,1.25,1.69767441860465,1.34146341463415,0.643137254901961,1,115,65,25,28,0.45,0.25,0.1,0.11,25.09,0.822535351239625,5.55555555555556,0.333333333333333,0.956862745098039,0.45,0.384,0.412,0.452,"RENZO GUERRINI;LUISA GALLI;ROLANDO CIMAZ;ELENA CHIAPPINI;MAURIZIO DE MARTINO;LORENZO GENITORI;IACOPO SARDI;CHIARA AZZARI;FRANCA RUSCONI;MAURIZIO DE MARTINO;FRANCO BAMBI;MARIA ALICE DONATI;SILVIA FAVILLI;FRANCESCA MORI;ELISABETTA VENTURINI;SIMONA BARNI;SONIA TONI;PAOLO LIONETTI;ELENA PARRINI;CLAUDIO FAVRE","25;14;14;11;11;10;9;9;9;9;8;8;8;7;7;7;7;6;6;6","FRANCA RUSCONI;RENZO GUERRINI;LUISA GALLI;MAURIZIO DE MARTINO;MAURIZIO DE MARTINO;ELENA CHIAPPINI;CHIARA AZZARI;ROLANDO CIMAZ;SILVIA FAVILLI;LORENZO GENITORI;STEFANO STAGI;ELISABETTA VENTURINI;FRANCESCA MORI;IACOPO SARDI;SIMONA BARNI;ANDREA BASSI;PAOLO LIONETTI;MARIA ALICE DONATI;ELIO NOVEMBRE;IACOPO OLIVOTTO","1.8;1.74;1.63;1.53;1.31;1.31;1.31;1.22;1.11;1.03;0.89;0.89;0.84;0.81;0.8;0.8;0.8;0.8;0.74;0.73","RENZO GUERRINI;LUISA GALLI;ROLANDO CIMAZ;ELENA CHIAPPINI;MAURIZIO DE MARTINO;LORENZO GENITORI;IACOPO SARDI;CHIARA AZZARI;FRANCA RUSCONI;MAURIZIO DE MARTINO;FRANCO BAMBI;MARIA ALICE DONATI;SILVIA FAVILLI;FRANCESCA MORI;ELISABETTA VENTURINI;SIMONA BARNI;SONIA TONI;PAOLO LIONETTI;ELENA PARRINI;CLAUDIO FAVRE","25;14;14;11;11;10;9;9;9;9;8;8;8;7;7;7;7;6;6;6","FRANCA RUSCONI;RENZO GUERRINI;LUISA GALLI;MAURIZIO DE MARTINO;MAURIZIO DE MARTINO;ELENA CHIAPPINI;CHIARA AZZARI;ROLANDO CIMAZ;SILVIA FAVILLI;LORENZO GENITORI;STEFANO STAGI;ELISABETTA VENTURINI;FRANCESCA MORI;IACOPO SARDI;SIMONA BARNI;ANDREA BASSI;PAOLO LIONETTI;MARIA ALICE DONATI;ELIO NOVEMBRE;SONIA TONI","1.8;1.74;1.63;1.53;1.31;1.31;1.31;1.22;1.11;1.03;0.89;0.89;0.84;0.81;0.8;0.8;0.8;0.8;0.74;0.69","RENZO GUERRINI;PASQUALE STRIANO;ANNAPURNA PODURI;JOHANNES R. LEMKE;ROLANDO CIMAZ;KATHERINE L. HELBIG;JORDI ANTÓN;YOSEF UZIEL;RIKKE S. MØLLER;SANJAY M. SISODIYA;SARAH WECKHUYSEN;SEBASTIAAN J. VASTERT;SHA TANG;CAROLINE NAVA;ANGELO RAVELLI;NICO WULFFRAAT;VALERIO CONTI;BOBBY P.C. KOELEMAN;DAVIDE MEI;FABRIZIO DE BENEDETTI","1378;623;607;580;549;508;473;452;441;441;441;441;434;433;432;429;375;366;347;334","RENZO GUERRINI;ROLANDO CIMAZ;VALERIO CONTI;DAVIDE MEI;CLAUDIO FAVRE;FRANCO BAMBI;ELENA PARRINI;CARLA MARINI;PAOLO LIONETTI;BENEDETTA MAZZINGHI;FRANCESCA BECHERUCCI;LETIZIA DE CHIARA;GABRIELE SIMONINI;MARIA ALICE DONATI;FRANCA RUSCONI;FRANCESCA MORI;ELEONORA GAMBINERI;MATTEO DELLA MONICA;CHIARA AZZARI;MARINA VIGNOLI","1308;542;375;347;313;290;263;236;236;214;214;214;211;204;202;186;167;152;150;150","RENZO GUERRINI;MAURIZIO DE MARTINO;LUISA GALLI;ROLANDO CIMAZ;ELENA CHIAPPINI;FRANCA RUSCONI;LORENZO GENITORI;IACOPO SARDI;CHIARA AZZARI;MARIA ALICE DONATI;SILVIA FAVILLI;FRANCO BAMBI;ELISABETTA VENTURINI;SIMONA BARNI;FRANCESCA MORI;SONIA TONI;BARBARA PICCINI;ELENA PARRINI;GIANCARLO LA MARCA;PAOLO LIONETTI","22;19;13;13;11;9;9;9;9;8;8;8;7;7;7;7;6;6;6;6","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;ECONOMICS;SOCIOLOGY;POLITICAL SCIENCE;GEOLOGY;HISTORY;MATERIALS SCIENCE;ART;GEOGRAPHY;PHILOSOPHY","224;99;25;22;21;20;14;12;11;7;5;2;2;2;1;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;SURGERY;PATHOLOGY;IMMUNOLOGY;PSYCHIATRY;BIOCHEMISTRY;NEUROSCIENCE;RADIOLOGY;DERMATOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;OPTICS;CANCER RESEARCH;CARDIOLOGY;CELL BIOLOGY;ONCOLOGY","147;77;73;56;54;42;36;26;25;20;18;18;18;18;18;14;13;13;13;11","GENE;DISEASE;COHORT;EPILEPSY;POPULATION;MAGNETIC RESONANCE IMAGING;PREGNANCY;RETROSPECTIVE COHORT STUDY;INCIDENCE (GEOMETRY);ALTERNATIVE MEDICINE;ANTIBODY;DIABETES MELLITUS;IMMUNE SYSTEM;ALLERGY;ARTHRITIS;COHORT STUDY;PROSPECTIVE COHORT STUDY;BACTERIA;CYSTIC FIBROSIS;TRANSPLANTATION","47;37;18;18;17;14;14;13;12;11;11;11;10;9;9;9;9;8;8;8","PHENOTYPE;MUTATION;GENOTYPE;TYPE 1 DIABETES;ALLELE;CARDIOMYOPATHY;GENOME;GESTATIONAL AGE;INFLAMMATORY BOWEL DISEASE;PROTOCOL (SCIENCE);ANAPHYLAXIS;BIRTH WEIGHT;EMBRYONIC STEM CELL;FOOD ALLERGY;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNOGLOBULIN E;LOW BIRTH WEIGHT;ADALIMUMAB;DACARBAZINE;EXON;GESTATION;GLYCEMIC;HEART TRANSPLANTATION;LISSENCEPHALY;MITOCHONDRIAL DNA;NEISSERIA MENINGITIDIS;PHENYLALANINE;PRIMARY IMMUNODEFICIENCY;TYPE 2 DIABETES;WHITE MATTER","21;14;9;7;6;5;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","MISSENSE MUTATION;BRONCHOPULMONARY DYSPLASIA;INDUCED PLURIPOTENT STEM CELL;PROBAND;MITOCHONDRIAL MYOPATHY;ORAL FOOD CHALLENGE;PENETRANCE;ANAPLASTIC ASTROCYTOMA;BUSULFAN;CALPROTECTIN;DERMATAN SULFATE;EGG ALLERGY;EXOME SEQUENCING;HAPLOTYPE;HOMOCYSTINURIA;INSULIN PUMP;LATENT TUBERCULOSIS;LOSS FUNCTION;MENINGOCOCCAL DISEASE;OMALIZUMAB;PACHYGYRIA;PEANUT ALLERGY;PHENYLKETONURIAS;PROGENITOR;RETINOPATHY OF PREMATURITY;SINGLE-NUCLEOTIDE POLYMORPHISM","8;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;CHILD;;ADOLESCENT;ITALY;CHILD, PRESCHOOL;INFANT;ADULT;RETROSPECTIVE STUDIES;MUTATION;INFANT, NEWBORN;YOUNG ADULT;DIABETES MELLITUS, TYPE 1;BRAIN;EPILEPSY;ARTHRITIS, JUVENILE;CYSTIC FIBROSIS;TREATMENT OUTCOME","167;127;121;86;84;77;67;62;50;44;41;29;28;28;26;25;25;23;21;21","HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPIDEMIOLOGY AND PATHOGENESIS OF BACTERIAL MENINGITIS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPILEPSY AND SEIZURES;GLIOMAS;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EATING DISORDERS AND BODY IMAGE CONCERNS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;MINIMALLY INVASIVE REPAIR OF PECTUS EXCAVATUM;PEDIATRIC PAIN ASSESSMENT AND MANAGEMENT;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION","8;6;5;5;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3","TREATMENT;DIABETES;TYPE 1 DIABETES;CONTINUOUS GLUCOSE MONITORING;CYSTIC FIBROSIS;ETIOLOGY;JUVENILE IDIOPATHIC ARTHRITIS;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;EPILEPSY;GIRL;ADULT CONGENITAL HEART DISEASE;BRONCHOPULMONARY DYSPLASIA;CARDIAC IMAGING;CONCOMITANT;CONGENITAL HEART DISEASE;DEPRESSION (ECONOMICS);HEMATOPOIETIC CELL TRANSPLANTATION;PRIMARY IMMUNODEFICIENCY;PROBAND;ALLERGEN IMMUNOTHERAPY","10;8;8;7;7;7;7;7;5;5;4;4;4;4;4;4;4;4;4;3","CYSTIC FIBROSIS;DE NOVO;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;STEM CELL;CELL TRANSPLANTATION;COHORT STUDY;EMERGENCY DEPARTMENT;EPILEPTIC ENCEPHALOPATHY;MAGNETIC RESONANCE;OBSERVATIONAL STUDY;PLURIPOTENT STEM;STEM CELLS;TYPE DIABETES;ADOPTED CHILDREN;BIRTH COHORT;CONGENITAL HEART;HEART DISEASE;HEMATOPOIETIC STEM;INTERNATIONALLY ADOPTED;MULTICENTER STUDY;NINFEA BIRTH;PEDIATRIC PATIENTS;RETROSPECTIVE STUDY;SINGLE CENTER;SYSTEMIC SCLEROSIS;ACUTE KIDNEY;ADRENOCEPTOR STIMULATION;AIEOP PROTOCOL;ALLOGENEIC HEMATOPOIETIC","7;6;6;6;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","PUBMED SCOPUS;CROSSREF PUBMED;DE NOVO;RISK FACTORS;DISEASE ACTIVITY;MAGNETIC RESONANCE;NH SCAVENGERS;PALMOPLANTAR ECCRINE;CYSTIC FIBROSIS;EXOME SEQUENCING;BIRTH WEIGHT;CARGLUMIC ACID;ECCRINE HIDRADENITIS;VITRO FERTILIZATION;CONGENITAL TB;CONGENITAL TUBERCULOSIS;ENTERAL FEEDING;GENET -ABSTRACT;INFANT FORMULA;JIA PATIENTS;BM MSC;FIBROSIS CF;HUM GENET;MEDIAN AGE;MISSENSE VARIANTS;MOLECULAR DIAGNOSIS;RESONANCE IMAGING;SYSTEMIC SCLEROSIS;TOURETTE SYNDROME;TP MUTATION","60;41;18;13;11;11;11;11;10;10;9;9;9;9;8;8;8;8;8;8;7;7;7;7;7;7;7;7;7;7",133,0.52,8.5,8,2,1,1,4,2,0,1,9,0,1,7.25,1,1.25,1,2.5,4,5,0,0,70,69,3,0,1,2,0,0,0,1,0,0,0,0,2,1,1,2,4,2.3,2,0,3,4,0,0,1,0,0,1,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"CALVANI MAURA;FILIPPI LUCA;GEPPETTI PIERANGELO;AZZARI CHIARA;FORT ADA;LA MARCA GIANCARLO;MORI FRANCESCA;MUGNAINI MARCO;NOVEMBRE ELIO;PUCCI NERI","2;2;2;1;1;1;1;1;1;1","AZIENDA OSPEDALIERO UNIV MEYER;UNIV DEGLI STUDI DI FIRENZE;AZIENDA OSPEDALIERO UNIVERSITARIA MEYER;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;UNIVERSITA DEGLI STUDI DI FIRENZE;UNIVERSITA DEGLI STUDI DI SIENA","2;2;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3204 IMMUNOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","5;1;1;1;1","PEDIATRIC","1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","1;1;1","A61K31/138;A61K31/18;A61P35/00;C12M1/34;G01N33/49;G01N33/543;G01N33/66;G01N33/68;H01J49/00;H01J49/04","2;2;1;1;1;1;1;1;1;1","A61K31/138;A61K31/18;A61P35/00;G01N2800/24;G01N33/492;G01N33/5438;G01N33/553;G01N33/66;G01N33/6854;G01N33/6893","2;2;2;1;1;1;1;1;1;1",11,7.09,365.64,3.65,6,0.55,45.91,0,1,1,0,6,0,0,3,0,8,3,0,0,0,0,0,0,11,0,0,11,0,0,0,0,0,0,0,0,0,"United States;Canada;France;Italy;Japan;Turkey","6;1;1;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","11;8;2;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;PEDIATRIC;AUTOIMMUNE DISEASE;CANCER;LUNG;BIOTECHNOLOGY;CYSTIC FIBROSIS;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;ARTHRITIS;CROHN'S DISEASE;GENETICS;HUMAN GENOME;NEUROBLASTOMA;NEUROSCIENCES;NUTRITION;ORPHAN DRUG;OSTEOPOROSIS","8;8;8;7;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;CONGENITAL;INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL;MUSCULOSKELETAL;RESPIRATORY","2;2;2;2;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","8;2;2;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA;COLON AND RECTAL CANCER;LUNG CANCER;NEUROBLASTOMA","2;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.2 ENDOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","2;1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"FRONTIERS;SPRINGER NATURE;AMERICAN CHEMICAL SOCIETY","3;2;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY;4203 HEALTH SERVICES AND SYSTEMS","7;6;4;2;1;1;1","CLINICAL RESEARCH;GENETIC TESTING;GENETICS;NEURODEGENERATIVE;RARE DISEASES;AGING;BIOTECHNOLOGY;EYE DISEASE AND DISORDERS OF VISION;NEUROSCIENCES","3;3;3;3;2;1;1;1;1","NEUROLOGICAL;CANCER;CONGENITAL","3;1;1","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS","3;2;1;1;1","CLINICAL;BIOMEDICAL","3;2","CLINICAL MEDICINE AND SCIENCE","5","NOT SITE-SPECIFIC CANCER","1",NA,NA
"IRCCS_MEYER",2019,257,14.5291828793774,3.0272373540856,0.319066147859922,0.326848249027237,0.431906614785992,2.39384615384615,1.3015873015873,1.90909090909091,1.37037037037037,0.618677042801556,1,123,55,20,29,0.48,0.21,0.08,0.11,27.14,1.11609999810502,6.0315870570108,0.369649805447471,0.949416342412451,0.526,0.483,0.462,0.451,"RENZO GUERRINI;ROLANDO CIMAZ;TERESA GIANI;GABRIELE SIMONINI;CHIARA AZZARI;LUISA GALLI;ELENA CHIAPPINI;FRANCESCA MORI;LORENZO GENITORI;AUGUSTO VAGLIO;LORENZO MASIERI;SILVIA RICCI;GIUSEPPE INDOLFI;SIMONA BARNI;SABRINA GIGLIO;DAVIDE MEI;CARLA MARINI;ANNA MARIA BUCCOLIERO;MAURIZIO DE MARTINO;IACOPO SARDI","28;21;16;16;15;14;12;11;11;10;10;10;9;8;8;8;8;8;8;7","ROLANDO CIMAZ;TERESA GIANI;GABRIELE SIMONINI;RENZO GUERRINI;ELENA CHIAPPINI;LUISA GALLI;MILENA GUIDI;LORENZO MASIERI;LORENZO GENITORI;CHIARA AZZARI;FRANCESCA MORI;MAURIZIO DE MARTINO;TERESA ORANGES;LISA GAMALERO;GIUSEPPE INDOLFI;SIMONA BARNI;IACOPO SARDI;ENRICO LOMBARDI;SILVIA RICCI;CHIARA CINI","3.08;2.81;2.41;2.1;1.89;1.66;1.34;1.27;1.23;1.22;1.1;1.06;1.04;0.96;0.9;0.87;0.86;0.86;0.83;0.82","RENZO GUERRINI;ROLANDO CIMAZ;TERESA GIANI;GABRIELE SIMONINI;CHIARA AZZARI;LUISA GALLI;ELENA CHIAPPINI;FRANCESCA MORI;LORENZO GENITORI;AUGUSTO VAGLIO;LORENZO MASIERI;SILVIA RICCI;GIUSEPPE INDOLFI;SIMONA BARNI;SABRINA GIGLIO;DAVIDE MEI;CARLA MARINI;ANNA MARIA BUCCOLIERO;MAURIZIO DE MARTINO;IACOPO SARDI","28;21;16;16;15;14;12;11;11;10;10;10;9;8;8;8;8;8;8;7","ROLANDO CIMAZ;TERESA GIANI;GABRIELE SIMONINI;RENZO GUERRINI;ELENA CHIAPPINI;LUISA GALLI;MILENA GUIDI;LORENZO MASIERI;LORENZO GENITORI;CHIARA AZZARI;FRANCESCA MORI;MAURIZIO DE MARTINO;TERESA ORANGES;LISA GAMALERO;GIUSEPPE INDOLFI;SIMONA BARNI;IACOPO SARDI;ENRICO LOMBARDI;SILVIA RICCI;CHIARA CINI","3.08;2.81;2.41;2.1;1.89;1.66;1.34;1.27;1.23;1.22;1.1;1.06;1.04;0.96;0.9;0.87;0.86;0.86;0.83;0.82","RENZO GUERRINI;CARLO SALVARANI;ROLANDO CIMAZ;SALVATORE GROSSO;ALMA NUNZIA OLIVIERI;ANTONELLA INSALACO;CARLA GAGGIANO;CLAUDIA FABIANI;DONATO RIGANTE;FABRIZIO DE BENEDETTI;FRANCESCO LA TORRE;GIUSEPPE LOPALCO;JURGEN SOTA;LUCA CANTARINI;MANUELA PARDEO;MARCO CATTALINI;MARIA ALESSIO;MARIA CRISTINA MAGGIO;PAOLO SFRISO;ROMINA GALLIZZI","1040;856;845;706;643;643;643;643;643;643;643;643;643;643;643;643;643;643;643;643","RENZO GUERRINI;ROLANDO CIMAZ;AUGUSTO VAGLIO;ENRICO LOMBARDI;DAVIDE MEI;CHIARA AZZARI;CARLA MARINI;FRANCESCA MORI;FRANCA RUSCONI;SILVIA RICCI;ANNA MARIA BUCCOLIERO;CLAUDIO FAVRE;GIUSEPPE INDOLFI;SIMONA BARNI;CHIARA MARVISI;FEDERICA MARITATI;MARIA ALICE DONATI;GABRIELE SIMONINI;LORENZO MASIERI;GIANCARLO LA MARCA","978;768;611;461;397;370;291;291;230;221;214;210;203;202;199;199;197;189;178;177","RENZO GUERRINI;ROLANDO CIMAZ;TERESA GIANI;GABRIELE SIMONINI;CHIARA AZZARI;LUISA GALLI;ELENA CHIAPPINI;LORENZO GENITORI;AUGUSTO VAGLIO;FRANCESCA MORI;LORENZO MASIERI;SILVIA RICCI;ANNA MARIA BUCCOLIERO;MAURIZIO DE MARTINO;GIUSEPPE INDOLFI;CARLA MARINI;SABRINA GIGLIO;SIMONA BARNI;DAVIDE MEI;CHIARA CINI","24;16;15;15;14;14;12;11;10;10;10;10;9;9;9;8;8;8;8;7","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;PSYCHOLOGY;COMPUTER SCIENCE;MATHEMATICS;ECONOMICS;ENGINEERING;SOCIOLOGY;POLITICAL SCIENCE;BUSINESS;ART;MATERIALS SCIENCE;PHILOSOPHY;GEOGRAPHY;GEOLOGY;HISTORY","233;106;23;22;18;17;9;6;6;6;5;4;2;2;2;1;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;PATHOLOGY;SURGERY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;GASTROENTEROLOGY;NEUROSCIENCE;DERMATOLOGY;BIOCHEMISTRY;RADIOLOGY;INTENSIVE CARE MEDICINE;CANCER RESEARCH;OPTICS;BIOINFORMATICS;MICROBIOLOGY;PHARMACOLOGY;ENDOCRINOLOGY;FAMILY MEDICINE","154;88;72;59;59;48;27;27;24;24;22;21;21;19;16;15;12;11;10;9;9","GENE;DISEASE;EPILEPSY;POPULATION;COHORT;RETROSPECTIVE COHORT STUDY;ADVERSE EFFECT;PREGNANCY;CANCER;CONFIDENCE INTERVAL;INCIDENCE (GEOMETRY);CYSTIC FIBROSIS;ALLERGY;ANTIBIOTICS;ETIOLOGY;MAGNETIC RESONANCE IMAGING;ANTIBODY;ARTHRITIS;ASTHMA;EPIDEMIOLOGY;ODDS RATIO;VACCINATION","53;52;26;25;23;23;13;13;12;11;11;10;9;9;9;9;8;8;8;8;8;8","PHENOTYPE;MUTATION;GENOTYPE;ALLELE;GESTATIONAL AGE;HYDRONEPHROSIS;VASCULITIS;EPIGENETICS;ETANERCEPT;GENE EXPRESSION;CORTICAL DYSPLASIA;FETUS;GENOME;HAZARD RATIO;NEUROBLASTOMA;WHITE MATTER;ANAKINRA;ASTROCYTOMA;BIRTH WEIGHT;CARDIOMYOPATHY;CD8;CHROMOSOME;DRUG ALLERGY;ENZYME REPLACEMENT THERAPY;FOOD ALLERGY;HEMATOPOIETIC STEM CELL TRANSPLANTATION;LANGERHANS CELL HISTIOCYTOSIS;METHYLATION;MITOCHONDRIAL DNA;PI3K/AKT/MTOR PATHWAY;POLYMERASE CHAIN REACTION;RARE DISEASE;RNA;SEROLOGY;SOMATIC CELL;STREPTOCOCCUS PNEUMONIAE;T CELL","17;15;11;7;6;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","MISSENSE MUTATION;PYELOPLASTY;COMPOUND HETEROZYGOSITY;EXOME SEQUENCING;COMPARATIVE GENOMIC HYBRIDIZATION;DNA METHYLATION;GENETIC HETEROGENEITY;KRAS;PNEUMOCOCCAL CONJUGATE VACCINE;PROBAND;RETINOPATHY OF PREMATURITY;SINGLE-NUCLEOTIDE POLYMORPHISM;SUBEPENDYMAL GIANT CELL ASTROCYTOMA;CANAKINUMAB;COPY-NUMBER VARIATION;CORONAVIRUS DISEASE 2019 (COVID-19);GRANULOMATOSIS WITH POLYANGIITIS;GREY MATTER;HEMIMEGALENCEPHALY;IVACAFTOR;LOSS FUNCTION;MENINGOCOCCAL DISEASE;METHYLENETETRAHYDROFOLATE REDUCTASE;ORAL FOOD CHALLENGE;PDGFRA;PNEUMOCOCCAL INFECTIONS;RNA SPLICING","7;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;CHILD;;CHILD, PRESCHOOL;ADOLESCENT;INFANT;ITALY;ADULT;RETROSPECTIVE STUDIES;MIDDLE AGED;INFANT, NEWBORN;TREATMENT OUTCOME;EPILEPSY;CYSTIC FIBROSIS;YOUNG ADULT;MUTATION;PHENOTYPE;GENETIC PREDISPOSITION TO DISEASE","165;119;114;96;90;70;62;60;55;38;38;30;28;27;26;22;21;18;17;16","GLIOMAS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PEDIATRIC URINARY TRACT INFECTIONS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPILEPSY AND SEIZURES;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF IGG4-RELATED DISEASE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;NEUROBLASTOMA RESEARCH AND TREATMENT;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION;CHRONIC RHINOSINUSITIS AND NASAL POLYPS;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN","7;6;6;6;6;6;5;5;4;4;4;4;4;4;4;4;4;3;3;3","ETIOLOGY;TREATMENT;CYSTIC FIBROSIS;EPILEPSY;PYELOPLASTY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;COMPOUND HETEROZYGOSITY;DRUG HYPERSENSITIVITY;EXOME SEQUENCING;FOOD ALLERGY;INTERFERON-? PATHWAY DEFECTS;JUVENILE IDIOPATHIC ARTHRITIS;NEUROBLASTOMA;PRETERM INFANTS;BRAIN DEVELOPMENT;CHILDHOOD CANCER SURVIVOR STUDY;COMPARATIVE GENOMIC HYBRIDIZATION;DIAGNOSIS;DISCONTINUATION;DNA METHYLATION","9;9;8;8;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3","CYSTIC FIBROSIS;HYPERTROPHIC CARDIOMYOPATHY;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;OBSERVATIONAL STUDY;ADULT PATIENTS;CD CD;CELL HISTIOCYTOSIS;HEALTHCARE WORKERS;LANGERHANS CELL;MYOCLONIC EPILEPSY;NATIONAL SURVEY;PAEDIATRIC EMERGENCY;PAEDIATRIC HOSPITAL;PNEUMOCOCCAL CONJUGATE;PRETERM INFANTS;RETROSPECTIVE STUDY;SINGLE CENTER;SUBEPENDYMAL GIANT;SYSTEMIC JUVENILE;TUSCANY ITALY;TYPE DIABETES;ADULT MYOCLONIC;ADVERSE CHILDHOOD;ANCA-ASSOCIATED GLOMERULONEPHRITIS;BOWEL DISEASE;BRAIN MALFORMATIONS;CELL ASTROCYTOMAS;CELL DISEASE;CHILDHOOD EXPERIENCES","11;5;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","NEONATAL COMPARTMENT;COMPARTMENT SYNDROME;RISK FACTORS;MEDIAN AGE;ADVERSE EVENTS;PUBMED SCOPUS;CORTICAL DYSPLASIA;DISEASE ACTIVITY;FOCAL CORTICAL;GENE THERAPY;COMPOSITE OUTCOME;PATHOGENIC VARIANTS;CHILDREN AGED;GRANTRESEARCH SUPPORT;INTENSIVE CARE;SIGNIFICANT DIFFERENCES;DE NOVO;LIC VALUES;MAGNETIC RESONANCE;PATIENTS TREATED;ROLANDO CIMAZ;SIGNIFICANTLY LOWER;SPEAKERS BUREAU;TM PATIENTS;ABBVIE SPEAKERS;ANTIBIOTIC THERAPY;BUREAU ABBVIE;COHORT STUDY;COMPOUND HETEROZYGOUS;CROSSREF PUBMED","18;17;17;15;14;14;13;12;12;12;10;10;9;9;9;9;8;8;8;8;8;8;8;8;7;7;7;7;7;7",146,0.57,8,10,2,1.25,1,1,1,1,1,11,1,1,9.75,1,1,1,3,7,3.5,0,0,58.5,58.5,1,0,0,1,0,0,0,0,0,0,0,0,0,0,1,0,4,0.51,2,0,1,1,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ALEX CHERKASSKIY;BLAS CERDA;GIANCARLO LA MARCA;YIJUN LI","1;1;1;1","AZIENDA OSPEDALIERO UNIV MEYER DI FIRENZE;PERKINELMER HEALTH SCI INC","1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","2;1",NA,NA,NA,NA,"A61K31/185;A61K31/41;B01L99/00","1;1;1","A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833;Y10T436/201666;Y10T436/24;Y10T436/2525","1;1;1;1;1;1;1;1;1;1",15,5.6,255.93,4.81,6,0.4,51.27,0,0,2,0,7,0,0,6,0,10,5,0,0,0,0,0,0,15,0,0,15,0,0,0,0,0,0,0,0,0,"United States;Italy;France;Germany;Netherlands","10;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3212 OPHTHALMOLOGY AND OPTOMETRY;3213 PAEDIATRICS;4205 NURSING;46 INFORMATION AND COMPUTING SCIENCES;4610 LIBRARY AND INFORMATION STUDIES;5202 BIOLOGICAL PSYCHOLOGY","12;8;3;3;3;2;1;1;1;1;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES;CANCER;PEDIATRIC RESEARCH INITIATIVE;AUTOIMMUNE DISEASE;HEMATOLOGY;NEUROSCIENCES;ORPHAN DRUG;PEDIATRIC CANCER;ASSISTIVE TECHNOLOGY;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;CHILDHOOD LEUKEMIA;DIABETES;LUNG;NEUROBLASTOMA;NEURODEGENERATIVE","15;11;8;6;6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2","CANCER;METABOLIC AND ENDOCRINE;RESPIRATORY;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;NEUROLOGICAL;RENAL AND UROGENITAL","3;2;2;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","9;2;1;1;1","LEUKEMIA / LEUKAEMIA;NEUROBLASTOMA;NOT SITE-SPECIFIC CANCER;BLOOD CANCER;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;LUNG CANCER;SARCOMA","2;2;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","3;2;1;1",1,417127,208563.5,3,2,2,1,0,69521.1666666667,3.69671586830869,"MEYER CHILDREN'S HOSPITAL;UNIVERSITY OF JAÉN","1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","RIGHTS, EQUALITY AND CITIZENSHIP PROGRAMME (PROGRAMME)","1","44 HUMAN SOCIETY;4403 DEMOGRAPHY;47 LANGUAGE, COMMUNICATION AND CULTURE;4702 CULTURAL STUDIES","1;1;1;1","CLINICAL RESEARCH;HEALTH SERVICES;VIOLENCE RESEARCH","1;1;1",NA,NA,"8.1 ORGANISATION AND DELIVERY OF SERVICES","1",NA,NA,NA,NA,"C20 SOCIAL WORK AND SOCIAL POLICY","1","16 PEACE, JUSTICE AND STRONG INSTITUTIONS;8 DECENT WORK AND ECONOMIC GROWTH","1;1",18,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;ZENODO;TAYLOR & FRANCIS GROUP","9;6;2;1","31 BIOLOGICAL SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;3202 CLINICAL SCIENCES;49 MATHEMATICAL SCIENCES;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3107 MICROBIOLOGY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES;4904 PURE MATHEMATICS","20;16;9;4;3;3;2;1;1;1;1;1;1;1","GENETICS;CLINICAL RESEARCH;PEDIATRIC;HUMAN GENOME;PREVENTION;BIOTECHNOLOGY;GENETIC TESTING;HEMATOLOGY;CARDIOVASCULAR;RARE DISEASES;AUTOIMMUNE DISEASE;IMMUNIZATION;INFECTIOUS DISEASES;PATIENT SAFETY;SEPSIS;VACCINE RELATED","10;9;8;6;6;5;5;4;2;2;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;INFECTION","5;2","4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.4 SURVEILLANCE AND DISTRIBUTION;3.4 VACCINES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS","6;4;1;1;1;1","BIOMEDICAL;CLINICAL","7;3","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE;PUBLIC HEALTH","11;3;1",NA,NA,"3 GOOD HEALTH AND WELL BEING","4"
"IRCCS_MEYER",2020,333,15.6516516516517,2.82582582582583,0.303303303303303,0.273273273273273,0.324324324324324,2.46719160104987,1.2948717948718,1.93617021276596,1.47945205479452,0.648648648648649,3,133,89,34,24,0.4,0.27,0.1,0.07,18.25,0.724217753378539,6.73245901639345,0.342342342342342,0.945945945945946,0.546,0.496,0.424,0.481,"RENZO GUERRINI;ELENA CHIAPPINI;MATTIA GIOVANNINI;CHIARA AZZARI;PAOLA ROMAGNANI;LUISA GALLI;SILVIA RICCI;FRANCESCA MORI;AUGUSTO VAGLIO;SIMONA BARNI;GIUSEPPE INDOLFI;SABRINA GIGLIO;ROLANDO CIMAZ;GABRIELE SIMONINI;GIANCARLO LA MARCA;ELIO NOVEMBRE;GIAN LUIGI MARSEGLIA;AMELIA MORRONE;GIULIA LICCIOLI;IACOPO OLIVOTTO","24;18;17;17;16;16;16;14;13;13;12;12;12;11;11;11;11;10;9;9","ELENA CHIAPPINI;PAOLA ROMAGNANI;LUISA GALLI;MATTIA GIOVANNINI;GABRIELE SIMONINI;FRANCESCA MORI;SILVIA RICCI;SANDRA TRAPANI;SIMONA BARNI;RENZO GUERRINI;CHIARA AZZARI;ELIO NOVEMBRE;GIULIA LICCIOLI;AMELIA LICARI;GIAN LUIGI MARSEGLIA;GIUSEPPE INDOLFI;ELISA PANI;AMELIA MORRONE;ANTONINO MORABITO;TERESA ORANGES","3.07;2.69;2.38;2.15;1.83;1.73;1.57;1.55;1.49;1.37;1.36;1.31;1.25;1.22;1.2;1.16;1.14;1.14;1.07;1.04","RENZO GUERRINI;ELENA CHIAPPINI;MATTIA GIOVANNINI;CHIARA AZZARI;PAOLA ROMAGNANI;LUISA GALLI;SILVIA RICCI;FRANCESCA MORI;AUGUSTO VAGLIO;SIMONA BARNI;GIUSEPPE INDOLFI;SABRINA GIGLIO;ROLANDO CIMAZ;GABRIELE SIMONINI;GIANCARLO LA MARCA;ELIO NOVEMBRE;AMELIA MORRONE;GIULIA LICCIOLI;SANDRA TRAPANI;SILVIA FAVILLI","24;18;17;17;16;16;16;14;13;13;12;12;12;11;11;11;10;9;9;9","ELENA CHIAPPINI;PAOLA ROMAGNANI;LUISA GALLI;MATTIA GIOVANNINI;GABRIELE SIMONINI;FRANCESCA MORI;SILVIA RICCI;SANDRA TRAPANI;SIMONA BARNI;RENZO GUERRINI;CHIARA AZZARI;ELIO NOVEMBRE;GIULIA LICCIOLI;GIUSEPPE INDOLFI;ELISA PANI;AMELIA MORRONE;ANTONINO MORABITO;TERESA ORANGES;SUSANNE MASI;GIANCARLO LA MARCA","3.07;2.69;2.38;2.15;1.83;1.73;1.57;1.55;1.49;1.37;1.36;1.31;1.25;1.16;1.14;1.14;1.07;1.04;1;0.97","RENZO GUERRINI;MATTEO LENGE;ENRICO FELICI;ROBERTA GIACCHERO;CHIARA AZZARI;LUISA GALLI;PAOLA ROMAGNANI;RAFFAELE BADOLATO;DANILO BUONSENSO;AUGUSTO VAGLIO;ELISABETTA VENTURINI;NICCOLÓ PARRI;IVANA RABBONE;LIVIANA DA DALT;SANJAY M. SISODIYA;MARIASAVINA SEVERINO;MARIO MASCALCHI;ORRIN DEVINSKY;MARIA EUGENIA CALIGIURI;ANDREA BERNASCONI","924;558;545;508;472;399;385;361;357;348;341;340;337;333;328;318;298;295;291;287","RENZO GUERRINI;MATTEO LENGE;CHIARA AZZARI;LUISA GALLI;PAOLA ROMAGNANI;AUGUSTO VAGLIO;ELISABETTA VENTURINI;MARIO MASCALCHI;TERESA ORANGES;CARLOTTA MONTAGNANI;SILVIA RICCI;CESARE FILIPPESCHI;NICCOLÓ PARRI;GIUSEPPE INDOLFI;PAOLO LIONETTI;ANNALISA VETRO;FRANCA RUSCONI;ELENA PARRINI;STEFANO MASI;SALVATORE DE MASI","872;545;468;398;385;348;341;298;283;278;256;250;249;222;194;189;176;174;174;166","RENZO GUERRINI;ELENA CHIAPPINI;CHIARA AZZARI;PAOLA ROMAGNANI;MATTIA GIOVANNINI;LUISA GALLI;FRANCESCA MORI;AUGUSTO VAGLIO;SILVIA RICCI;SIMONA BARNI;GIUSEPPE INDOLFI;SABRINA GIGLIO;ELIO NOVEMBRE;AMELIA MORRONE;GABRIELE SIMONINI;GIULIA LICCIOLI;ANNA MARIA BUCCOLIERO;GIANCARLO LA MARCA;FRANCA RUSCONI;SILVIA FAVILLI","22;17;16;16;15;15;14;13;13;13;12;11;11;10;10;9;9;9;9;9","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;POLITICAL SCIENCE;SOCIOLOGY;MATHEMATICS;ECONOMICS;PHILOSOPHY;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;GEOLOGY;HISTORY","302;115;28;27;24;24;15;13;13;12;10;6;3;3;2;1;1","INTERNAL MEDICINE;PEDIATRICS;PATHOLOGY;GENETICS;IMMUNOLOGY;SURGERY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;RADIOLOGY;PSYCHIATRY;BIOCHEMISTRY;FAMILY MEDICINE;GASTROENTEROLOGY;ENDOCRINOLOGY;VIROLOGY;CARDIOLOGY;CANCER RESEARCH;CELL BIOLOGY;DERMATOLOGY;NURSING","201;113;83;75;75;59;39;39;33;29;28;27;25;23;22;18;16;15;15;14","DISEASE;GENE;POPULATION;ANTIBODY;COHORT;RETROSPECTIVE COHORT STUDY;EPILEPSY;MAGNETIC RESONANCE IMAGING;IMMUNE SYSTEM;PREGNANCY;ADVERSE EFFECT;ALLERGY;HEALTH CARE;KIDNEY;CANCER;DIABETES MELLITUS;INCIDENCE (GEOMETRY);OUTBREAK;RANDOMIZED CONTROLLED TRIAL;VACCINATION","88;54;31;24;24;18;17;16;14;14;12;12;12;12;11;11;11;11;11;11","INFECTIOUS DISEASE (MEDICAL SPECIALTY);PHENOTYPE;MUTATION;2019-20 CORONAVIRUS OUTBREAK;IMMUNIZATION;CARDIOMYOPATHY;VASCULITIS;IMMUNOGLOBULIN E;ANAPHYLAXIS;CHROMATIN;DILATED CARDIOMYOPATHY;FETUS;GENOME;GENOTYPE;INFLAMMATORY BOWEL DISEASE;MULTICENTER STUDY;RITUXIMAB;SYSTEMIC LUPUS ERYTHEMATOSUS;AUTISM SPECTRUM DISORDER;CLINICAL ENDPOINT;GENE EXPRESSION;GESTATIONAL AGE;IMMUNODEFICIENCY;LUPUS NEPHRITIS;NEISSERIA MENINGITIDIS;PRIMARY IMMUNODEFICIENCY;PROTEINURIA","28;18;15;9;8;7;7;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;CHROMATIN REMODELING;COMPOUND HETEROZYGOSITY;GRANULOMATOSIS WITH POLYANGIITIS;MICROSCOPIC POLYANGIITIS;OMALIZUMAB;ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY;COPY-NUMBER VARIATION;DNA METHYLATION;MENINGOCOCCAL DISEASE;MEPOLIZUMAB;MISSENSE MUTATION;PROBAND;RUBELLA;ABATACEPT;ANCA-ASSOCIATED VASCULITIS;ANTIRETROVIRAL THERAPY;CIRCULATING TUMOR CELL;CLAVULANIC ACID;DNA FRAGMENTATION;ECULIZUMAB;ERDHEIM–CHESTER DISEASE;FRACTIONAL ANISOTROPY;GENETIC HETEROGENEITY;GLOBAL DEVELOPMENTAL DELAY;GLOBUS PALLIDUS;GREY MATTER;HAPLOINSUFFICIENCY;INTRAVENTRICULAR HEMORRHAGE;LATENT TUBERCULOSIS;MENINGOCOCCAL VACCINE;METASTATIC BREAST CANCER;PENETRANCE;RENAL STEM CELL;SEROPREVALENCE;SINGLE-NUCLEOTIDE POLYMORPHISM;SOX10;VEMURAFENIB","28;7;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;CHILD;MALE;ADOLESCENT;ITALY;CHILD, PRESCHOOL;ADULT;INFANT;RETROSPECTIVE STUDIES;BRAIN;CORONAVIRUS INFECTIONS;PNEUMONIA, VIRAL;YOUNG ADULT;INFANT, NEWBORN;MIDDLE AGED;COVID-19;MUTATION;TREATMENT OUTCOME","180;143;86;80;79;47;46;41;40;36;32;24;22;22;22;21;21;18;18;15","DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;EPILEPSY AND SEIZURES;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EPIDEMIOLOGY AND PATHOGENESIS OF BACTERIAL MENINGITIS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION;ASTHMA;AUTOINFLAMMATORY BONE DISORDERS;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF URTICARIA;GLIOMAS;HEMATOPOIETIC STEM CELL BIOLOGY","7;6;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;ETIOLOGY;NEPHROLOGY;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;DILATED CARDIOMYOPATHY;EPILEPSY;TREATMENT;ASTHMA;FETAL DNA ANALYSIS;GIRL;INTERQUARTILE RANGE;JUVENILE IDIOPATHIC ARTHRITIS;REGIMEN;BRAIN DEVELOPMENT;CARDIAC IMAGING;CLINICAL ENDPOINT;CLINICAL PRACTICE;COMPOUND HETEROZYGOSITY;DIAGNOSIS","14;9;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4","CYSTIC FIBROSIS;LONG-TERM FOLLOW-UP;CLINICAL FEATURES;INFLAMMATORY BOWEL;KIDNEY DISEASE;ADOPTED CHILDREN;BOWEL DISEASE;EMERGENCY DEPARTMENT;IDIOPATHIC ARTHRITIS;INTERNATIONALLY ADOPTED;ITALIAN PEDIATRIC;JUVENILE IDIOPATHIC;MULTICENTER STUDY;NEWBORN SCREENING;OBSERVATIONAL STUDY;PEDIATRIC PATIENTS;PRIMARY IMMUNODEFICIENCY;RETROSPECTIVE STUDY;ASSOCIAZIONE ITALIANA;CHRONIC HEPATITIS;CHRONIC KIDNEY;CHRONIC NON-BACTERIAL;COVID- PANDEMIC;DIFFERENTIAL DIAGNOSIS;EOSINOPHILIC GRANULOMATOSIS;ITALIAN ASSOCIATION;ITALIAN PRIMARY;ITALIAN SOCIETY;LUNG DISEASE;LUPUS NEPHRITIS","6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;RESEARCH FUNDING;INTENSIVE CARE;SARS-COV- INFECTION;CLIN IMMUNOL;EPUB AHEAD;PRINT DOI;HEALTH CARE;MEDIAN AGE;ADVISORY COMMITTEES;ENTITYS BOARD;CLINICAL FEATURES;DERMATOLOGY UNIT;LUNG DISEASE;CORONAVIRUS DISEASE;CHILDRENS HOSPITALS;CLINICAL PRACTICE;COVID- PANDEMIC;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;PRIMARY IMMUNODEFICIENCY;XMLNSMMLHTTPWWWWORGMATHMATHML IDMMMLMIPMMLMIMMLMOLTMMLMOMMLMNMMLMNMMLMATH;ALLERGY CLIN;PATIENTS AGED;COMMON VARIABLE;CROSSREF MEDLINE;CYSTIC FIBROSIS;DE NOVO;DISEASE ACTIVITY;INFLUENZA VACCINATION","33;23;22;18;18;17;17;17;16;16;15;15;14;14;14;13;12;12;12;12;12;12;11;11;10;10;10;10;10;10",179,0.54,9.5,10.5,2,1,0,3,2.25,1,1,13,0,1,10.75,1,1.25,2,3,7,5,0,0,50,49.5,3,0,0,4,0,1,0,0,0,0,0,0,1,1,3,0,7.4,3.94,2.2,0,5,4,0,0,1,0,0,0,0,0,1,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ALEX CHERKASSKIY;ARCOVIO ELENA;BLAS CERDA;BUONAMICI FRANCESCO;CARFAGNI MONICA;FURFERI ROCCO;GIANCARLO LA MARCA;GOVERNI LAPO;MCGREEVY KATHLEEN;MUSSA FEDERICO","2;2;2;2;2;2;2;2;2;2","AZIENDA OSPEDALIERO UNIV MEYER;AZIENDA OSPEDALIERO UNIV MEYER DI FIRENZE;PERKINELMER HEALTH SCI INC;UNIV DEGLI STUDI DI FIRENZE;AZIENDA OSPEDALIERO-UNIVERSITARIA MEYER;UNIVERSITA DEGLI STUDI DI FIRENZE;UNIVERSITA DEGLI STUDI DI SIENA","2;2;2;2;1;1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;31 BIOLOGICAL SCIENCES;3103 ECOLOGY;40 ENGINEERING","4;2;1;1;1",NA,NA,NA,NA,"A61K31/185;A61K31/41;B01L99/00;A61B;A61B17/29;A61B18/00;A61B18/12;A61B18/14;B01L3/00;G01N27/00","2;2;2;1;1;1;1;1;1;1","A61B18/12;A61B18/148;A61B2017/2944;A61B2018/00601;A61B2018/1475;A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848","2;2;2;2;2;2;2;2;2;2",12,5.27,741.73,3.38,6,0.5,53.67,0,0,3,1,4,0,0,4,0,9,2,0,0,0,0,0,0,12,0,0,11,1,0,0,0,0,0,0,0,0,"United States;Japan","7;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3213 PAEDIATRICS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES","12;5;3;2;2;1;1","CLINICAL RESEARCH;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;CHRONIC PAIN;HEADACHES;INFANT MORTALITY;LUNG;MIGRAINES;PAIN RESEARCH;PREVENTION;ASTHMA;BIOMEDICAL IMAGING;BRAIN DISORDERS;GENETICS;HEMATOLOGY;IMMUNIZATION;NEUROSCIENCES;NUTRITION","11;10;8;4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;RESPIRATORY","1;1;1","6.1 PHARMACEUTICALS;3.4 VACCINES;7.3 MANAGEMENT AND DECISION MAKING","9;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;BRAIN TUMOR;NOT SITE-SPECIFIC CANCER;SARCOMA","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","4",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"PUBLIC LIBRARY OF SCIENCE","5","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","5;1;1;1;1",NA,NA,NA,NA,"7.3 MANAGEMENT AND DECISION MAKING","1","CLINICAL","2","CLINICAL MEDICINE AND SCIENCE","3",NA,NA,NA,NA
"IRCCS_MEYER",2021,386,17.259067357513,2.88082901554404,0.297927461139896,0.282383419689119,0.349740932642487,2.72549019607843,1.26373626373626,1.94642857142857,1.45161290322581,0.655440414507772,1,164,96,30,21,0.42,0.25,0.08,0.05,11.55,0.748774280127643,6.73519553072626,0.39119170984456,0.953367875647668,0.538,0.452,0.417,0.459,"RENZO GUERRINI;MATTIA GIOVANNINI;GABRIELE SIMONINI;LUISA GALLI;GIUSEPPE INDOLFI;ELENA CHIAPPINI;FRANCESCA MORI;SILVIA FAVILLI;TERESA ORANGES;GIOVANNI TACCETTI;CHIARA AZZARI;ELISABETTA VENTURINI;SIMONA BARNI;PAOLA ROMAGNANI;VITO TERLIZZI;LORENZO GENITORI;GIULIA LICCIOLI;ANTONINO MORABITO;GIANCARLO LA MARCA;SANJAY M. SISODIYA","35;24;18;18;16;16;15;15;13;12;12;12;11;11;11;11;10;10;10;10","MATTIA GIOVANNINI;GABRIELE SIMONINI;RENZO GUERRINI;LUISA GALLI;GIANCARLO LA MARCA;SILVIA FAVILLI;TERESA ORANGES;FRANCESCA MORI;ELENA CHIAPPINI;ANTONINO MORABITO;ILARIA MACCORA;GIUSEPPE INDOLFI;PAOLA ROMAGNANI;RICCARDO COLETTA;VITO TERLIZZI;GIOVANNI TACCETTI;LORENZO MASIERI;SIMONA BARNI;CESARE FILIPPESCHI;CHIARA AZZARI","2.91;2.38;1.79;1.77;1.73;1.72;1.66;1.61;1.57;1.52;1.49;1.48;1.39;1.32;1.28;1.27;1.24;1.22;1.2;1.19","RENZO GUERRINI;MATTIA GIOVANNINI;GABRIELE SIMONINI;LUISA GALLI;GIUSEPPE INDOLFI;ELENA CHIAPPINI;FRANCESCA MORI;SILVIA FAVILLI;TERESA ORANGES;GIOVANNI TACCETTI;CHIARA AZZARI;ELISABETTA VENTURINI;SIMONA BARNI;PAOLA ROMAGNANI;VITO TERLIZZI;LORENZO GENITORI;GIULIA LICCIOLI;ANTONINO MORABITO;GIANCARLO LA MARCA;LORENZO MASIERI","35;24;18;18;16;16;15;15;13;12;12;12;11;11;11;11;10;10;10;10","MATTIA GIOVANNINI;GABRIELE SIMONINI;RENZO GUERRINI;LUISA GALLI;GIANCARLO LA MARCA;SILVIA FAVILLI;TERESA ORANGES;FRANCESCA MORI;ELENA CHIAPPINI;ANTONINO MORABITO;ILARIA MACCORA;GIUSEPPE INDOLFI;PAOLA ROMAGNANI;RICCARDO COLETTA;VITO TERLIZZI;GIOVANNI TACCETTI;LORENZO MASIERI;SIMONA BARNI;CESARE FILIPPESCHI;CHIARA AZZARI","2.91;2.38;1.79;1.77;1.73;1.72;1.66;1.61;1.57;1.52;1.49;1.48;1.39;1.32;1.28;1.27;1.24;1.22;1.2;1.19","RENZO GUERRINI;ALBERTO VILLANI;PASQUALE STRIANO;GABRIELE SIMONINI;JORDI ANTÓN;ROLANDO CIMAZ;SANJAY M. SISODIYA;DAVIDE MEI;CLAUDIA BRACAGLIA;MATTEO LENGE;LUISA GALLI;GIANCARLO LA MARCA;MARCO CATTALINI;CARMEN BARBA;ALESSANDRA MARCHESI;ANDREA TADDIO;FIAMMETTA ZUNICA;FRANCESCO LA TORRE;GIAN VINCENZO ZUCCOTTI;SARA DELLA PAOLERA","734;339;339;288;224;224;219;215;213;199;198;195;193;192;188;188;188;188;188;188","RENZO GUERRINI;GABRIELE SIMONINI;DAVIDE MEI;MATTEO LENGE;GIANCARLO LA MARCA;GIOVANNI TACCETTI;LUISA GALLI;FRANCESCA BECHERUCCI;ELISABETTA VENTURINI;VITO TERLIZZI;VIVIANA PALAZZO;CARMELA ERRICHIELLO;CARLA MARINI;AUGUSTO VAGLIO;CARMEN BARBA;ELENA CHIAPPINI;MATTIA GIOVANNINI;CHIARA AZZARI;GIUSEPPE INDOLFI;ANNALISA VETRO","592;288;215;199;195;181;181;179;177;170;158;154;144;142;138;138;136;130;125;122","RENZO GUERRINI;MATTIA GIOVANNINI;GABRIELE SIMONINI;LUISA GALLI;ELENA CHIAPPINI;FRANCESCA MORI;SILVIA FAVILLI;GIUSEPPE INDOLFI;TERESA ORANGES;GIOVANNI TACCETTI;ELISABETTA VENTURINI;PAOLA ROMAGNANI;VITO TERLIZZI;ANTONINO MORABITO;LORENZO MASIERI;SIMONA BARNI;GIANCARLO LA MARCA;CHIARA AZZARI;LORENZO GENITORI;CESARE FILIPPESCHI","32;21;17;17;16;15;15;14;13;12;11;11;11;10;10;10;10;10;10;9","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;CHEMISTRY;MATHEMATICS;POLITICAL SCIENCE;SOCIOLOGY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;BUSINESS;ART;PHILOSOPHY;GEOGRAPHY;GEOLOGY;HISTORY","358;154;38;34;27;16;16;15;15;13;10;8;7;5;4;2;1;1","INTERNAL MEDICINE;PEDIATRICS;GENETICS;PATHOLOGY;SURGERY;IMMUNOLOGY;INTENSIVE CARE MEDICINE;PSYCHIATRY;GASTROENTEROLOGY;NEUROSCIENCE;ENVIRONMENTAL HEALTH;BIOINFORMATICS;OPTICS;BIOCHEMISTRY;DERMATOLOGY;CANCER RESEARCH;ENDOCRINOLOGY;RADIOLOGY;VIROLOGY;FAMILY MEDICINE","243;129;106;95;69;59;47;42;35;34;32;24;23;22;21;20;20;20;18;17","DISEASE;GENE;COHORT;EPILEPSY;POPULATION;RETROSPECTIVE COHORT STUDY;INCIDENCE (GEOMETRY);PREGNANCY;CANCER;CYSTIC FIBROSIS;ANTIBODY;EPIDEMIOLOGY;OUTBREAK;ANTIBIOTICS;RECEPTOR;ALLERGY;CONFIDENCE INTERVAL;DIABETES MELLITUS;HEALTH CARE;PROSPECTIVE COHORT STUDY;TRANSPLANTATION","107;77;38;32;30;29;20;18;17;15;14;14;14;13;13;12;12;12;12;11;11","INFECTIOUS DISEASE (MEDICAL SPECIALTY);PHENOTYPE;MUTATION;2019-20 CORONAVIRUS OUTBREAK;GENOTYPE;INFLAMMATORY BOWEL DISEASE;CARDIOMYOPATHY;GENE EXPRESSION;GESTATIONAL AGE;MITOCHONDRIAL DNA;VASCULITIS;ALLELE;CROHN'S DISEASE;DRAVET SYNDROME;FETUS;FOOD ALLERGY;PEDIATRIC GASTROENTEROLOGY;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;HEMATOPOIETIC STEM CELL TRANSPLANTATION;HYDRONEPHROSIS;IMMUNOGLOBULIN E;METASTASIS;PROTEINURIA;SEROLOGY","29;29;27;12;10;10;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5","CORONAVIRUS DISEASE 2019 (COVID-19);MISSENSE MUTATION;EXOME SEQUENCING;MITOCHONDRIAL DISEASE;DNA METHYLATION;OMALIZUMAB;PENETRANCE;PYELOPLASTY;SINGLE-NUCLEOTIDE POLYMORPHISM;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;IVACAFTOR;LOSS FUNCTION;PRENATAL DIAGNOSIS;PROBAND;RETINOPATHY OF PREMATURITY;VESICOURETERAL REFLUX;ABATACEPT;ALPORT SYNDROME;ANTIRETROVIRAL THERAPY;BURKHOLDERIA CEPACIA COMPLEX;CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS;FOCAL SEGMENTAL GLOMERULOSCLEROSIS;GENETIC HETEROGENEITY;GENOTYPING;GERMLINE MUTATION;GITELMAN SYNDROME;GLUTAMINE SYNTHETASE;GRANULOMATOSIS WITH POLYANGIITIS;KOUNIS SYNDROME;KRAS;MESALAZINE;MUCOPOLYSACCHARIDOSIS TYPE I;ORAL FOOD CHALLENGE;PNEUMOCOCCAL CONJUGATE VACCINE;PRIMARY TUMOR;SANGER SEQUENCING;SCORAD;VANCOMYCIN","29;17;10;6;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;CHILD;FEMALE;MALE;RETROSPECTIVE STUDIES;ITALY;INFANT;CHILD, PRESCHOOL;ADOLESCENT;ADULT;COVID-19;EPILEPSY;INFANT, NEWBORN;CYSTIC FIBROSIS;TREATMENT OUTCOME;MUTATION;BRAIN;SEIZURES;SARS-COV-2","208;174;101;88;78;54;51;47;42;39;35;34;34;28;26;25;24;19;18;17","THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPILEPSY AND SEIZURES;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PEDIATRIC URINARY TRACT INFECTIONS;SARCOMA RESEARCH AND TREATMENT;CLASSIFICATION AND TREATMENT OF VASCULAR ANOMALIES;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;PROVISION AND ASSESSMENT OF NUTRITION SUPPORT THERAPY;ASTHMA;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION","12;10;8;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;CYSTIC FIBROSIS;INTERQUARTILE RANGE;TREATMENT;ETIOLOGY;MICROCEPHALY;PRESENTATION (OBSTETRICS);DIAGNOSIS;DRAVET SYNDROME;EPILEPSY;FOOD ALLERGY;MITOCHONDRIAL DISEASE;PEDIATRIC GASTROENTEROLOGY;BRAIN DEVELOPMENT;CFTR;CLINICAL CHARACTERISTICS;DIABETES;INBORN ERRORS OF METABOLISM;MICROSURGICAL RECONSTRUCTION","18;11;11;11;8;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5","CYSTIC FIBROSIS;PEDIATRIC PATIENTS;SARS-COV- INFECTION;CONGENITAL HEART;COVID- PANDEMIC;CLINICAL FEATURES;DRAVET SYNDROME;PAEDIATRIC PATIENTS;PROSPECTIVE STUDY;RETROSPECTIVE STUDY;CANCER RISK;COHORT STUDY;CROHNS DISEASE;DNA METHYLATION;HEART DISEASE;HYPERTROPHIC CARDIOMYOPATHY;IDIOPATHIC ARTHRITIS;INFLAMMATORY BOWEL;INTENSIVE CARE;JUVENILE IDIOPATHIC;LUPUS ERYTHEMATOSUS;PANCREATIC CANCER;PATIENTS AFFECTED;PEDIATRIC PATIENT;PHENOTYPIC SPECTRUM;PROGNOSTIC FACTORS;SHORT BOWEL;SYSTEMIC LUPUS;TYPE DIABETES;BOWEL DISEASE","16;8;7;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3","RESEARCH FUNDING;SARS-COV- INFECTION;ADVISORY COMMITTEES;ENTITYS BOARD;MEDIAN AGE;PEDIATRIC UROLOGY;UROLOGY UNIT;RISK FACTORS;SEVERE COVID-;DNA METHYLATION;INTENSIVE CARE;UNIT DEPARTMENT;CLINICAL MANIFESTATIONS;PUBMED SCOPUS;CLINICAL FEATURES;COVID- PANDEMIC;DE NOVO;MEDIAN FOLLOW-UP;PEDIATRIC PATIENTS;ACUTE RESPIRATORY;ADULT PATIENTS;CLINICAL PRESENTATION;CYSTIC FIBROSIS;PANCREATIC CANCER;PATHOGENIC VARIANTS;RESPIRATORY SYNDROME;SEVERE ACUTE;HEALTH LITERACY;ICU ADMISSION;PAEDIATRIC PATIENTS","36;24;21;21;21;20;19;18;18;16;16;16;15;15;14;13;13;13;13;12;12;12;12;12;12;12;12;11;11;11",209,0.54,6.6,9,1.5,1,0,2.75,0,1,1,9,1,1,9,1,3,2,3,7,4,0,0,35,35,2,0,0,3,0,2,0,0,0,0,0,0,0,2,3,0,5.2,2.34,2.6,0,5,4,0,0,1,0,0,0,0,1,0,0,2,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,"ALEX CHERKASSKIY;BLAS CERDA;FORT ADA;GIANCARLO LA MARCA;MORI FRANCESCA;MUGNAINI MARCO;NOVEMBRE ELIO;PUCCI NERI;ROSSI MARIA ELISABETTA;VIGNOLI VALERIO","2;2;2;2;2;2;2;2;2;2","AZIENDA OSPEDALIERO UNIV MEYER;AZIENDA OSPEDALIERO UNIV MEYER DI FIRENZE;PERKINELMER HEALTH SCI INC;AZIENDA OSPEDALIERO UNIVERSITARIA MEYER DI FIRENZE;DEGLI STUDI DI SIENA, UNIVERSITY OF;PERKINELMER HEALTH SCIENCES INC;UNIV DEGLI STUDI DI FIRENZE;UNIV DEGLI STUDI DI SIENA;UNIVERSITA DEGLI STUDI DI FIRENZE;UNIVERSITA DEGLI STUDI DI SIENA","2;2;2;1;1;1;1;1;1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING","6;3;2;1;1","CLINICAL RESEARCH","1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1","A61K31/185;A61K31/41;B01L99/00;B01L3/00;G01N27/00;G01N33/68","3;3;3;2;2;1","A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833;Y10T436/201666;Y10T436/24;Y10T436/2525","3;3;3;3;3;3;3;3;3;3",19,3.42,420.21,5,9,0.47,55.37,0,0,3,1,9,0,0,6,0,14,5,0,0,0,0,0,0,19,0,0,19,0,0,0,0,0,0,0,0,0,"Denmark;Italy;Japan;France;United States","3;2;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;3208 MEDICAL PHYSIOLOGY;3213 PAEDIATRICS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING;43 HISTORY, HERITAGE AND ARCHAEOLOGY;4303 HISTORICAL STUDIES;5203 CLINICAL AND HEALTH PSYCHOLOGY","18;11;4;4;3;2;1;1;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;PATIENT SAFETY;CANCER;BRAIN DISORDERS;NEUROSCIENCES;CHRONIC PAIN;LUNG;PAIN RESEARCH;PREVENTION;HEADACHES;INFECTIOUS DISEASES;MENTAL HEALTH;MIGRAINES;ORPHAN DRUG;PEDIATRIC CANCER;BEHAVIORAL AND SOCIAL SCIENCE;BIOTECHNOLOGY","18;13;12;9;7;5;4;4;3;3;3;3;2;2;2;2;2;2;1;1","CANCER;INFECTION;BLOOD;CONGENITAL;MENTAL HEALTH;METABOLIC AND ENDOCRINE;NEUROLOGICAL","5;2;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;7.3 MANAGEMENT AND DECISION MAKING","13;2;1;1;1;1;1;1;1","BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;SARCOMA;BRAIN TUMOR;COLON AND RECTAL CANCER;NOT SITE-SPECIFIC CANCER","3;3;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","4;2;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,34,"PUBLIC LIBRARY OF SCIENCE;FRONTIERS;SPRINGER NATURE;ZENODO;KARGER PUBLISHERS;THE OPTICAL SOCIETY","10;8;8;6;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;52 PSYCHOLOGY;4202 EPIDEMIOLOGY;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;51 PHYSICAL SCIENCES;5107 PARTICLE AND HIGH ENERGY PHYSICS;5202 BIOLOGICAL PSYCHOLOGY;3102 BIOINFORMATICS AND COMPUTATIONAL BIOLOGY;3107 MICROBIOLOGY;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;38 ECONOMICS;3801 APPLIED ECONOMICS;4409 SOCIAL WORK;49 MATHEMATICAL SCIENCES","39;13;9;7;6;6;3;2;2;2;2;2;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;GENETICS;RARE DISEASES;NEUROSCIENCES;BRAIN DISORDERS;CANCER;EPILEPSY;HUMAN GENOME;NEURODEGENERATIVE;PATIENT SAFETY;PREVENTION;AUTOIMMUNE DISEASE;DIGESTIVE DISEASES;HEMATOLOGY;NEUROFIBROMATOSIS;PANCREATIC CANCER;PEDIATRIC;REGENERATIVE MEDICINE;TRANSPLANTATION;BEHAVIORAL AND SOCIAL SCIENCE","9;7;7;5;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;1","CANCER;NEUROLOGICAL;INFLAMMATORY AND IMMUNE SYSTEM;CONGENITAL;GENERIC HEALTH RELEVANCE;INFECTION","10;4;3;2;2;2","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;2.4 SURVEILLANCE AND DISTRIBUTION","7;4;2;1","CLINICAL;BIOMEDICAL;HEALTH SERVICES & SYSTEMS","8;4;3","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH;HEALTH SERVICES RESEARCH","22;2;1","BREAST CANCER;LEUKEMIA / LEUKAEMIA;NERVOUS SYSTEM;PANCREATIC CANCER","8;2;2;2","3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_MEYER",2022,393,17.0432569974555,2.93129770992366,0.28498727735369,0.279898218829517,0.366412213740458,2.26771653543307,1.31764705882353,1.92982456140351,1.46938775510204,0.740458015267176,3,174,84,19,10,0.44,0.21,0.05,0.03,7.96,0.89133121131708,5.8819969742814,0.427480916030534,0.977099236641221,0.544,0.479,0.413,0.483,"RENZO GUERRINI;LUISA GALLI;ELISABETTA VENTURINI;AUGUSTO VAGLIO;PAOLA ROMAGNANI;AMELIA MORRONE;GIUSEPPE INDOLFI;SILVIA FAVILLI;SANDRA TRAPANI;SUSANNA ESPOSITO;GABRIELE SIMONINI;MATTIA GIOVANNINI;CHIARA AZZARI;TOMMASO CASINI;VIERI LASTRUCCI;ANNAMARIA STAIANO;ANTONINO MORABITO;CLAUDIO FAVRE;NICOLA PRINCIPI;PAOLO LIONETTI","27;16;15;15;15;14;13;13;12;11;11;11;11;11;11;11;10;10;10;9","MARIAPAOLA GUIDI;PAOLA ROMAGNANI;SANDRA TRAPANI;GIUSEPPE INDOLFI;LUISA GALLI;STEFANO STAGI;RENZO GUERRINI;VITO TERLIZZI;TERESA ORANGES;AMELIA MORRONE;FRANCESCA BECHERUCCI;VIERI LASTRUCCI;LETIZIA DE CHIARA;SILVIA FAVILLI;ELENA LAZZERI;LUIGI CIRILLO;GABRIELE SIMONINI;ANTONINO MORABITO;ZACCARIA RICCI;MATTIA GIOVANNINI","2.2;2.04;1.96;1.74;1.57;1.48;1.46;1.44;1.3;1.26;1.25;1.23;1.22;1.2;1.15;1.11;1.1;1.1;1.1;1.08","RENZO GUERRINI;LUISA GALLI;ELISABETTA VENTURINI;AUGUSTO VAGLIO;PAOLA ROMAGNANI;AMELIA MORRONE;GIUSEPPE INDOLFI;SILVIA FAVILLI;SANDRA TRAPANI;GABRIELE SIMONINI;MATTIA GIOVANNINI;CHIARA AZZARI;TOMMASO CASINI;VIERI LASTRUCCI;ANTONINO MORABITO;CLAUDIO FAVRE;PAOLO LIONETTI;LORENZO LODI;GIOVANNI TACCETTI;NICCOLÓ PARRI","27;16;15;15;15;14;13;13;12;11;11;11;11;11;10;10;9;9;9;9","MARIAPAOLA GUIDI;PAOLA ROMAGNANI;SANDRA TRAPANI;GIUSEPPE INDOLFI;LUISA GALLI;STEFANO STAGI;RENZO GUERRINI;VITO TERLIZZI;TERESA ORANGES;AMELIA MORRONE;FRANCESCA BECHERUCCI;VIERI LASTRUCCI;LETIZIA DE CHIARA;SILVIA FAVILLI;LUIGI CIRILLO;GABRIELE SIMONINI;ANTONINO MORABITO;ZACCARIA RICCI;MATTIA GIOVANNINI;LAURA VAGNOLI","2.2;2.04;1.96;1.74;1.57;1.48;1.46;1.44;1.3;1.26;1.25;1.23;1.22;1.2;1.11;1.1;1.1;1.1;1.08;1.06","RENZO GUERRINI;FERNANDO CENDES;J. HELEN CROSS;CHRISTOPHER A. WALSH;DENNIS LAL;INGMAR BLÜMCKE;JEONG HO LEE;STÉPHANIE BAULAC;ANDRÉ PALMINI;ASSAM EL‐OSTA;DONG ZHOU;ELEONORA ARONICA;ELISEU PAGLIOLI;HAJIME MIYATA;HANS HOLTHAUSEN;HARVEY B. SARNAT;IMAD NAJM;KARL RÖSSLER;KATJA KOBOW;MARIA THOM","585;282;232;197;187;187;187;187;165;165;165;165;165;165;165;165;165;165;165;165","RENZO GUERRINI;GIUSEPPE INDOLFI;ELENA PROCOPIO;MATTEO LENGE;VITO TERLIZZI;AUGUSTO VAGLIO;CARMEN BARBA;GIOVANNI TACCETTI;AMELIA MORRONE;LUISA GALLI;SAMUELA LANDINI;PAOLA ROMAGNANI;STEFANO STAGI;NICCOLÓ PARRI;ELISABETTA VENTURINI;BENEDETTA MAZZINGHI;SONIA TONI;LUCA SCARALLO;ZACCARIA RICCI;GIANCARLO LA MARCA","567;158;129;129;112;108;108;104;96;90;89;87;82;80;79;78;76;72;72;70","RENZO GUERRINI;LUISA GALLI;AUGUSTO VAGLIO;ELISABETTA VENTURINI;PAOLA ROMAGNANI;AMELIA MORRONE;GIUSEPPE INDOLFI;SILVIA FAVILLI;GABRIELE SIMONINI;MATTIA GIOVANNINI;TOMMASO CASINI;VIERI LASTRUCCI;CLAUDIO FAVRE;PAOLO LIONETTI;CHIARA AZZARI;SANDRA TRAPANI;SILVIA RICCI;ANTONINO MORABITO;GIOVANNI TACCETTI;LUCA SCARALLO","26;16;15;15;15;14;13;12;11;11;11;11;10;10;10;10;10;9;9;9","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;PSYCHOLOGY;POLITICAL SCIENCE;MATHEMATICS;SOCIOLOGY;ENGINEERING;ECONOMICS;BUSINESS;PHILOSOPHY;MATERIALS SCIENCE;ART;GEOGRAPHY;HISTORY","360;141;31;31;25;25;22;18;17;15;13;8;7;6;3;3;2","INTERNAL MEDICINE;PEDIATRICS;GENETICS;PATHOLOGY;SURGERY;IMMUNOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;FAMILY MEDICINE;RADIOLOGY;BIOCHEMISTRY;CARDIOLOGY;ENDOCRINOLOGY;LAW;BIOINFORMATICS;NEUROSCIENCE;MICROBIOLOGY;ANESTHESIA","239;112;89;81;80;64;50;39;38;36;33;28;27;27;26;21;20;20;19;18","DISEASE;GENE;COHORT;RETROSPECTIVE COHORT STUDY;POPULATION;PREGNANCY;EPILEPSY;ANTIBIOTICS;ANTIBODY;HEART FAILURE;ADVERSE EFFECT;CANCER;MAGNETIC RESONANCE IMAGING;CYSTIC FIBROSIS;INCIDENCE (GEOMETRY);PROSPECTIVE COHORT STUDY;ALTERNATIVE MEDICINE;DIABETES MELLITUS;HEALTH CARE;OBSERVATIONAL STUDY","87;68;45;35;33;23;20;17;17;17;16;16;16;15;15;13;12;12;12;12","INFECTIOUS DISEASE (MEDICAL SPECIALTY);MUTATION;PHENOTYPE;GESTATIONAL AGE;ANTIBIOTIC PROPHYLAXIS;CARDIOMYOPATHY;FETUS;GENOTYPE;INFLAMMATORY BOWEL DISEASE;VASCULITIS;GENE EXPRESSION;TYPE 1 DIABETES;2019-20 CORONAVIRUS OUTBREAK;ALLELE;COLORECTAL CANCER;CROHN'S DISEASE;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;HEPATITIS C VIRUS;CLINICAL ENDPOINT;DRAVET SYNDROME;EPILEPSY SURGERY;GENOME;HYDRONEPHROSIS;LIVER TRANSPLANTATION;MEASLES;POISSON REGRESSION;PROTOCOL (SCIENCE);RITUXIMAB;SEROLOGY;TEMPORAL LOBE;TYPE 2 DIABETES;VIRAL LOAD","28;22;17;12;11;11;9;8;8;8;7;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;MISSENSE MUTATION;DNA METHYLATION;GRANULOMATOSIS WITH POLYANGIITIS;HIPPOCAMPAL SCLEROSIS;ANTIRETROVIRAL THERAPY;BRENTUXIMAB VEDOTIN;COMPOUND HETEROZYGOSITY;CONGENITAL CENTRAL HYPOVENTILATION SYNDROME;IVACAFTOR;MYH7;PYELOPLASTY;RIBAVIRIN;ALLERGEN IMMUNOTHERAPY;BILIARY ATRESIA;CALPROTECTIN;COLONOSCOPY;CONGENITAL NEUTROPENIA;DYSKINESIA;FENFLURAMINE;GENETIC HETEROGENEITY;GROWTH HORMONE DEFICIENCY;HAPLOINSUFFICIENCY;IFOSFAMIDE;IMMUNOGLOBULIN A;KRAS;LOSS FUNCTION;MACE;MICROSCOPIC POLYANGIITIS;PROBAND;PROCTITIS;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;PTEN;RETINOPATHY OF PREMATURITY;SINGLE-NUCLEOTIDE POLYMORPHISM;SMALL FOR GESTATIONAL AGE;TRANSCRIPTOME;TRINUCLEOTIDE REPEAT EXPANSION;USTEKINUMAB;VACCINATION SCHEDULE","28;13;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;CHILD;FEMALE;RETROSPECTIVE STUDIES;COVID-19;MALE;ADOLESCENT;ADULT;EPILEPSY;INFANT;INFANT, NEWBORN;MUTATION;MAGNETIC RESONANCE IMAGING;DIABETES MELLITUS, TYPE 1;CHILD, PRESCHOOL;TREATMENT OUTCOME;ITALY;PROSPECTIVE STUDIES;SURVEYS AND QUESTIONNAIRES","219;170;108;48;47;44;40;37;32;24;24;23;23;22;21;18;18;17;15;15","EPILEPSY AND SEIZURES;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;STANDARDS AND GUIDELINES FOR GENETIC VARIANT INTERPRETATION;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GLIOMAS;HEPATITIS C INFECTION AND TREATMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PEDIATRIC URINARY TRACT INFECTIONS;PREVENTION AND MANAGEMENT OF SURGICAL SITE INFECTIONS;ROLE OF LUNG ULTRASOUND IN CRITICAL CARE;LYMPHOID NEOPLASMS;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;ANALYSIS OF BRAIN FUNCTIONAL CONNECTIVITY NETWORKS;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE","13;12;11;8;8;7;7;6;6;6;6;6;6;6;5;5;5;5;4;4","PANDEMIC;CARDIAC IMAGING;ETIOLOGY;INTERQUARTILE RANGE;CYSTIC FIBROSIS;CROSS-SECTIONAL STUDY;DIABETES;DISCONTINUATION;EPILEPSY;TREATMENT;TYPE 1 DIABETES;2019-20 CORONAVIRUS OUTBREAK;REGIMEN;SURGICAL SITE INFECTION;DELPHI METHOD;EXOME;HEPATITIS C;HUMAN INBORN ERRORS;REFRACTORY (PLANETARY SCIENCE);STATUS EPILEPTICUS","21;13;9;9;8;7;7;7;7;7;7;6;6;6;5;5;5;5;5;5","COHORT STUDY;CYSTIC FIBROSIS;APPROPRIATENESS METHOD;CONSENSUS STUDY;METHOD CONSENSUS;RANDUCLA APPROPRIATENESS;ANTIMICROBIAL PROPHYLAXIS;RETROSPECTIVE STUDY;COVID- PANDEMIC;MULTICENTER STUDY;TYPE DIABETES;PEDIATRIC PATIENTS;SURGICAL ANTIMICROBIAL;HYPERTROPHIC CARDIOMYOPATHY;ITALIAN SOCIETY;NATURAL HISTORY;NEWBORN SCREENING;PROSPECTIVE STUDY;THALASSEMIA MAJOR;ACUTE KIDNEY;HEALTH LITERACY;HODGKIN LYMPHOMA;KIDNEY DISEASES;KIDNEY INJURY;LONG-TERM OUTCOME;PAEDIATRIC PATIENTS;PEDIATRIC AGE;RETROSPECTIVE COHORT;ADULT PATIENTS;BRENTUXIMAB VEDOTIN","12;10;9;9;9;9;8;8;7;7;7;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;3;3","GENETIC TESTING;MEDIAN AGE;PEDIATRIC PATIENTS;COVID- PANDEMIC;BOLOGNA ITALY;RISK FACTORS;CYSTIC FIBROSIS;MAGNETIC RESONANCE;GENETIC DIAGNOSIS;HEALTH CARE;IRR CI;ADVERSE EVENTS;INCREASED RISK;INFLUENZA VACCINATION;ITALY VP;MB LP;MG FP;SURGICAL PROCEDURES;VP CC;AZIENDA OSPEDALIERO-UNIVERSITARIA;DE NOVO;DI BOLOGNA;IRCCS AZIENDA;OSPEDALIERO-UNIVERSITARIA DI;UNIT IRCCS;CARDIOLOGY UNIT;HEART FAILURE;INTENSIVE CARE;KIDNEY DISEASE;ADULT PATIENTS","38;26;26;20;19;19;18;18;17;16;16;15;15;15;15;15;15;15;15;14;14;14;14;14;14;13;13;13;13;12",231,0.59,9.28,11,1,1,0,6.5,1,1,1.5,13,1.5,1,10.25,1,1,1,4,8,5,0,0,22,22,1,0,0,1,0,1,0,0,0,0,0,0,0,1,1,0,4,0.69,2,0,2,2,0,0,0,0,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0,0,0,0,0,0,0,0,1,0,0,0,"CERDA BLAS;CHERKASSKIY ALEX;LA MARCA GIANCARLO;LI YIJUN","2;2;2;2","AZIENDA OSPEDALIERO UNIV MEYER DI FIRENZE;PERKINELMER HEALTH SCI INC;PERKINELMER HEALTH SCIENCES INC","2;1;1","34 CHEMICAL SCIENCES;3401 ANALYTICAL CHEMISTRY","4;2",NA,NA,NA,NA,"A61K31/185;A61K31/41;B01L99/00;G01N33/68","2;2;2;2","A61P3/00;G01N2800/04;G01N2800/50;G01N33/64;G01N33/6848;Y10T436/147777;Y10T436/200833;Y10T436/201666;Y10T436/24;Y10T436/2525","2;2;2;2;2;2;2;2;2;2",12,3.67,261.42,2.5,7,0.58,78.83,1,0,0,0,10,0,0,1,0,11,1,0,0,0,0,0,0,12,0,0,12,0,0,0,0,0,0,0,0,0,"United States;Germany;Japan","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;52 PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;5202 BIOLOGICAL PSYCHOLOGY","12;6;2;2;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;RARE DISEASES;NEUROSCIENCES;BRAIN DISORDERS;NEURODEGENERATIVE;EPILEPSY;LUNG;CYSTIC FIBROSIS;PATIENT SAFETY;ORPHAN DRUG;PREVENTION;TUBEROUS SCLEROSIS;AGING;AUTOIMMUNE DISEASE;CANCER;CHRONIC PAIN;GENETICS;HEADACHES","12;10;9;7;6;5;5;4;4;3;3;2;2;2;1;1;1;1;1;1","NEUROLOGICAL;CONGENITAL;CANCER;RESPIRATORY","3;2;1;1","6.1 PHARMACEUTICALS","10","BRAIN TUMOR;LEUKEMIA / LEUKAEMIA;LUNG CANCER;NON-HODGKIN'S LYMPHOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;SPRINGER NATURE","10;5;3","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3208 MEDICAL PHYSIOLOGY;37 EARTH SCIENCES;3105 GENETICS;42 HEALTH SCIENCES;36 CREATIVE ARTS AND WRITING;3701 ATMOSPHERIC SCIENCES;3704 GEOINFORMATICS;4203 HEALTH SERVICES AND SYSTEMS","25;9;5;3;3;2;2;1;1;1;1","PEDIATRIC;CLINICAL RESEARCH;RARE DISEASES;GENETICS;AUTOIMMUNE DISEASE;HEMATOLOGY;PREVENTION;BIODEFENSE;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIABETES;DIGESTIVE DISEASES;INFECTIOUS DISEASES;LUNG;ORPHAN DRUG;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;TUBERCULOSIS;VACCINE RELATED","9;8;8;7;6;6;3;1;1;1;1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;CONGENITAL;INFECTION;METABOLIC AND ENDOCRINE","7;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS","2;1","BIOMEDICAL;CLINICAL;HEALTH SERVICES & SYSTEMS","7;1;1","CLINICAL MEDICINE AND SCIENCE;PUBLIC HEALTH","14;1",NA,NA,"3 GOOD HEALTH AND WELL BEING","1"
"IRCCS_MEYER",2023,400,19.0025,3.1875,0.3075,0.37,0.3525,2.73019271948608,1.30851063829787,2.38709677419355,1.42424242424242,0.6975,2,179,69,25,31,0.45,0.17,0.06,0.08,4.16,0.948531866745823,5.52892561983472,0.4075,0.95,0.543,0.433,0.404,0.441,"RENZO GUERRINI;GABRIELE SIMONINI;IACOPO OLIVOTTO;GIOVANNI TACCETTI;VITO TERLIZZI;FLAVIO GIORDANO;AUGUSTO VAGLIO;PAOLA ROMAGNANI;EDOARDO MARRANI;FRANCESCA MORI;LUISA GALLI;DAVIDE MEI;LORENZO GENITORI;GIUSEPPE INDOLFI;MATTIA GIOVANNINI;ILARIA MACCORA;GIACOMO EMMI;MAURA CALVANI;ANTONINO MORABITO;MARIA VINCENZA MASTROLIA","28;28;26;19;15;15;14;14;14;13;13;13;13;12;12;12;12;11;11;11","IACOPO OLIVOTTO;SANDRA TRAPANI;GABRIELE SIMONINI;PAOLA ROMAGNANI;VITO TERLIZZI;RENZO GUERRINI;FRANCESCA MORI;LUISA GALLI;GIOVANNI TACCETTI;ANTONINO MORABITO;LORENZO GENITORI;ZACCARIA RICCI;MAURA CALVANI;ILARIA MACCORA;EDOARDO MARRANI;ELENA CHIAPPINI;LUIGI CIRILLO;FLAVIO GIORDANO;ELENA LAZZERI;GIUSEPPE INDOLFI","3.03;2.6;2.44;1.9;1.78;1.76;1.76;1.71;1.58;1.54;1.54;1.49;1.48;1.46;1.43;1.38;1.37;1.34;1.23;1.22","RENZO GUERRINI;GABRIELE SIMONINI;IACOPO OLIVOTTO;GIOVANNI TACCETTI;VITO TERLIZZI;FLAVIO GIORDANO;AUGUSTO VAGLIO;PAOLA ROMAGNANI;EDOARDO MARRANI;FRANCESCA MORI;LUISA GALLI;DAVIDE MEI;LORENZO GENITORI;GIUSEPPE INDOLFI;MATTIA GIOVANNINI;ILARIA MACCORA;MAURA CALVANI;ANTONINO MORABITO;MARIA VINCENZA MASTROLIA;ZACCARIA RICCI","28;28;26;19;15;15;14;14;14;13;13;13;13;12;12;12;11;11;11;11","IACOPO OLIVOTTO;SANDRA TRAPANI;GABRIELE SIMONINI;PAOLA ROMAGNANI;VITO TERLIZZI;RENZO GUERRINI;FRANCESCA MORI;LUISA GALLI;GIOVANNI TACCETTI;ANTONINO MORABITO;LORENZO GENITORI;ZACCARIA RICCI;MAURA CALVANI;ILARIA MACCORA;EDOARDO MARRANI;ELENA CHIAPPINI;LUIGI CIRILLO;FLAVIO GIORDANO;GIUSEPPE INDOLFI;MARIA VINCENZA MASTROLIA","3.03;2.6;2.44;1.9;1.78;1.76;1.76;1.71;1.58;1.54;1.54;1.49;1.48;1.46;1.43;1.38;1.37;1.34;1.22;1.2","AUGUSTO VAGLIO;RENZO GUERRINI;SARA MONTI;BENJAMIN TERRIER;MARÍA C. CID;PETER A. MERKEL;ALVISE BERTI;DAVID JAYNE;ÖMER KARADAĞ;ALFRED MAHR;BERNHARD HELLMICH;ALADDIN J MOHAMMAD;ANDREAS KRONBICHLER;BEATRIZ SÁNCHEZ‐ÁLAMO;CHETAN MUKHTYAR;DANIËL BLOCKMANS;DIMITRIOS VASSILOPOULOS;FIONA PRICE-KUEHNE;GUNNAR TÓMASSON;JACEK MUSIAŁ","290;278;255;247;238;238;237;237;236;232;232;228;228;228;228;228;228;228;228;228","AUGUSTO VAGLIO;RENZO GUERRINI;MATTIA GIOVANNINI;VALERIO CONTI;IACOPO OLIVOTTO;PAOLA ROMAGNANI;DAVIDE MEI;SIMONA BARNI;GABRIELE SIMONINI;ZACCARIA RICCI;SIMONA BALESTRINI;VITO TERLIZZI;FRANCESCA GIROLAMI;LUISA GALLI;LUIGI CIRILLO;GIOVANNI TACCETTI;DANIELA DOLCE;MARIA ALICE DONATI;BENEDETTA MAZZINGHI;GIUSEPPE INDOLFI","290;271;201;148;124;94;83;77;76;75;72;59;54;54;50;44;34;34;33;32","IACOPO OLIVOTTO;RENZO GUERRINI;GABRIELE SIMONINI;GIOVANNI TACCETTI;VITO TERLIZZI;EDOARDO MARRANI;FLAVIO GIORDANO;PAOLA ROMAGNANI;AUGUSTO VAGLIO;DAVIDE MEI;FRANCESCA MORI;LUISA GALLI;LORENZO GENITORI;ANNA MARIA BUCCOLIERO;ILARIA PAGNINI;MARIA VINCENZA MASTROLIA;MATTIA GIOVANNINI;MAURA CALVANI;ANTONINO MORABITO;ILARIA MACCORA","32;27;26;19;15;14;14;14;13;13;13;13;12;11;11;11;11;11;10;10","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;CHEMISTRY;PHYSICS;ECONOMICS;ENGINEERING;MATHEMATICS;SOCIOLOGY;POLITICAL SCIENCE;BUSINESS;PHILOSOPHY;MATERIALS SCIENCE;ART;GEOGRAPHY;HISTORY","375;130;31;28;22;21;19;14;13;12;10;6;6;3;2;2;1","INTERNAL MEDICINE;PEDIATRICS;PATHOLOGY;GENETICS;SURGERY;IMMUNOLOGY;PSYCHIATRY;CARDIOLOGY;GASTROENTEROLOGY;INTENSIVE CARE MEDICINE;ENVIRONMENTAL HEALTH;RADIOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;CANCER RESEARCH;DERMATOLOGY;CELL BIOLOGY;ANESTHESIA;FAMILY MEDICINE;NEUROSCIENCE;NURSING","268;110;99;77;70;59;51;49;48;47;37;30;29;27;26;25;21;18;18;18;18","DISEASE;GENE;COHORT;POPULATION;RETROSPECTIVE COHORT STUDY;HEART FAILURE;CYSTIC FIBROSIS;EPILEPSY;CANCER;HYPERTROPHIC CARDIOMYOPATHY;ADVERSE EFFECT;RECEPTOR;CHEMOTHERAPY;ASYMPTOMATIC;COHORT STUDY;HEALTH CARE;IMMUNE SYSTEM;MAGNETIC RESONANCE IMAGING;PREGNANCY;ALTERNATIVE MEDICINE;BLOOD PRESSURE;LUNG","111;61;52;37;37;27;23;23;20;19;18;15;14;13;13;13;13;13;13;12;12;12","PHENOTYPE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);MUTATION;CARDIOMYOPATHY;INFLAMMATORY BOWEL DISEASE;VASCULITIS;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;ULCERATIVE COLITIS;CLINICAL ENDPOINT;GENOTYPE;SWEAT TEST;2019-20 CORONAVIRUS OUTBREAK;ANAKINRA;COLORECTAL CANCER;CROHN'S DISEASE;DRAVET SYNDROME;ENZYME REPLACEMENT THERAPY;FETUS;NEUROBLASTOMA;PLACEBO","20;18;18;17;10;10;8;7;6;6;6;5;5;5;5;5;5;5;5;5","CORONAVIRUS DISEASE 2019 (COVID-19);EXOME SEQUENCING;GRANULOMATOSIS WITH POLYANGIITIS;MISSENSE MUTATION;IVACAFTOR;PENETRANCE;ERDHEIM–CHESTER DISEASE;HERPESVIRIDAE;SINGLE-NUCLEOTIDE POLYMORPHISM;ANAPLASTIC ASTROCYTOMA;ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY;CALPROTECTIN;COLONOSCOPY;MEPOLIZUMAB;MICROSCOPIC POLYANGIITIS;PRENATAL DIAGNOSIS;PROBAND;PROCTITIS;VINORELBINE;ACID SPHINGOMYELINASE;ANAPLASTIC LYMPHOMA KINASE;CANAKINUMAB;CONGENITAL DIAPHRAGMATIC HERNIA;CONGENITAL NEUTROPENIA;COPY-NUMBER VARIATION;DOPPLER ECHOCARDIOGRAPHY;DYSKINESIA;FENFLURAMINE;GENOTYPE-PHENOTYPE DISTINCTION;GERMLINE MUTATION;HAPLOINSUFFICIENCY;HUMAN GENOME;IDIOPATHIC SHORT STATURE;INDUCED PLURIPOTENT STEM CELL;KARYOTYPE;LOSS FUNCTION;MEK INHIBITOR;PANCREATIC DUCTAL ADENOCARCINOMA;PHENOCOPY;PODOCYTE;POLYPLOID;PRIMARY CILIARY DYSKINESIA;PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS;RIBAVIRIN;SYNOVIAL FLUID;TRAMETINIB;UNDERWEIGHT;UREA CYCLE;USTEKINUMAB;VEDOLIZUMAB;VINCRISTINE;WHOLE GENOME SEQUENCING","18;9;7;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;CHILD;FEMALE;RETROSPECTIVE STUDIES;MALE;ADULT;ADOLESCENT;ITALY;COVID-19;CHILD, PRESCHOOL;MAGNETIC RESONANCE IMAGING;INFANT, NEWBORN;INFANT;MUTATION;CYSTIC FIBROSIS;EPILEPSY;TREATMENT OUTCOME;ANIMALS;INFLAMMATORY BOWEL DISEASES","203;189;93;48;48;36;30;26;26;24;21;18;17;16;16;15;15;14;13;12","DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;EPILEPSY AND SEIZURES;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;GLIOMAS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;METABOLIC DISORDERS AND BIOCHEMICAL GENETICS;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;DIAGNOSIS AND MANAGEMENT OF KAWASAKI DISEASE;CLASSIFICATION AND TREATMENT OF HISTIOCYTIC DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;SARCOMA RESEARCH AND TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF CYTOMEGALOVIRUS INFECTION;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY INJURY","19;19;14;11;11;9;9;9;8;8;6;6;5;5;5;5;4;4;4;4","CARDIAC IMAGING;CYSTIC FIBROSIS;PANDEMIC;TREATMENT;CONCOMITANT;DILATED CARDIOMYOPATHY;ETIOLOGY;INTERQUARTILE RANGE;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;GRANULOMATOSIS WITH POLYANGIITIS;JUVENILE IDIOPATHIC ARTHRITIS;CLINICAL ENDPOINT;DISCONTINUATION;INBORN ERRORS OF METABOLISM;PHENOTYPE ANALYSIS;REFRACTORY (PLANETARY SCIENCE);SINGLE CENTER;SWEAT TEST;2019-20 CORONAVIRUS OUTBREAK;CARDIAC METABOLISM","17;15;12;11;9;9;8;8;8;7;7;6;6;6;6;6;6;6;5;5","CYSTIC FIBROSIS;HYPERTROPHIC CARDIOMYOPATHY;COHORT STUDY;STILLS DISEASE;INFLAMMATORY BOWEL;MULTICENTER STUDY;PEDIATRIC PATIENTS;ACUTE KIDNEY;BOWEL DISEASE;CLINICAL PRACTICE;DISEASE ACTIVITY;DRAVET SYNDROME;EOSINOPHILIC GRANULOMATOSIS;IDIOPATHIC ARTHRITIS;JUVENILE IDIOPATHIC;KIDNEY INJURY;AIDA NETWORK;CLINICAL FEATURES;CLUSTER ANALYSIS;COVID- PANDEMIC;CRITICALLY ILL;CROHNS DISEASE;IBD PORTO;ITALIAN EXPERIENCE;ITALIAN REGISTRY;OBSTRUCTIVE HYPERTROPHIC;RETROSPECTIVE MULTICENTER;TUBULAR CELLS;CHILDHOOD CHRONIC;CLINICAL OUTCOMES","21;15;9;7;6;6;6;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;3;3","LEFT VENTRICULAR;MEDIAN AGE;CLINICAL PRACTICE;DISEASE ACTIVITY;PEDIATRIC PATIENTS;PATIENTS TREATED;ADVERSE EVENTS;CLINICAL FEATURES;POLYPLOID TC;RISK FACTORS;HYPERTROPHIC CARDIOMYOPATHY;STILLS DISEASE;SIGNIFICANT DIFFERENCES;MEDIAN IQR;NYHA CLASS;FLUID BALANCE;HCM PATIENTS;MAGNETIC RESONANCE;STATISTICALLY SIGNIFICANT;BRISTOL MYERS;CARDIOMYOPATHY HCM;CLINICAL PRESENTATION;CORONARY ARTERY;COVID- PANDEMIC;CYSTIC FIBROSIS;DRAVET SYNDROME;EJECTION FRACTION;GENETIC TESTING;HEART FAILURE;PATHOGENIC VARIANTS","38;38;22;22;22;21;19;19;19;19;17;17;15;14;14;13;13;13;13;12;12;12;12;12;12;12;12;12;12;12",205,0.51,8,9,1,1.5,0,3,0,1,1,10,1,1,8.75,1,1,2,4,6,6,0,0,9,9,1,0,0,2,0,0,0,0,0,0,0,0,1,0,1,0,5,0.78,4,0,2,2,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,"ANCONA ANDREA;CAUDA VALENTINA;RICCI ZACCARIA;ROMAGNOLI STEFANO;VILLA GIANLUCA","2;2;2;2;2","AZIENDA OSPEDALIERO UNIV MEYER;TORINO POLITECNICO;AZIENDA OSPEDALIERO UNIV CAREGGI;AZIENDA OSPEDALIERO UNIV DI CAREGGI;UNIV DEGLI STUDI DI FIRENZE;UNIVERSITA’ DEGLI STUDI DI FIRENZE","2;2;1;1;1;1","31 BIOLOGICAL SCIENCES;3101 BIOCHEMISTRY AND CELL BIOLOGY;32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","3;1;1;1","CLINICAL RESEARCH","1",NA,NA,"A61M1/36;A61B5/00;A61M1/16;A61M1/34;G01N1/14;G01N35/10","2;1;1;1;1;1","A61B2562/0219;A61B2562/0261;A61B2562/0271;A61B5/14546;A61B5/6866;A61M1/1609;A61M1/1619;A61M1/3413;A61M1/361;A61M1/3612","2;2;2;2;2;2;2;2;2;2",6,4.5,175.5,1.35,0,0,45.5,0,0,0,1,4,0,0,1,0,6,0,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,"United States;Denmark;Ireland;Italy","4;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","6;4;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;PATIENT SAFETY;AUTOIMMUNE DISEASE;NEUROSCIENCES;NUTRITION;PREVENTION;BRAIN DISORDERS;CARDIOVASCULAR;CHRONIC PAIN;COMPLEMENTARY AND INTEGRATIVE HEALTH;CROHN'S DISEASE;HEADACHES;HEART DISEASE;MIGRAINES;PAIN RESEARCH","6;6;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1","ORAL AND GASTROINTESTINAL;CARDIOVASCULAR;INFECTION;NEUROLOGICAL","3;1;1;1","6.1 PHARMACEUTICALS","5","COLON AND RECTAL CANCER","1","3.3 CHEMOPREVENTION;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"FRONTIERS;PUBLIC LIBRARY OF SCIENCE;TAYLOR & FRANCIS GROUP","3;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3204 IMMUNOLOGY;3207 MEDICAL MICROBIOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;42 HEALTH SCIENCES","10;3;1;1;1;1","CLINICAL RESEARCH;NEURODEGENERATIVE;PEDIATRIC;AGING;DIABETES;EYE DISEASE AND DISORDERS OF VISION;HIV/AIDS;INFECTIOUS DISEASES;KIDNEY DISEASE;NEUROSCIENCES;RARE DISEASES","2;2;2;1;1;1;1;1;1;1;1","EYE;INFECTION;METABOLIC AND ENDOCRINE;RENAL AND UROGENITAL","1;1;1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;6.1 PHARMACEUTICALS","1;1","CLINICAL;BIOMEDICAL;HEALTH SERVICES & SYSTEMS","2;1;1","CLINICAL MEDICINE AND SCIENCE;BASIC SCIENCE","2;1",NA,NA,NA,NA
"IRCCS_MEYER",2024,397,20.3274559193955,2.89420654911839,0.244332493702771,0.272040302267003,0.289672544080605,2.77294685990338,1.29333333333333,2.11764705882353,1.35294117647059,0.659949622166247,0,203,66,25,21,0.51,0.17,0.06,0.05,0.97,1.01735647485947,4.57799381352187,0.445843828715365,0.984886649874055,0.513,0.486,0.467,0.467,"IACOPO OLIVOTTO;RENZO GUERRINI;GABRIELE SIMONINI;MATTIA GIOVANNINI;AUGUSTO VAGLIO;GIUSEPPE INDOLFI;LUCA SCARALLO;FRANCESCA MORI;ANJALI OWENS;PAOLA ROMAGNANI;MARTIN S. MARON;ROBERTO BARRIALES‐VILLA;STEPHEN B. HEITNER;PABLO GARCÍA‐PAVÍA;AHMAD MASRI;FADY I. MALIK;FLAVIO GIORDANO;STUART KUPFER;ANNALISA TONDO;DANIEL JACOBY","33;20;20;20;18;16;16;15;15;14;14;13;13;13;13;13;13;13;12;12","IACOPO OLIVOTTO;GABRIELE SIMONINI;GIUSEPPE INDOLFI;RENZO GUERRINI;PAOLA ROMAGNANI;AUGUSTO VAGLIO;MATTIA GIOVANNINI;ANNALISA TONDO;ILARIA MACCORA;LORENZO GENITORI;FRANCESCA MORI;ELENA LAZZERI;STEFANO STAGI;LUIGI CIRILLO;SANDRA TRAPANI;LUCA SCARALLO;LETIZIA DE CHIARA;MAURA CALVANI;MIRKO SCAGNET;SILVIA RICCI","2.21;2.03;1.94;1.92;1.87;1.55;1.52;1.34;1.23;1.2;1.15;1.14;1.11;1.09;1.05;1.04;0.98;0.92;0.88;0.87","IACOPO OLIVOTTO;RENZO GUERRINI;GABRIELE SIMONINI;MATTIA GIOVANNINI;AUGUSTO VAGLIO;GIUSEPPE INDOLFI;LUCA SCARALLO;FRANCESCA MORI;PAOLA ROMAGNANI;FLAVIO GIORDANO;ANNALISA TONDO;SIMONA BARNI;SILVIA RICCI;SANDRA TRAPANI;ZACCARIA RICCI;LORENZO GENITORI;IACOPO SARDI;AMELIA MORRONE;CHIARA AZZARI;STEFANO STAGI","33;20;20;20;18;16;16;15;14;13;12;11;11;10;10;10;9;9;9;9","IACOPO OLIVOTTO;GABRIELE SIMONINI;GIUSEPPE INDOLFI;RENZO GUERRINI;PAOLA ROMAGNANI;AUGUSTO VAGLIO;MATTIA GIOVANNINI;ANNALISA TONDO;ILARIA MACCORA;LORENZO GENITORI;FRANCESCA MORI;STEFANO STAGI;LUIGI CIRILLO;SANDRA TRAPANI;LUCA SCARALLO;MAURA CALVANI;MIRKO SCAGNET;SILVIA RICCI;SIMONA BARNI;AMADA PASHA","2.21;2.03;1.94;1.92;1.87;1.55;1.52;1.34;1.23;1.2;1.15;1.11;1.09;1.05;1.04;0.92;0.88;0.87;0.85;0.84","IACOPO OLIVOTTO;AHMAD MASRI;THEODORE P. ABRAHAM;ANJALI OWENS;PABLO GARCÍA‐PAVÍA;LUBNA CHOUDHURY;SARA SABERI;ARTUR ORĘZIAK;SHEILA M. HEGDE;FLORIAN RADER;MARGARET ROSENFELD;MARTIN S. MARON;DANIEL JACOBY;FADY I. MALIK;LISA MENG;STEPHEN B. HEITNER;STUART KUPFER;AMY WOHLTMAN;CAROLINE COATS;TIM SEIDLER","80;46;46;39;38;36;35;34;33;29;27;27;26;26;26;26;26;25;25;25","IACOPO OLIVOTTO;GIOVANNI TACCETTI;MATTIA GIOVANNINI;FRANCESCA BECHERUCCI;RENZO GUERRINI;GIUSEPPE INDOLFI;LUIGI CIRILLO;SAMANTHA INNOCENTI;MATTIA TARGETTI;SIMONA BALESTRINI;PAOLA ROMAGNANI;DAVIDE MEI;GIACOMO MARIA BACCI;IDANNA SFORZI;ZACCARIA RICCI;CLAUDIA CALOGERO;LUCIA TIBERI;SANDRA TRAPANI;VIVIANA PALAZZO;CARMEN BARBA","74;23;20;18;18;17;15;15;13;13;12;11;11;11;11;10;10;10;10;9","IACOPO OLIVOTTO;RENZO GUERRINI;MATTIA GIOVANNINI;GABRIELE SIMONINI;AUGUSTO VAGLIO;GIUSEPPE INDOLFI;LUCA SCARALLO;FRANCESCA MORI;PAOLA ROMAGNANI;CHIARA AZZARI;FLAVIO GIORDANO;SIMONA BARNI;PAOLO LIONETTI;SANDRA TRAPANI;SILVIA RICCI;ZACCARIA RICCI;CARMEN BARBA;AMELIA MORRONE;IACOPO SARDI;LORENZO GENITORI","36;20;20;20;18;16;16;15;14;11;11;11;10;10;10;10;9;9;9;9","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;PHYSICS;CHEMISTRY;MATHEMATICS;ECONOMICS;SOCIOLOGY;PHILOSOPHY;ENGINEERING;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;ART;GEOLOGY;ENVIRONMENTAL SCIENCE;HISTORY","369;101;36;31;29;28;23;17;17;16;14;14;6;4;3;2;2;1;1","INTERNAL MEDICINE;PEDIATRICS;PATHOLOGY;IMMUNOLOGY;SURGERY;GENETICS;INTENSIVE CARE MEDICINE;CARDIOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;RADIOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;CANCER RESEARCH;DERMATOLOGY;ENDOCRINOLOGY;ONCOLOGY;CELL BIOLOGY;NEUROSCIENCE","255;102;87;63;63;62;51;48;38;30;26;26;21;19;18;18;18;17;16;16","DISEASE;GENE;COHORT;HEART FAILURE;HYPERTROPHIC CARDIOMYOPATHY;EPILEPSY;RETROSPECTIVE COHORT STUDY;MAGNETIC RESONANCE IMAGING;POPULATION;ALTERNATIVE MEDICINE;ALLERGY;CANCER;ADVERSE EFFECT;ANTIBODY;CONFIDENCE INTERVAL;COHORT STUDY;HEALTH CARE;KIDNEY;RANDOMIZED CONTROLLED TRIAL;CHEMOTHERAPY;CYSTIC FIBROSIS","94;48;35;30;24;21;21;20;20;18;16;16;15;15;14;13;13;13;13;12;12","CARDIOMYOPATHY;PHENOTYPE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLAMMATORY BOWEL DISEASE;OBSTRUCTIVE CARDIOMYOPATHY;VASCULITIS;PLACEBO;EJECTION FRACTION;ALLELE;FOOD ALLERGY;GENOTYPE;CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;HAZARD RATIO;MUTATION;PROGENITOR CELL;CARDIAC MAGNETIC RESONANCE;CARDIAC MAGNETIC RESONANCE IMAGING;EPILEPSY SURGERY;GENE EXPRESSION;HEMATOPOIETIC STEM CELL TRANSPLANTATION;IMMUNOGLOBULIN E;LUPUS NEPHRITIS;MACROPHAGE ACTIVATION SYNDROME","21;21;13;11;11;11;10;9;8;8;8;7;7;7;6;5;5;5;5;5;5;5;5","CORONAVIRUS DISEASE 2019 (COVID-19);IVACAFTOR;ANCA-ASSOCIATED VASCULITIS;MISSENSE MUTATION;EXOME SEQUENCING;INFLAMMATORY BOWEL DISEASES;GRANULOMATOSIS WITH POLYANGIITIS;SINGLE-NUCLEOTIDE POLYMORPHISM;ALCOHOL SEPTAL ABLATION;DISEASE MANAGEMENT;ERDHEIM–CHESTER DISEASE;LOSS FUNCTION;PODOCYTE;ABATACEPT;CILIOPATHIES;CILIOPATHY;COMPOUND HETEROZYGOSITY;COPY-NUMBER VARIATION;DNA METHYLATION;ENHANCER;GENOTYPE-PHENOTYPE DISTINCTION;GLOBAL DEVELOPMENTAL DELAY;HAPLOINSUFFICIENCY;HEMATOPOIETIC STEM CELL;HETEROZYGOTE ADVANTAGE;HIPPOCAMPAL SCLEROSIS;IMMUNOGLOBULIN D;LOSS OF HETEROZYGOSITY;MICROSCOPIC POLYANGIITIS;MILK ALLERGY;OMALIZUMAB;PEANUT ALLERGY;PRIMARY CILIARY DYSKINESIA;PROBAND;VO2 MAX","13;7;6;6;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;CHILD;MALE;FEMALE;ADOLESCENT;CHILD, PRESCHOOL;RETROSPECTIVE STUDIES;INFANT;ITALY;ADULT;MIDDLE AGED;TREATMENT OUTCOME;YOUNG ADULT;INFANT, NEWBORN;PROSPECTIVE STUDIES;SURVEYS AND QUESTIONNAIRES;MAGNETIC RESONANCE IMAGING;COVID-19;EPILEPSY","225;168;97;93;91;63;56;39;37;35;34;21;20;17;13;13;13;12;11;11","DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;EPILEPSY AND SEIZURES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF FOOD ALLERGY;EPIDEMIOLOGY AND MANAGEMENT OF OCULAR INFLAMMATORY DISEASES;CLASSIFICATION AND MANAGEMENT OF VASCULITIDES;EPIDEMIOLOGY AND PATHOGENESIS OF RESPIRATORY VIRAL INFECTIONS;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND RELATED DISORDERS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;SARCOMA RESEARCH AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;MOLECULAR BASIS OF RETT SYNDROME AND RELATED DISORDERS;PATHOPHYSIOLOGY OF GLOMERULAR DISEASES AND NEPHROTIC SYNDROMES;ALLERGIC RHINITIS AND ITS IMPACT ON ASTHMA;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;GLIOMAS;HYPERSENSITIVITY REACTIONS TO DRUGS AND MEDICATIONS;MANAGEMENT AND OUTCOMES OF ACUTE KIDNEY INJURY","25;12;10;10;9;9;8;8;8;8;7;7;6;6;6;5;5;5;5;5","CARDIAC IMAGING;EPILEPSY;DILATED CARDIOMYOPATHY;FOOD ALLERGY;CARDIAC REMODELING;SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;CLINICAL OUTCOMES;DELPHI METHOD;ETIOLOGY;TREATMENT;ANCA-ASSOCIATED VASCULITIS;BRAIN DEVELOPMENT;CARDIAC RESYNCHRONIZATION THERAPY;CENTER (CATEGORY THEORY);CROSS-SECTIONAL STUDY;CYSTIC FIBROSIS;INTERQUARTILE RANGE;IVACAFTOR;PANDEMIC","15;11;9;9;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6","HYPERTROPHIC CARDIOMYOPATHY;OBSTRUCTIVE HYPERTROPHIC;PEDIATRIC PATIENTS;CYSTIC FIBROSIS;INFLAMMATORY BOWEL;COHORT STUDY;MAGNETIC RESONANCE;MULTICENTER STUDY;BOWEL DISEASE;JUVENILE IDIOPATHIC;IDIOPATHIC ARTHRITIS;LUPUS NEPHRITIS;MULTICENTRE STUDY;REPLACEMENT THERAPY;ANCA-ASSOCIATED VASCULITIS;CARDIAC MAGNETIC;CLINICAL FEATURES;CLINICAL MANAGEMENT;EWING SARCOMA;FOOD ALLERGY;HEMATOPOIETIC STEM;ITALIAN SOCIETY;LONG-TERM OUTCOMES;PHASE II;POSITION PAPER;PROSPECTIVE STUDY;RESONANCE IMAGING;RETROSPECTIVE STUDY;ADULT PATIENTS;ASSESS QUALITY","23;15;11;9;8;7;7;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3","MEDIAN AGE;KIDNEY BIOPSY;KIDNEY DISEASE;HYPERTROPHIC CARDIOMYOPATHY;LEFT VENTRICULAR;LUNG FUNCTION;PEDIATRIC PATIENTS;ADVERSE EVENTS;CYSTIC FIBROSIS;DISEASE ACTIVITY;HR CI;CLINICAL FEATURES;CONFIDENCE INTERVAL;EPILEPSY SURGERY;FOOD ALLERGY;KIDNEY FUNCTION;MAGNETIC RESONANCE;PUBMED SCOPUS;REGRESSION ANALYSIS;HEMATOPOIETIC STEM;LUNG TRANSPLANTATION;OBSTRUCTIVE HYPERTROPHIC;RETROSPECTIVE STUDY;RISK FACTORS;ABSTRACT OBJECTIVE;DISEASE ONSET;EMERGENCY DEPARTMENT;FLUID OVERLOAD;HEALTHCARE WORKERS;HEART FAILURE","24;21;19;17;17;15;15;13;13;13;13;12;12;12;12;12;12;12;12;11;11;11;11;11;10;10;10;10;10;10",5,0.01,1,3,0,0,0,1,0,1,0,3,0,0,4.25,0,0,0,2,3,1,0,0,1,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
